BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Weng AP, Ferrando AA, Lee W, Morris JP, Silverman LB, Sanchez-Irizarry C, Blacklow SC, Look AT, Aster JC. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science. 2004;306:269-271. [PMID: 15472075 DOI: 10.1126/science.1102160] [Cited by in Crossref: 1917] [Cited by in F6Publishing: 1785] [Article Influence: 106.5] [Reference Citation Analysis]
Number Citing Articles
1 Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA, Kinzler KW. Cancer genome landscapes. Science. 2013;339:1546-1558. [PMID: 23539594 DOI: 10.1126/science.1235122] [Cited by in Crossref: 4552] [Cited by in F6Publishing: 3999] [Article Influence: 505.8] [Reference Citation Analysis]
2 Minato Y, Yasutomo K. Regulation of Acquired Immune System by Notch Signaling. International Journal of Hematology 2005;82:302-6. [DOI: 10.1532/ijh97.05095] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
3 Campese AF, Garbe AI, Zhang F, Grassi F, Screpanti I, von Boehmer H. Notch1-dependent lymphomagenesis is assisted by but does not essentially require pre-TCR signaling. Blood 2006;108:305-10. [PMID: 16507772 DOI: 10.1182/blood-2006-01-0143] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 2.6] [Reference Citation Analysis]
4 Clappier E, Gerby B, Sigaux F, Delord M, Touzri F, Hernandez L, Ballerini P, Baruchel A, Pflumio F, Soulier J. Clonal selection in xenografted human T cell acute lymphoblastic leukemia recapitulates gain of malignancy at relapse. J Exp Med 2011;208:653-61. [PMID: 21464223 DOI: 10.1084/jem.20110105] [Cited by in Crossref: 141] [Cited by in F6Publishing: 137] [Article Influence: 12.8] [Reference Citation Analysis]
5 Bigas A, Rodriguez-Sevilla JJ, Espinosa L, Gallardo F. Recent advances in T-cell lymphoid neoplasms. Exp Hematol 2021:S0301-472X(21)00622-6. [PMID: 34879258 DOI: 10.1016/j.exphem.2021.12.191] [Reference Citation Analysis]
6 Su Q, Xin L. Notch signaling in prostate cancer: refining a therapeutic opportunity. Histol Histopathol 2016;31:149-57. [PMID: 26521657 DOI: 10.14670/HH-11-685] [Cited by in F6Publishing: 16] [Reference Citation Analysis]
7 Wu HT, Chen WT, Li GW, Shen JX, Ye QQ, Zhang ML, Chen WJ, Liu J. Analysis of the Differentially Expressed Genes Induced by Cisplatin Resistance in Oral Squamous Cell Carcinomas and Their Interaction. Front Genet 2019;10:1328. [PMID: 32038705 DOI: 10.3389/fgene.2019.01328] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
8 Wang Y, Armstrong SA. Genome-wide SNP analysis in cancer: leukemia shows the way. Cancer Cell 2007;11:308-9. [PMID: 17418407 DOI: 10.1016/j.ccr.2007.03.017] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
9 Kim HS, Jung G. Notch1 increases Snail expression under high reactive oxygen species conditions in hepatocellular carcinoma cells. Free Radic Res 2014;48:806-13. [PMID: 24684482 DOI: 10.3109/10715762.2014.909595] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
10 Buonamici S, Aifantis I. Hexamethylene bisacetamide as a treatment for T-cell leukemia (T-ALL). Leuk Res 2008;32:689-90. [PMID: 18164760 DOI: 10.1016/j.leukres.2007.11.018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
11 Grieselhuber NR, Klco JM, Verdoni AM, Lamprecht T, Sarkaria SM, Wartman LD, Ley TJ. Notch signaling in acute promyelocytic leukemia. Leukemia 2013;27:1548-57. [PMID: 23455394 DOI: 10.1038/leu.2013.68] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
12 Hannon MM, Lohan F, Erbilgin Y, Sayitoglu M, O'Hagan K, Mills K, Ozbek U, Keeshan K. Elevated TRIB2 with NOTCH1 activation in paediatric/adult T-ALL. Br J Haematol 2012;158:626-34. [PMID: 22775572 DOI: 10.1111/j.1365-2141.2012.09222.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
13 Persano L, Zagoura D, Louisse J, Pistollato F. Role of Environmental Chemicals, Processed Food Derivatives, and Nutrients in the Induction of Carcinogenesis. Stem Cells and Development 2015;24:2337-52. [DOI: 10.1089/scd.2015.0081] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
14 Montaño A, Forero-Castro M, Marchena-Mendoza D, Benito R, Hernández-Rivas JM. New Challenges in Targeting Signaling Pathways in Acute Lymphoblastic Leukemia by NGS Approaches: An Update. Cancers (Basel) 2018;10:E110. [PMID: 29642462 DOI: 10.3390/cancers10040110] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
15 Fregona V, Bayet M, Gerby B. Oncogene-Induced Reprogramming in Acute Lymphoblastic Leukemia: Towards Targeted Therapy of Leukemia-Initiating Cells. Cancers (Basel) 2021;13:5511. [PMID: 34771671 DOI: 10.3390/cancers13215511] [Reference Citation Analysis]
16 Cleveland SM, Smith S, Tripathi R, Mathias EM, Goodings C, Elliott N, Peng D, El-Rifai W, Yi D, Chen X, Li L, Mullighan C, Downing JR, Love P, Davé UP. Lmo2 induces hematopoietic stem cell-like features in T-cell progenitor cells prior to leukemia. Stem Cells 2013;31:882-94. [PMID: 23378057 DOI: 10.1002/stem.1345] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 4.6] [Reference Citation Analysis]
17 Kridel R, Meissner B, Rogic S, Boyle M, Telenius A, Woolcock B, Gunawardana J, Jenkins C, Cochrane C, Ben-Neriah S, Tan K, Morin RD, Opat S, Sehn LH, Connors JM, Marra MA, Weng AP, Steidl C, Gascoyne RD. Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma. Blood 2012;119:1963-71. [PMID: 22210878 DOI: 10.1182/blood-2011-11-391474] [Cited by in Crossref: 238] [Cited by in F6Publishing: 214] [Article Influence: 21.6] [Reference Citation Analysis]
18 Moore G, Annett S, McClements L, Robson T. Top Notch Targeting Strategies in Cancer: A Detailed Overview of Recent Insights and Current Perspectives. Cells 2020;9:E1503. [PMID: 32575680 DOI: 10.3390/cells9061503] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 11.5] [Reference Citation Analysis]
19 Yang L, Zhang S, George SK, Teng R, You X, Xu M, Liu H, Sun X, Amin HM, Shi W. Targeting Notch1 and proteasome as an effective strategy to suppress T-cell lymphoproliferative neoplasms. Oncotarget 2015;6:14953-69. [PMID: 25879451 DOI: 10.18632/oncotarget.3621] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
20 Tan MJ, White EA, Sowa ME, Harper JW, Aster JC, Howley PM. Cutaneous β-human papillomavirus E6 proteins bind Mastermind-like coactivators and repress Notch signaling. Proc Natl Acad Sci U S A 2012;109:E1473-80. [PMID: 22547818 DOI: 10.1073/pnas.1205991109] [Cited by in Crossref: 94] [Cited by in F6Publishing: 85] [Article Influence: 9.4] [Reference Citation Analysis]
21 Zhang Y, Liu X, Zhou CX, Li TJ. Notch activation leads to loss of myoepithelial differentiation and poor outcome in solid adenoid cystic carcinoma. Oral Dis 2020;26:1677-86. [PMID: 32531852 DOI: 10.1111/odi.13480] [Reference Citation Analysis]
22 Pajerowski AG, Nguyen C, Aghajanian H, Shapiro MJ, Shapiro VS. NKAP is a transcriptional repressor of notch signaling and is required for T cell development. Immunity 2009;30:696-707. [PMID: 19409814 DOI: 10.1016/j.immuni.2009.02.011] [Cited by in Crossref: 54] [Cited by in F6Publishing: 56] [Article Influence: 4.2] [Reference Citation Analysis]
23 Sanchez-Martin M, Ambesi-Impiombato A, Qin Y, Herranz D, Bansal M, Girardi T, Paietta E, Tallman MS, Rowe JM, De Keersmaecker K, Califano A, Ferrando AA. Synergistic antileukemic therapies in NOTCH1-induced T-ALL. Proc Natl Acad Sci U S A 2017;114:2006-11. [PMID: 28174276 DOI: 10.1073/pnas.1611831114] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 7.0] [Reference Citation Analysis]
24 Krop I, Demuth T, Guthrie T, Wen PY, Mason WP, Chinnaiyan P, Butowski N, Groves MD, Kesari S, Freedman SJ, Blackman S, Watters J, Loboda A, Podtelezhnikov A, Lunceford J, Chen C, Giannotti M, Hing J, Beckman R, Lorusso P. Phase I pharmacologic and pharmacodynamic study of the gamma secretase (Notch) inhibitor MK-0752 in adult patients with advanced solid tumors. J Clin Oncol. 2012;30:2307-2313. [PMID: 22547604 DOI: 10.1200/jco.2011.39.1540] [Cited by in Crossref: 200] [Cited by in F6Publishing: 116] [Article Influence: 20.0] [Reference Citation Analysis]
25 Lee CW, Raskett CM, Prudovsky I, Altieri DC. Molecular dependence of estrogen receptor-negative breast cancer on a notch-survivin signaling axis. Cancer Res. 2008;68:5273-5281. [PMID: 18593928 DOI: 10.1158/0008-5472.can-07-6673] [Cited by in Crossref: 88] [Cited by in F6Publishing: 50] [Article Influence: 6.3] [Reference Citation Analysis]
26 Remke M, Pfister S, Kox C, Toedt G, Becker N, Benner A, Werft W, Breit S, Liu S, Engel F, Wittmann A, Zimmermann M, Stanulla M, Schrappe M, Ludwig WD, Bartram CR, Radlwimmer B, Muckenthaler MU, Lichter P, Kulozik AE. High-resolution genomic profiling of childhood T-ALL reveals frequent copy-number alterations affecting the TGF-beta and PI3K-AKT pathways and deletions at 6q15-16.1 as a genomic marker for unfavorable early treatment response. Blood 2009;114:1053-62. [PMID: 19406988 DOI: 10.1182/blood-2008-10-186536] [Cited by in Crossref: 79] [Cited by in F6Publishing: 77] [Article Influence: 6.1] [Reference Citation Analysis]
27 Solomon A, Mian Y, Ortega-Cava C, Liu VW, Gurumurthy CB, Naramura M, Band V, Band H. Upregulation of the let-7 microRNA with precocious development in lin-12/Notch hypermorphic Caenorhabditis elegans mutants. Dev Biol 2008;316:191-9. [PMID: 18334253 DOI: 10.1016/j.ydbio.2007.12.046] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
28 Liu RB, Guo JG, Liu TZ, Guo CC, Fan XX, Zhang X, Hu WH, Cai XY. Meta-analysis of the clinical characteristics and prognostic relevance of NOTCH1 and FBXW7 mutation in T-cell acute lymphoblastic leukemia. Oncotarget 2017;8:66360-70. [PMID: 29029518 DOI: 10.18632/oncotarget.18576] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
29 Bonn BR, Rohde M, Zimmermann M, Krieger D, Oschlies I, Niggli F, Wrobel G, Attarbaschi A, Escherich G, Klapper W, Reiter A, Burkhardt B. Incidence and prognostic relevance of genetic variations in T-cell lymphoblastic lymphoma in childhood and adolescence. Blood 2013;121:3153-60. [PMID: 23396305 DOI: 10.1182/blood-2012-12-474148] [Cited by in Crossref: 70] [Cited by in F6Publishing: 64] [Article Influence: 7.8] [Reference Citation Analysis]
30 Kumar V, Palermo R, Talora C, Campese AF, Checquolo S, Bellavia D, Tottone L, Testa G, Miele E, Indraccolo S, Amadori A, Ferretti E, Gulino A, Vacca A, Screpanti I. Notch and NF-kB signaling pathways regulate miR-223/FBXW7 axis in T-cell acute lymphoblastic leukemia. Leukemia 2014;28:2324-35. [PMID: 24727676 DOI: 10.1038/leu.2014.133] [Cited by in Crossref: 102] [Cited by in F6Publishing: 107] [Article Influence: 12.8] [Reference Citation Analysis]
31 Mühlbacher V, Zenger M, Schnittger S, Weissmann S, Kunze F, Kohlmann A, Bellos F, Kern W, Haferlach T, Haferlach C. Acute lymphoblastic leukemia with low hypodiploid/near triploid karyotype is a specific clinical entity and exhibits a very high TP53 mutation frequency of 93%: Characterization of Low Hypodiploid ALL. Genes Chromosomes Cancer 2014;53:524-36. [DOI: 10.1002/gcc.22163] [Cited by in Crossref: 52] [Cited by in F6Publishing: 47] [Article Influence: 6.5] [Reference Citation Analysis]
32 Yui MA, Feng N, Zhang JA, Liaw CY, Rothenberg EV, Longmate JA. Loss of T cell progenitor checkpoint control underlies leukemia initiation in Rag1-deficient nonobese diabetic mice. J Immunol 2013;190:3276-88. [PMID: 23440410 DOI: 10.4049/jimmunol.1202970] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
33 Moharram SA, Shah K, Khanum F, Marhäll A, Gazi M, Kazi JU. Efficacy of the CDK inhibitor dinaciclib in vitro and in vivo in T-cell acute lymphoblastic leukemia. Cancer Letters 2017;405:73-8. [DOI: 10.1016/j.canlet.2017.07.019] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
34 Marks DI, Rowntree C. Management of adults with T-cell lymphoblastic leukemia. Blood 2017;129:1134-42. [DOI: 10.1182/blood-2016-07-692608] [Cited by in Crossref: 66] [Cited by in F6Publishing: 64] [Article Influence: 13.2] [Reference Citation Analysis]
35 Mendes RD, Sarmento LM, Canté-Barrett K, Zuurbier L, Buijs-Gladdines JG, Póvoa V, Smits WK, Abecasis M, Yunes JA, Sonneveld E, Horstmann MA, Pieters R, Barata JT, Meijerink JP. PTEN microdeletions in T-cell acute lymphoblastic leukemia are caused by illegitimate RAG-mediated recombination events. Blood 2014;124:567-78. [PMID: 24904117 DOI: 10.1182/blood-2014-03-562751] [Cited by in Crossref: 56] [Cited by in F6Publishing: 53] [Article Influence: 7.0] [Reference Citation Analysis]
36 Cavazzana-calvo M, Six E, André-schmutz I, Coulombel L. Hématopoïèse humaine : des cellules CD34 aux lymphocytes T. Med Sci (Paris) 2007;23:151-60. [DOI: 10.1051/medsci/2007232151] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
37 Thai M, Ting PY, McLaughlin J, Cheng D, Müschen M, Witte ON, Colicelli J. ABL fusion oncogene transformation and inhibitor sensitivity are mediated by the cellular regulator RIN1. Leukemia. 2011;25:290-300. [PMID: 21102429 DOI: 10.1038/leu.2010.268] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
38 Lasky JL, Wu H. Notch signaling, brain development, and human disease. Pediatr Res 2005;57:104R-9R. [PMID: 15817497 DOI: 10.1203/01.PDR.0000159632.70510.3D] [Cited by in Crossref: 91] [Cited by in F6Publishing: 52] [Article Influence: 5.4] [Reference Citation Analysis]
39 Agnusdei V, Minuzzo S, Frasson C, Grassi A, Axelrod F, Satyal S, Gurney A, Hoey T, Seganfreddo E, Basso G, Valtorta S, Moresco RM, Amadori A, Indraccolo S. Therapeutic antibody targeting of Notch1 in T-acute lymphoblastic leukemia xenografts. Leukemia 2014;28:278-88. [PMID: 23774673 DOI: 10.1038/leu.2013.183] [Cited by in Crossref: 75] [Cited by in F6Publishing: 69] [Article Influence: 8.3] [Reference Citation Analysis]
40 Gordon WR, Vardar-Ulu D, Histen G, Sanchez-Irizarry C, Aster JC, Blacklow SC. Structural basis for autoinhibition of Notch. Nat Struct Mol Biol 2007;14:295-300. [PMID: 17401372 DOI: 10.1038/nsmb1227] [Cited by in Crossref: 234] [Cited by in F6Publishing: 217] [Article Influence: 15.6] [Reference Citation Analysis]
41 Giambra V, Gusscott S, Gracias D, Song R, Lam SH, Panelli P, Tyshchenko K, Jenkins CE, Hoofd C, Lorzadeh A, Carles A, Hirst M, Eaves CJ, Weng AP. Epigenetic Restoration of Fetal-like IGF1 Signaling Inhibits Leukemia Stem Cell Activity. Cell Stem Cell 2018;23:714-726.e7. [PMID: 30269902 DOI: 10.1016/j.stem.2018.08.018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
42 Liang KL, Rishi L, Keeshan K. Tribbles in acute leukemia. Blood 2013;121:4265-70. [PMID: 23550039 DOI: 10.1182/blood-2012-12-471300] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 4.2] [Reference Citation Analysis]
43 Anusewicz D, Orzechowska M, Bednarek AK. Notch Signaling Pathway in Cancer-Review with Bioinformatic Analysis. Cancers (Basel) 2021;13:768. [PMID: 33673145 DOI: 10.3390/cancers13040768] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Walter D, Döring C, Feldhahn M, Battke F, Hartmann S, Winkelmann R, Schneider M, Bankov K, Schnitzbauer A, Zeuzem S, Hansmann ML, Peveling-Oberhag J. Intratumoral heterogeneity of intrahepatic cholangiocarcinoma. Oncotarget 2017;8:14957-68. [PMID: 28146430 DOI: 10.18632/oncotarget.14844] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
45 Yin M, Baslan T, Walker RL, Zhu YJ, Freeland A, Matsukawa T, Sridharan S, Nussenzweig A, Pruitt SC, Lowe SW, Meltzer PS, Aplan PD. A unique mutator phenotype reveals complementary oncogenic lesions leading to acute leukemia. JCI Insight 2019;4:131434. [PMID: 31622281 DOI: 10.1172/jci.insight.131434] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
46 Wang S, Aoki M, Nakashima Y, Shinozuka Y, Tanaka H, Taniwaki M, Hattori M, Minato N. Development of Notch-dependent T-cell leukemia by deregulated Rap1 signaling. Blood 2008;111:2878-86. [DOI: 10.1182/blood-2007-07-103119] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
47 Lejman M, Włodarczyk M, Styka B, Pastorczak A, Zawitkowska J, Taha J, Sędek Ł, Skonieczka K, Braun M, Haus O, Szczepański T, Młynarski W, Kowalczyk JR. Advantages and Limitations of SNP Array in the Molecular Characterization of Pediatric T-Cell Acute Lymphoblastic Leukemia. Front Oncol 2020;10:1184. [PMID: 32766158 DOI: 10.3389/fonc.2020.01184] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
48 Yamamoto K, Nakamachi Y, Yakushijin K, Miyata Y, Okamura A, Kawano S, Matsuoka H, Minami H. A novel TRB@/NOTCH1 fusion gene in T-cell lymphoblastic lymphoma with t(7;9)(q34;q34). Eur J Haematol 2013;90:68-75. [PMID: 23033986 DOI: 10.1111/ejh.12019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
49 Bao B, Prasad AS. Targeting CSC in a Most Aggressive Subtype of Breast Cancer TNBC. In: Ahmad A, editor. Breast Cancer Metastasis and Drug Resistance. Cham: Springer International Publishing; 2019. pp. 311-34. [DOI: 10.1007/978-3-030-20301-6_17] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
50 Grigorenko AP, Moliaka YK, Plotnikova OV, Smirnov A, Nikishina VA, Goltsov AY, Gusev F, Andreeva TV, Nelson O, Bezprozvanny I, Rogaev EI. Mutational re-modeling of di-aspartyl intramembrane proteases: uncoupling physiologically-relevant activities from those associated with Alzheimer's disease. Oncotarget 2017;8:82006-26. [PMID: 29137240 DOI: 10.18632/oncotarget.18299] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
51 Sakamoto K. Notch signaling in oral squamous neoplasia. Pathol Int 2016;66:609-17. [PMID: 27671927 DOI: 10.1111/pin.12461] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
52 Ferrante F, Giaimo BD, Bartkuhn M, Zimmermann T, Close V, Mertens D, Nist A, Stiewe T, Meier-Soelch J, Kracht M, Just S, Klöble P, Oswald F, Borggrefe T. HDAC3 functions as a positive regulator in Notch signal transduction. Nucleic Acids Res 2020;48:3496-512. [PMID: 32107550 DOI: 10.1093/nar/gkaa088] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
53 Morrugares R, Correa-Sáez A, Moreno R, Garrido-Rodríguez M, Muñoz E, de la Vega L, Calzado MA. Phosphorylation-dependent regulation of the NOTCH1 intracellular domain by dual-specificity tyrosine-regulated kinase 2. Cell Mol Life Sci 2020;77:2621-39. [PMID: 31605148 DOI: 10.1007/s00018-019-03309-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
54 Kluk MJ, Ashworth T, Wang H, Knoechel B, Mason EF, Morgan EA, Dorfman D, Pinkus G, Weigert O, Hornick JL, Chirieac LR, Hirsch M, Oh DJ, South AP, Leigh IM, Pourreyron C, Cassidy AJ, Deangelo DJ, Weinstock DM, Krop IE, Dillon D, Brock JE, Lazar AJ, Peto M, Cho RJ, Stoeck A, Haines BB, Sathayanrayanan S, Rodig S, Aster JC. Gauging NOTCH1 Activation in Cancer Using Immunohistochemistry. PLoS One 2013;8:e67306. [PMID: 23825651 DOI: 10.1371/journal.pone.0067306] [Cited by in Crossref: 76] [Cited by in F6Publishing: 68] [Article Influence: 8.4] [Reference Citation Analysis]
55 Jundt F, Acikgöz O, Kwon SH, Schwarzer R, Anagnostopoulos I, Wiesner B, Mathas S, Hummel M, Stein H, Reichardt HM, Dörken B. Aberrant expression of Notch1 interferes with the B-lymphoid phenotype of neoplastic B cells in classical Hodgkin lymphoma. Leukemia 2008;22:1587-94. [PMID: 18449208 DOI: 10.1038/leu.2008.101] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 3.6] [Reference Citation Analysis]
56 Arai MA, Ebihara I, Makita Y, Hara Y, Yaguchi T, Ishibashi M. Isolation of nocobactin NAs as Notch signal inhibitors from Nocardia farcinica, a possibility of invasive evolution. J Antibiot (Tokyo) 2021;74:255-9. [PMID: 33318622 DOI: 10.1038/s41429-020-00393-z] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
57 Sakhdari A, Thakral B, Loghavi S, Kanagal-Shamanna R, Yin CC, Zuo Z, Routbort MJ, Luthra R, Medeiros LJ, Wang SA, Patel KP, Ok CY. RAS and TP53 can predict survival in adults with T-cell lymphoblastic leukemia treated with hyper-CVAD. Cancer Med 2020;9:849-58. [PMID: 31804006 DOI: 10.1002/cam4.2757] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
58 Stoyanova T, Riedinger M, Lin S, Faltermeier CM, Smith BA, Zhang KX, Going CC, Goldstein AS, Lee JK, Drake JM, Rice MA, Hsu EC, Nowroozizadeh B, Castor B, Orellana SY, Blum SM, Cheng D, Pienta KJ, Reiter RE, Pitteri SJ, Huang J, Witte ON. Activation of Notch1 synergizes with multiple pathways in promoting castration-resistant prostate cancer. Proc Natl Acad Sci U S A 2016;113:E6457-66. [PMID: 27694579 DOI: 10.1073/pnas.1614529113] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
59 te Raa GD, Derks IAM, Navrkalova V, Skowronska A, Moerland PD, van Laar J, Oldreive C, Monsuur H, Trbusek M, Malcikova J, Lodén M, Geisler CH, Hüllein J, Jethwa A, Zenz T, Pospisilova S, Stankovic T, van Oers MHJ, Kater AP, Eldering E. The impact of SF3B1 mutations in CLL on the DNA-damage response. Leukemia 2015;29:1133-42. [DOI: 10.1038/leu.2014.318] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 6.0] [Reference Citation Analysis]
60 Blackburn JS, Liu S, Raiser DM, Martinez SA, Feng H, Meeker ND, Gentry J, Neuberg D, Look AT, Ramaswamy S, Bernards A, Trede NS, Langenau DM. Notch signaling expands a pre-malignant pool of T-cell acute lymphoblastic leukemia clones without affecting leukemia-propagating cell frequency. Leukemia 2012;26:2069-78. [PMID: 22538478 DOI: 10.1038/leu.2012.116] [Cited by in Crossref: 55] [Cited by in F6Publishing: 48] [Article Influence: 5.5] [Reference Citation Analysis]
61 Gonda TJ, Ramsay RG. Directly targeting transcriptional dysregulation in cancer. Nat Rev Cancer 2015;15:686-94. [PMID: 26493648 DOI: 10.1038/nrc4018] [Cited by in Crossref: 69] [Cited by in F6Publishing: 57] [Article Influence: 11.5] [Reference Citation Analysis]
62 Shalom B, Farago M, Pikarsky E, Katzav S. Vav1 mutations identified in human cancers give rise to different oncogenic phenotypes. Oncogenesis 2018;7:80. [PMID: 30297765 DOI: 10.1038/s41389-018-0091-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
63 Medyouf H, Alcalde H, Berthier C, Guillemin MC, dos Santos NR, Janin A, Decaudin D, de Thé H, Ghysdael J. Targeting calcineurin activation as a therapeutic strategy for T-cell acute lymphoblastic leukemia. Nat Med 2007;13:736-41. [DOI: 10.1038/nm1588] [Cited by in Crossref: 103] [Cited by in F6Publishing: 96] [Article Influence: 6.9] [Reference Citation Analysis]
64 Ksionda O, Limnander A, Roose JP. RasGRP Ras guanine nucleotide exchange factors in cancer. Front Biol (Beijing) 2013;8:508-32. [PMID: 24744772 DOI: 10.1007/s11515-013-1276-9] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 4.3] [Reference Citation Analysis]
65 Giaimo BD, Ferrante F, Vallejo DM, Hein K, Gutierrez-Perez I, Nist A, Stiewe T, Mittler G, Herold S, Zimmermann T, Bartkuhn M, Schwarz P, Oswald F, Dominguez M, Borggrefe T. Histone variant H2A.Z deposition and acetylation directs the canonical Notch signaling response. Nucleic Acids Res 2018;46:8197-215. [PMID: 29986055 DOI: 10.1093/nar/gky551] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 8.7] [Reference Citation Analysis]
66 Xin Z, Wu X, Yu Z, Shang J, Xu B, Jiang S, Yang Y. Mechanisms explaining the efficacy of psoralidin in cancer and osteoporosis, a review. Pharmacological Research 2019;147:104334. [DOI: 10.1016/j.phrs.2019.104334] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
67 Clark AD, Oldenbroek M, Boyer TG. Mediator kinase module and human tumorigenesis. Crit Rev Biochem Mol Biol 2015;50:393-426. [PMID: 26182352 DOI: 10.3109/10409238.2015.1064854] [Cited by in F6Publishing: 46] [Reference Citation Analysis]
68 Touzart A, Mayakonda A, Smith C, Hey J, Toth R, Cieslak A, Andrieu GP, Tran Quang C, Latiri M, Ghysdael J, Spicuglia S, Dombret H, Ifrah N, Macintyre E, Lutsik P, Boissel N, Plass C, Asnafi V. Epigenetic analysis of patients with T-ALL identifies poor outcomes and a hypomethylating agent-responsive subgroup. Sci Transl Med 2021;13:eabc4834. [PMID: 34039737 DOI: 10.1126/scitranslmed.abc4834] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
69 Cui H, Kong Y, Xu M, Zhang H. Notch3 functions as a tumor suppressor by controlling cellular senescence. Cancer Res 2013;73:3451-9. [PMID: 23610446 DOI: 10.1158/0008-5472.CAN-12-3902] [Cited by in Crossref: 67] [Cited by in F6Publishing: 41] [Article Influence: 7.4] [Reference Citation Analysis]
70 Chadwick N, Zeef L, Portillo V, Fennessy C, Warrander F, Hoyle S, Buckle AM. Identification of novel Notch target genes in T cell leukaemia. Mol Cancer 2009;8:35. [PMID: 19508709 DOI: 10.1186/1476-4598-8-35] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 3.2] [Reference Citation Analysis]
71 Sandy AR, Maillard I. Notch signaling in the hematopoietic system. Expert Opin Biol Ther 2009;9:1383-98. [PMID: 19743891 DOI: 10.1517/14712590903260777] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 3.1] [Reference Citation Analysis]
72 Shimizu D, Taki T, Utsunomiya A, Nakagawa H, Nomura K, Matsumoto Y, Nishida K, Horiike S, Taniwaki M. Detection of NOTCH1 mutations in adult T-cell leukemia/lymphoma and peripheral T-cell lymphoma. Int J Hematol 2007;85:212-8. [PMID: 17483057 DOI: 10.1532/IJH97.06165] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
73 Wang J, Ma Y, Cooper MK. Cancer stem cells in glioma: challenges and opportunities. Transl Cancer Res 2013;2:429-41. [PMID: 24634854 DOI: 10.3978/j.issn.2218-676X.2013.08.01] [Cited by in F6Publishing: 15] [Reference Citation Analysis]
74 Gavai AV, Quesnelle C, Norris D, Han WC, Gill P, Shan W, Balog A, Chen K, Tebben A, Rampulla R. Discovery of Clinical Candidate BMS-906024: A Potent Pan-Notch Inhibitor for the Treatment of Leukemia and Solid Tumors. ACS Med Chem Lett. 2015;6:523-527. [PMID: 26005526 DOI: 10.1021/acsmedchemlett.5b00001] [Cited by in Crossref: 50] [Cited by in F6Publishing: 45] [Article Influence: 7.1] [Reference Citation Analysis]
75 He Z, Liao Z, Chen S, Li B, Yu Z, Luo G, Yang L, Zeng C, Li Y. Downregulated miR-17, miR-29c, miR-92a and miR-214 may be related to BCL11B overexpression in T cell acute lymphoblastic leukemia. Asia Pac J Clin Oncol 2018;14:e259-65. [PMID: 29749698 DOI: 10.1111/ajco.12979] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
76 Oyama T, Harigaya K, Muradil A, Hozumi K, Habu S, Oguro H, Iwama A, Matsuno K, Sakamoto R, Sato M, Yoshida N, Kitagawa M. Mastermind-1 is required for Notch signal-dependent steps in lymphocyte development in vivo. Proc Natl Acad Sci U S A 2007;104:9764-9. [PMID: 17535917 DOI: 10.1073/pnas.0700240104] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 2.5] [Reference Citation Analysis]
77 Zhdanovskaya N, Firrincieli M, Lazzari S, Pace E, Scribani Rossi P, Felli MP, Talora C, Screpanti I, Palermo R. Targeting Notch to Maximize Chemotherapeutic Benefits: Rationale, Advanced Strategies, and Future Perspectives. Cancers (Basel) 2021;13:5106. [PMID: 34680255 DOI: 10.3390/cancers13205106] [Reference Citation Analysis]
78 Tavakoli Shirazi P, Eadie LN, Heatley SL, Hughes TP, Yeung DT, White DL. The effect of co-occurring lesions on leukaemogenesis and drug response in T-ALL and ETP-ALL. Br J Cancer 2020;122:455-64. [PMID: 31792348 DOI: 10.1038/s41416-019-0647-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
79 Sharma VM, Calvo JA, Draheim KM, Cunningham LA, Hermance N, Beverly L, Krishnamoorthy V, Bhasin M, Capobianco AJ, Kelliher MA. Notch1 contributes to mouse T-cell leukemia by directly inducing the expression of c-myc. Mol Cell Biol. 2006;26:8022-8031. [PMID: 16954387 DOI: 10.1128/mcb.01091-06] [Cited by in Crossref: 193] [Cited by in F6Publishing: 126] [Article Influence: 12.1] [Reference Citation Analysis]
80 Pinnix CC, Herlyn M. The many faces of Notch signaling in skin-derived cells. Pigment Cell Res. 2007;20:458-465. [PMID: 17935489 DOI: 10.1111/j.1600-0749.2007.00410.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 38] [Article Influence: 3.4] [Reference Citation Analysis]
81 Tan SH, Bertulfo FC, Sanda T. Leukemia-Initiating Cells in T-Cell Acute Lymphoblastic Leukemia. Front Oncol 2017;7:218. [PMID: 29034206 DOI: 10.3389/fonc.2017.00218] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
82 Burns M, Armstrong SA, Gutierrez A. Pathobiology of Acute Lymphoblastic Leukemia. Hematology. Elsevier; 2018. pp. 1005-1019.e11. [DOI: 10.1016/b978-0-323-35762-3.00064-0] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
83 Lee K, Nam KT, Cho SH, Gudapati P, Hwang Y, Park DS, Potter R, Chen J, Volanakis E, Boothby M. Vital roles of mTOR complex 2 in Notch-driven thymocyte differentiation and leukemia. J Exp Med 2012;209:713-28. [PMID: 22473959 DOI: 10.1084/jem.20111470] [Cited by in Crossref: 86] [Cited by in F6Publishing: 79] [Article Influence: 8.6] [Reference Citation Analysis]
84 Harbuzariu A, Oprea-Ilies GM, Gonzalez-Perez RR. The Role of Notch Signaling and Leptin-Notch Crosstalk in Pancreatic Cancer. Medicines (Basel) 2018;5:E68. [PMID: 30004402 DOI: 10.3390/medicines5030068] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
85 Revandkar A, Perciato ML, Toso A, Alajati A, Chen J, Gerber H, Dimitrov M, Rinaldi A, Delaleu N, Pasquini E, D'Antuono R, Pinton S, Losa M, Gnetti L, Arribas A, Fraering P, Bertoni F, Nepveu A, Alimonti A. Inhibition of Notch pathway arrests PTEN-deficient advanced prostate cancer by triggering p27-driven cellular senescence. Nat Commun 2016;7:13719. [PMID: 27941799 DOI: 10.1038/ncomms13719] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
86 Sarmento LM, Barata JT. Therapeutic potential of Notch inhibition in T-cell acute lymphoblastic leukemia: rationale, caveats and promises. Expert Rev Anticancer Ther 2011;11:1403-15. [PMID: 21929314 DOI: 10.1586/era.11.73] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
87 Pajcini KV, Xu L, Shao L, Petrovic J, Palasiewicz K, Ohtani Y, Bailis W, Lee C, Wertheim GB, Mani R, Muthusamy N, Li Y, Meijerink JPP, Blacklow SC, Faryabi RB, Cherry S, Pear WS. MAFB enhances oncogenic Notch signaling in T cell acute lymphoblastic leukemia. Sci Signal 2017;10:eaam6846. [PMID: 29138297 DOI: 10.1126/scisignal.aam6846] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
88 Biggs JR, Zhang D. Molecular Basis of Lymphoid and Myeloid Diseases. Molecular Pathology. Elsevier; 2018. pp. 299-328. [DOI: 10.1016/b978-0-12-802761-5.00016-x] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
89 van Vlierberghe P, Meijerink JPP, Lee C, Ferrando AA, Look AT, van Wering ER, Beverloo HB, Aster JC, Pieters R. A new recurrent 9q34 duplication in pediatric T-cell acute lymphoblastic leukemia. Leukemia 2006;20:1245-53. [DOI: 10.1038/sj.leu.2404247] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 1.9] [Reference Citation Analysis]
90 Tasian SK, Hunger SP. Genomic characterization of paediatric acute lymphoblastic leukaemia: an opportunity for precision medicine therapeutics. Br J Haematol 2017;176:867-82. [PMID: 27984637 DOI: 10.1111/bjh.14474] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 7.5] [Reference Citation Analysis]
91 Mansur MB, van Delft FW, Colman SM, Furness CL, Gibson J, Emerenciano M, Kempski H, Clappier E, Cave H, Soulier J, Pombo-de-Oliveira MS, Greaves M, Ford AM. Distinctive genotypes in infants with T-cell acute lymphoblastic leukaemia. Br J Haematol 2015;171:574-84. [PMID: 26205622 DOI: 10.1111/bjh.13613] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 3.9] [Reference Citation Analysis]
92 Louvi A, Artavanis-Tsakonas S. Notch and disease: a growing field. Semin Cell Dev Biol 2012;23:473-80. [PMID: 22373641 DOI: 10.1016/j.semcdb.2012.02.005] [Cited by in Crossref: 135] [Cited by in F6Publishing: 123] [Article Influence: 13.5] [Reference Citation Analysis]
93 Hagenbeek TJ, Wu X, Choy L, Sanchez-irizarry C, Seshagiri S, Stinson J, Siebel CW, Spits H. Murine Pten−/− T-ALL requires non-redundant PI3K/mTOR and DLL4/Notch1 signals for maintenance and γc/TCR signals for thymic exit. Cancer Letters 2014;346:237-48. [DOI: 10.1016/j.canlet.2013.12.027] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
94 Schultheis AM, de Bruijn I, Selenica P, Macedo GS, da Silva EM, Piscuoglio S, Jungbluth AA, Park KJ, Klimstra DS, Wardelmann E, Hartmann W, Gerharz CD, von Petersdorff M, Buettner R, Reis-Filho JS, Weigelt B. Genomic characterization of small cell carcinomas of the uterine cervix. Mol Oncol 2021. [PMID: 33830625 DOI: 10.1002/1878-0261.12962] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
95 Kramer AC, Kothari A, Wilson WC, Celik H, Nikitas J, Mallaney C, Ostrander EL, Eultgen E, Martens A, Valentine MC, Young AL, Druley TE, Figueroa ME, Zhang B, Challen GA. Dnmt3a regulates T-cell development and suppresses T-ALL transformation. Leukemia 2017;31:2479-90. [PMID: 28321121 DOI: 10.1038/leu.2017.89] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
96 Dang M, Fogley R, Zon LI. Identifying Novel Cancer Therapies Using Chemical Genetics and Zebrafish. Adv Exp Med Biol 2016;916:103-24. [PMID: 27165351 DOI: 10.1007/978-3-319-30654-4_5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
97 Buratin A, Paganin M, Gaffo E, Dal Molin A, Roels J, Germano G, Siddi MT, Serafin V, De Decker M, Gachet S, Durinck K, Speleman F, Taghon T, Te Kronnie G, Van Vlierberghe P, Bortoluzzi S. Large-scale circular RNA deregulation in T-ALL: unlocking unique ectopic expression of molecular subtypes. Blood Adv 2020;4:5902-14. [PMID: 33259601 DOI: 10.1182/bloodadvances.2020002337] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
98 Kopan R. Notch signaling. Cold Spring Harb Perspect Biol 2012;4:a011213. [PMID: 23028119 DOI: 10.1101/cshperspect.a011213] [Cited by in Crossref: 132] [Cited by in F6Publishing: 132] [Article Influence: 13.2] [Reference Citation Analysis]
99 Shin HM, Minter LM, Cho OH, Gottipati S, Fauq AH, Golde TE, Sonenshein GE, Osborne BA. Notch1 augments NF-kappaB activity by facilitating its nuclear retention. EMBO J 2006;25:129-38. [PMID: 16319921 DOI: 10.1038/sj.emboj.7600902] [Cited by in Crossref: 219] [Cited by in F6Publishing: 212] [Article Influence: 12.9] [Reference Citation Analysis]
100 Lobry C, Oh P, Mansour MR, Look AT, Aifantis I. Notch signaling: switching an oncogene to a tumor suppressor. Blood. 2014;123:2451-2459. [PMID: 24608975 DOI: 10.1182/blood-2013-08-355818] [Cited by in Crossref: 140] [Cited by in F6Publishing: 138] [Article Influence: 17.5] [Reference Citation Analysis]
101 Firth LC, Baker NE. Extracellular Signals Responsible for Spatially Regulated Proliferation in the Differentiating Drosophila Eye. Developmental Cell 2005;8:541-51. [DOI: 10.1016/j.devcel.2005.01.017] [Cited by in Crossref: 113] [Cited by in F6Publishing: 115] [Article Influence: 6.6] [Reference Citation Analysis]
102 Dose M, Gounari F. Fifty ways to Notch T-ALL. Blood 2008;112:457-8. [PMID: 18650457 DOI: 10.1182/blood-2008-05-155747] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
103 Lehal R, Zaric J, Vigolo M, Urech C, Frismantas V, Zangger N, Cao L, Berger A, Chicote I, Loubéry S, Choi SH, Koch U, Blacklow SC, Palmer HG, Bornhauser B, González-Gaitán M, Arsenijevic Y, Zoete V, Aster JC, Bourquin JP, Radtke F. Pharmacological disruption of the Notch transcription factor complex. Proc Natl Acad Sci U S A 2020;117:16292-301. [PMID: 32601208 DOI: 10.1073/pnas.1922606117] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
104 Jin Q, Martinez CA, Arcipowski KM, Zhu Y, Gutierrez-Diaz BT, Wang KK, Johnson MR, Volk AG, Wang F, Wu J, Grove C, Wang H, Sokirniy I, Thomas PM, Goo YA, Abshiru NA, Hijiya N, Peirs S, Vandamme N, Berx G, Goosens S, Marshall SA, Rendleman EJ, Takahashi YH, Wang L, Rawat R, Bartom ET, Collings CK, Van Vlierberghe P, Strikoudis A, Kelly S, Ueberheide B, Mantis C, Kandela I, Bourquin JP, Bornhauser B, Serafin V, Bresolin S, Paganin M, Accordi B, Basso G, Kelleher NL, Weinstock J, Kumar S, Crispino JD, Shilatifard A, Ntziachristos P. USP7 Cooperates with NOTCH1 to Drive the Oncogenic Transcriptional Program in T-Cell Leukemia. Clin Cancer Res 2019;25:222-39. [PMID: 30224337 DOI: 10.1158/1078-0432.CCR-18-1740] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 8.8] [Reference Citation Analysis]
105 De Salvo M, Raimondi L, Vella S, Adesso L, Ciarapica R, Verginelli F, Pannuti A, Citti A, Boldrini R, Milano GM, Cacchione A, Ferrari A, Collini P, Rosolen A, Bisogno G, Alaggio R, Inserra A, Locatelli M, Stifani S, Screpanti I, Miele L, Locatelli F, Rota R. Hyper-activation of Notch3 amplifies the proliferative potential of rhabdomyosarcoma cells. PLoS One 2014;9:e96238. [PMID: 24797362 DOI: 10.1371/journal.pone.0096238] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
106 Sanda T, Leong WZ. TAL1 as a master oncogenic transcription factor in T-cell acute lymphoblastic leukemia. Exp Hematol 2017;53:7-15. [PMID: 28652130 DOI: 10.1016/j.exphem.2017.06.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
107 Parikh SA, Litzow MR. Philadelphia chromosome-negative acute lymphoblastic leukemia: therapies under development. Future Oncology 2014;10:2201-12. [DOI: 10.2217/fon.14.81] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
108 Staffas A, Karlsson C, Persson M, Palmqvist L, Bergo MO. Wild-type KRAS inhibits oncogenic KRAS-induced T-ALL in mice. Leukemia 2015;29:1032-40. [PMID: 25371176 DOI: 10.1038/leu.2014.315] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 3.6] [Reference Citation Analysis]
109 Zuurbier L, Homminga I, Calvert V, te Winkel ML, Buijs-Gladdines JG, Kooi C, Smits WK, Sonneveld E, Veerman AJ, Kamps WA, Horstmann M, Petricoin EF 3rd, Pieters R, Meijerink JP. NOTCH1 and/or FBXW7 mutations predict for initial good prednisone response but not for improved outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on DCOG or COALL protocols. Leukemia 2010;24:2014-22. [PMID: 20861909 DOI: 10.1038/leu.2010.204] [Cited by in Crossref: 93] [Cited by in F6Publishing: 92] [Article Influence: 7.8] [Reference Citation Analysis]
110 Kalkat M, De Melo J, Hickman KA, Lourenco C, Redel C, Resetca D, Tamachi A, Tu WB, Penn LZ. MYC Deregulation in Primary Human Cancers. Genes (Basel) 2017;8:E151. [PMID: 28587062 DOI: 10.3390/genes8060151] [Cited by in Crossref: 146] [Cited by in F6Publishing: 120] [Article Influence: 29.2] [Reference Citation Analysis]
111 Stockhausen MT, Sjölund J, Axelson H. Regulation of the Notch target gene Hes-1 by TGFalpha induced Ras/MAPK signaling in human neuroblastoma cells. Exp Cell Res 2005;310:218-28. [PMID: 16120441 DOI: 10.1016/j.yexcr.2005.07.011] [Cited by in Crossref: 67] [Cited by in F6Publishing: 71] [Article Influence: 3.9] [Reference Citation Analysis]
112 Kushwah R, Guezguez B, Lee JB, Hopkins CI, Bhatia M. Pleiotropic roles of Notch signaling in normal, malignant, and developmental hematopoiesis in the human. EMBO Rep 2014;15:1128-38. [PMID: 25252682 DOI: 10.15252/embr.201438842] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
113 Bandapalli OR, Zimmermann M, Kox C, Stanulla M, Schrappe M, Ludwig WD, Koehler R, Muckenthaler MU, Kulozik AE. NOTCH1 activation clinically antagonizes the unfavorable effect of PTEN inactivation in BFM-treated children with precursor T-cell acute lymphoblastic leukemia. Haematologica 2013;98:928-36. [PMID: 23349303 DOI: 10.3324/haematol.2012.073585] [Cited by in Crossref: 47] [Cited by in F6Publishing: 51] [Article Influence: 5.2] [Reference Citation Analysis]
114 Pratt EB, Wentzell JS, Maxson JE, Courter L, Hazelett D, Christian JL. The cell giveth and the cell taketh away: an overview of Notch pathway activation by endocytic trafficking of ligands and receptors. Acta Histochem 2011;113:248-55. [PMID: 20122714 DOI: 10.1016/j.acthis.2010.01.006] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
115 Jo VY, Chau NG, Hornick JL, Krane JF, Sholl LM. Recurrent IDH2 R172X mutations in sinonasal undifferentiated carcinoma. Mod Pathol 2017;30:650-9. [DOI: 10.1038/modpathol.2016.239] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 9.0] [Reference Citation Analysis]
116 Shi X, He BL, Ma AC, Leung AY. Fishing the targets of myeloid malignancies in the era of next generation sequencing. Blood Rev 2016;30:119-30. [PMID: 26443083 DOI: 10.1016/j.blre.2015.09.001] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
117 Liu F, Zou Y, Wang F, Yang B, Zhang Z, Luo Y, Liang M, Zhou J, Huang O. FBXW7 Mutations Promote Cell Proliferation, Migration, and Invasion in Cervical Cancer. Genet Test Mol Biomarkers 2019;23:409-17. [PMID: 31161818 DOI: 10.1089/gtmb.2018.0278] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
118 Blyth BJ, Kakinuma S, Sunaoshi M, Amasaki Y, Hirano-Sakairi S, Ogawa K, Shirakami A, Shang Y, Tsuruoka C, Nishimura M, Shimada Y. Genetic Analysis of T Cell Lymphomas in Carbon Ion-Irradiated Mice Reveals Frequent Interstitial Chromosome Deletions: Implications for Second Cancer Induction in Normal Tissues during Carbon Ion Radiotherapy. PLoS One 2015;10:e0130666. [PMID: 26125582 DOI: 10.1371/journal.pone.0130666] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
119 Marusyk A, Casás-Selves M, Henry CJ, Zaberezhnyy V, Klawitter J, Christians U, DeGregori J. Irradiation alters selection for oncogenic mutations in hematopoietic progenitors. Cancer Res 2009;69:7262-9. [PMID: 19738065 DOI: 10.1158/0008-5472.CAN-09-0604] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 2.6] [Reference Citation Analysis]
120 Capaccione KM, Pine SR. The Notch signaling pathway as a mediator of tumor survival. Carcinogenesis 2013;34:1420-30. [PMID: 23585460 DOI: 10.1093/carcin/bgt127] [Cited by in Crossref: 154] [Cited by in F6Publishing: 148] [Article Influence: 17.1] [Reference Citation Analysis]
121 Belmonte M, Hoofd C, Weng AP, Giambra V. Targeting leukemia stem cells: which pathways drive self-renewal activity in T-cell acute lymphoblastic leukemia? Curr Oncol 2016;23:34-41. [PMID: 26966402 DOI: 10.3747/co.23.2806] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
122 Bertagna A, Toptygin D, Brand L, Barrick D. The effects of conformational heterogeneity on the binding of the Notch intracellular domain to effector proteins: a case of biologically tuned disorder. Biochem Soc Trans 2008;36:157-66. [PMID: 18363556 DOI: 10.1042/BST0360157] [Cited by in Crossref: 37] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
123 Oruganti SR, Torres DJ, Krebsbach S, Asperti-Boursin F, Winters J, Matlawska-Wasowska K, Winter SS, Halsey C, Cannon JL. CARMA1 is a novel regulator of T-ALL disease and leukemic cell migration to the CNS. Leukemia 2017;31:255-8. [PMID: 27698445 DOI: 10.1038/leu.2016.272] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
124 De Keersmaecker K, Atak ZK, Li N, Vicente C, Patchett S, Girardi T, Gianfelici V, Geerdens E, Clappier E, Porcu M, Lahortiga I, Lucà R, Yan J, Hulselmans G, Vranckx H, Vandepoel R, Sweron B, Jacobs K, Mentens N, Wlodarska I, Cauwelier B, Cloos J, Soulier J, Uyttebroeck A, Bagni C, Hassan BA, Vandenberghe P, Johnson AW, Aerts S, Cools J. Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemia. Nat Genet 2013;45:186-90. [PMID: 23263491 DOI: 10.1038/ng.2508] [Cited by in Crossref: 267] [Cited by in F6Publishing: 255] [Article Influence: 26.7] [Reference Citation Analysis]
125 Winter SS, Jiang Z, Khawaja HM, Griffin T, Devidas M, Asselin BL, Larson RS; Children's Oncology Group. Identification of genomic classifiers that distinguish induction failure in T-lineage acute lymphoblastic leukemia: a report from the Children's Oncology Group. Blood 2007;110:1429-38. [PMID: 17495134 DOI: 10.1182/blood-2006-12-059790] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 2.6] [Reference Citation Analysis]
126 Aifantis I, Raetz E, Buonamici S. Molecular pathogenesis of T-cell leukaemia and lymphoma. Nat Rev Immunol 2008;8:380-90. [PMID: 18421304 DOI: 10.1038/nri2304] [Cited by in Crossref: 311] [Cited by in F6Publishing: 272] [Article Influence: 22.2] [Reference Citation Analysis]
127 van Tetering G, Bovenschen N, Meeldijk J, van Diest PJ, Vooijs M. Cleavage of Notch1 by granzyme B disables its transcriptional activity. Biochem J 2011;437:313-22. [PMID: 21548883 DOI: 10.1042/BJ20110226] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
128 Liu Y, Easton J, Shao Y, Maciaszek J, Wang Z, Wilkinson MR, McCastlain K, Edmonson M, Pounds SB, Shi L, Zhou X, Ma X, Sioson E, Li Y, Rusch M, Gupta P, Pei D, Cheng C, Smith MA, Auvil JG, Gerhard DS, Relling MV, Winick NJ, Carroll AJ, Heerema NA, Raetz E, Devidas M, Willman CL, Harvey RC, Carroll WL, Dunsmore KP, Winter SS, Wood BL, Sorrentino BP, Downing JR, Loh ML, Hunger SP, Zhang J, Mullighan CG. The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia. Nat Genet 2017;49:1211-8. [PMID: 28671688 DOI: 10.1038/ng.3909] [Cited by in Crossref: 342] [Cited by in F6Publishing: 329] [Article Influence: 68.4] [Reference Citation Analysis]
129 Ferrando A. NOTCH mutations as prognostic markers in T-ALL. Leukemia 2010;24:2003-4. [DOI: 10.1038/leu.2010.237] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
130 Mullighan CG. Genomic characterization of childhood acute lymphoblastic leukemia. Semin Hematol 2013;50:314-24. [PMID: 24246699 DOI: 10.1053/j.seminhematol.2013.10.001] [Cited by in Crossref: 64] [Cited by in F6Publishing: 55] [Article Influence: 7.1] [Reference Citation Analysis]
131 Bhojwani D, Yang JJ, Pui CH. Biology of childhood acute lymphoblastic leukemia. Pediatr Clin North Am 2015;62:47-60. [PMID: 25435111 DOI: 10.1016/j.pcl.2014.09.004] [Cited by in Crossref: 82] [Cited by in F6Publishing: 70] [Article Influence: 11.7] [Reference Citation Analysis]
132 Ballesteros-arias L, Silva JG, Paiva RA, Carbonetto B, Faísca P, Martins VC. T Cell Acute Lymphoblastic Leukemia as a Consequence of Thymus Autonomy. J I 2019;202:1137-44. [DOI: 10.4049/jimmunol.1801373] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
133 D S P, Chaturvedi PK, Shimokawa T, Kim KH, Park WY. Silencing of Fused Toes Homolog (FTS) Increases Radiosensitivity to Carbon-Ion Through Downregulation of Notch Signaling in Cervical Cancer Cells. Front Oncol 2021;11:730607. [PMID: 34765546 DOI: 10.3389/fonc.2021.730607] [Reference Citation Analysis]
134 Wang R, Zhang H, Xu J, Zhang N, Pan T, Zhong X, Zhang H, Yin L, Yao Y, Wu Q, Li Z, Liu X, Xu K, Niu M. MALT1 Inhibition as a Therapeutic Strategy in T-Cell Acute Lymphoblastic Leukemia by Blocking Notch1-Induced NF-κB Activation. Front Oncol 2020;10:558339. [PMID: 33072583 DOI: 10.3389/fonc.2020.558339] [Reference Citation Analysis]
135 Colombo M, Galletti S, Garavelli S, Platonova N, Paoli A, Basile A, Taiana E, Neri A, Chiaramonte R. Notch signaling deregulation in multiple myeloma: A rational molecular target. Oncotarget 2015;6:26826-40. [PMID: 26308486 DOI: 10.18632/oncotarget.5025] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 4.5] [Reference Citation Analysis]
136 Checquolo S, Palermo R, Cialfi S, Ferrara G, Oliviero C, Talora C, Bellavia D, Giovenco A, Grazioli P, Frati L, Gulino A, Screpanti I. Differential subcellular localization regulates c-Cbl E3 ligase activity upon Notch3 protein in T-cell leukemia. Oncogene 2010;29:1463-74. [PMID: 19966856 DOI: 10.1038/onc.2009.446] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
137 Akil A, Gutiérrez-García AK, Guenter R, Rose JB, Beck AW, Chen H, Ren B. Notch Signaling in Vascular Endothelial Cells, Angiogenesis, and Tumor Progression: An Update and Prospective. Front Cell Dev Biol 2021;9:642352. [PMID: 33681228 DOI: 10.3389/fcell.2021.642352] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
138 Hoofd C, Huang SJ, Gusscott S, Lam S, Wong R, Johnston A, Ben-Neriah S, Steidl C, Scott DW, Bruyere H, Gillan TL, Toze CL, Gerrie AS, Weng AP. Ultrasensitive Detection of NOTCH1 c.7544_7545delCT Mutations in Chronic Lymphocytic Leukemia by Droplet Digital PCR Reveals High Frequency of Subclonal Mutations and Predicts Clinical Outcome in Cases with Trisomy 12. J Mol Diagn 2020;22:571-8. [PMID: 32036086 DOI: 10.1016/j.jmoldx.2020.01.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
139 Stoyanova T, Goldstein AS, Cai H, Drake JM, Huang J, Witte ON. Regulated proteolysis of Trop2 drives epithelial hyperplasia and stem cell self-renewal via β-catenin signaling. Genes Dev 2012;26:2271-85. [PMID: 23070813 DOI: 10.1101/gad.196451.112] [Cited by in Crossref: 72] [Cited by in F6Publishing: 72] [Article Influence: 7.2] [Reference Citation Analysis]
140 Koch U, Radtke F. Notch in T-ALL: new players in a complex disease. Trends in Immunology 2011;32:434-42. [DOI: 10.1016/j.it.2011.06.005] [Cited by in Crossref: 50] [Cited by in F6Publishing: 48] [Article Influence: 4.5] [Reference Citation Analysis]
141 Broadus MR, Chen TW, Neitzel LR, Ng VH, Jodoin JN, Lee LA, Salic A, Robbins DJ, Capobianco AJ, Patton JG, Huppert SS, Lee E. Identification of a Paralog-Specific Notch1 Intracellular Domain Degron. Cell Rep 2016;15:1920-9. [PMID: 27210761 DOI: 10.1016/j.celrep.2016.04.070] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
142 Bi P, Yue F, Karki A, Castro B, Wirbisky SE, Wang C, Durkes A, Elzey BD, Andrisani OM, Bidwell CA, Freeman JL, Konieczny SF, Kuang S. Notch activation drives adipocyte dedifferentiation and tumorigenic transformation in mice. J Exp Med 2016;213:2019-37. [PMID: 27573812 DOI: 10.1084/jem.20160157] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 6.3] [Reference Citation Analysis]
143 Eguchi-Ishimae M, Eguchi M, Kempski H, Greaves M. NOTCH1 mutation can be an early, prenatal genetic event in T-ALL. Blood 2008;111:376-8. [PMID: 17901244 DOI: 10.1182/blood-2007-02-074690] [Cited by in Crossref: 44] [Cited by in F6Publishing: 37] [Article Influence: 2.9] [Reference Citation Analysis]
144 Taghon T, Van de Walle I, De Smet G, De Smedt M, Leclercq G, Vandekerckhove B, Plum J. Notch signaling is required for proliferation but not for differentiation at a well-defined beta-selection checkpoint during human T-cell development. Blood 2009;113:3254-63. [PMID: 18948571 DOI: 10.1182/blood-2008-07-168906] [Cited by in Crossref: 51] [Cited by in F6Publishing: 50] [Article Influence: 3.6] [Reference Citation Analysis]
145 Tao J, Jiang MM, Jiang L, Salvo JS, Zeng HC, Dawson B, Bertin TK, Rao PH, Chen R, Donehower LA, Gannon F, Lee BH. Notch activation as a driver of osteogenic sarcoma. Cancer Cell 2014;26:390-401. [PMID: 25203324 DOI: 10.1016/j.ccr.2014.07.023] [Cited by in Crossref: 83] [Cited by in F6Publishing: 72] [Article Influence: 10.4] [Reference Citation Analysis]
146 Krishnamoorthy V, Carr T, de Pooter RF, Emanuelle AO, Gounari F, Kee BL. Repression of Ccr9 transcription in mouse T lymphocyte progenitors by the Notch signaling pathway. J Immunol 2015;194:3191-200. [PMID: 25710912 DOI: 10.4049/jimmunol.1402443] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
147 Graux C, Cools J, Michaux L, Vandenberghe P, Hagemeijer A. Cytogenetics and molecular genetics of T-cell acute lymphoblastic leukemia: from thymocyte to lymphoblast. Leukemia 2006;20:1496-510. [DOI: 10.1038/sj.leu.2404302] [Cited by in Crossref: 188] [Cited by in F6Publishing: 152] [Article Influence: 11.8] [Reference Citation Analysis]
148 Mansour MR, He S, Li Z, Lobbardi R, Abraham BJ, Hug C, Rahman S, Leon TE, Kuang YY, Zimmerman MW, Blonquist T, Gjini E, Gutierrez A, Tang Q, Garcia-Perez L, Pike-Overzet K, Anders L, Berezovskaya A, Zhou Y, Zon LI, Neuberg D, Fielding AK, Staal FJT, Langenau DM, Sanda T, Young RA, Look AT. JDP2: An oncogenic bZIP transcription factor in T cell acute lymphoblastic leukemia. J Exp Med 2018;215:1929-45. [PMID: 29941549 DOI: 10.1084/jem.20170484] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
149 Bray SJ, Gomez-lamarca M. Notch after cleavage. Current Opinion in Cell Biology 2018;51:103-9. [DOI: 10.1016/j.ceb.2017.12.008] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 9.5] [Reference Citation Analysis]
150 Bergamo A, Dyson PJ, Sava G. The mechanism of tumour cell death by metal-based anticancer drugs is not only a matter of DNA interactions. Coordination Chemistry Reviews 2018;360:17-33. [DOI: 10.1016/j.ccr.2018.01.009] [Cited by in Crossref: 61] [Cited by in F6Publishing: 40] [Article Influence: 15.3] [Reference Citation Analysis]
151 Iacobucci I, Mullighan CG. Genetic Basis of Acute Lymphoblastic Leukemia. J Clin Oncol. 2017;35:975-983. [PMID: 28297628 DOI: 10.1200/jco.2016.70.7836] [Cited by in Crossref: 183] [Cited by in F6Publishing: 112] [Article Influence: 36.6] [Reference Citation Analysis]
152 Canalis E, Yu J, Schilling L, Yee SP, Zanotti S. The lateral meningocele syndrome mutation causes marked osteopenia in mice. J Biol Chem 2018;293:14165-77. [PMID: 30042232 DOI: 10.1074/jbc.RA118.004242] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
153 Kong L, Zhang X, Li C, Zhou L. Potential therapeutic targets and small molecular drugs for pediatric B-precursor acute lymphoblastic leukemia treatment based on microarray data. Oncol Lett 2017;14:1543-9. [PMID: 28789378 DOI: 10.3892/ol.2017.6343] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
154 Osborne BA, Minter LM. Notch signalling during peripheral T-cell activation and differentiation. Nat Rev Immunol 2007;7:64-75. [PMID: 17170755 DOI: 10.1038/nri1998] [Cited by in Crossref: 162] [Cited by in F6Publishing: 150] [Article Influence: 10.1] [Reference Citation Analysis]
155 Ridges S, Heaton WL, Joshi D, Choi H, Eiring A, Batchelor L, Choudhry P, Manos EJ, Sofla H, Sanati A, Welborn S, Agarwal A, Spangrude GJ, Miles RR, Cox JE, Frazer JK, Deininger M, Balan K, Sigman M, Müschen M, Perova T, Johnson R, Montpellier B, Guidos CJ, Jones DA, Trede NS. Zebrafish screen identifies novel compound with selective toxicity against leukemia. Blood 2012;119:5621-31. [PMID: 22490804 DOI: 10.1182/blood-2011-12-398818] [Cited by in Crossref: 107] [Cited by in F6Publishing: 99] [Article Influence: 10.7] [Reference Citation Analysis]
156 Sant DW, Tao W, Field MG, Pelaez D, Jin K, Capobianco A, Dubovy SR, Tse DT, Wang G. Whole Exome Sequencing of Lacrimal Gland Adenoid Cystic Carcinoma. Invest Ophthalmol Vis Sci 2017;58:BIO240-6. [PMID: 28820917 DOI: 10.1167/iovs.16-21097] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
157 Kathrein KL, Chari S, Winandy S. Ikaros directly represses the notch target gene Hes1 in a leukemia T cell line: implications for CD4 regulation. J Biol Chem 2008;283:10476-84. [PMID: 18287091 DOI: 10.1074/jbc.M709643200] [Cited by in Crossref: 43] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
158 Guo T, Califano JA. Molecular biology and immunology of head and neck cancer. Surg Oncol Clin N Am 2015;24:397-407. [PMID: 25979390 DOI: 10.1016/j.soc.2015.03.002] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
159 Buonamici S, Trimarchi T, Ruocco MG, Reavie L, Cathelin S, Mar BG, Klinakis A, Lukyanov Y, Tseng JC, Sen F, Gehrie E, Li M, Newcomb E, Zavadil J, Meruelo D, Lipp M, Ibrahim S, Efstratiadis A, Zagzag D, Bromberg JS, Dustin ML, Aifantis I. CCR7 signalling as an essential regulator of CNS infiltration in T-cell leukaemia. Nature 2009;459:1000-4. [PMID: 19536265 DOI: 10.1038/nature08020] [Cited by in Crossref: 178] [Cited by in F6Publishing: 170] [Article Influence: 13.7] [Reference Citation Analysis]
160 Rossi D, Rasi S, Fabbri G, Spina V, Fangazio M, Forconi F, Marasca R, Laurenti L, Bruscaggin A, Cerri M, Monti S, Cresta S, Famà R, De Paoli L, Bulian P, Gattei V, Guarini A, Deaglio S, Capello D, Rabadan R, Pasqualucci L, Dalla-Favera R, Foà R, Gaidano G. Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia. Blood 2012;119:521-9. [PMID: 22077063 DOI: 10.1182/blood-2011-09-379966] [Cited by in Crossref: 300] [Cited by in F6Publishing: 280] [Article Influence: 27.3] [Reference Citation Analysis]
161 Moeini A, Cornellà H, Villanueva A. Emerging signaling pathways in hepatocellular carcinoma. Liver Cancer 2012;1:83-93. [PMID: 24159576 DOI: 10.1159/000342405] [Cited by in Crossref: 111] [Cited by in F6Publishing: 111] [Article Influence: 13.9] [Reference Citation Analysis]
162 Chiang MY, Radojcic V, Maillard I. Oncogenic Notch signaling in T-cell and B-cell lymphoproliferative disorders. Curr Opin Hematol 2016;23:362-70. [PMID: 27135981 DOI: 10.1097/MOH.0000000000000254] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 4.2] [Reference Citation Analysis]
163 Sorrentino C, Cuneo A, Roti G. Therapeutic Targeting of Notch Signaling Pathway in Hematological Malignancies. Mediterr J Hematol Infect Dis 2019;11:e2019037. [PMID: 31308913 DOI: 10.4084/MJHID.2019.037] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
164 Thandapani P, Kloetgen A, Witkowski MT, Glytsou C, Lee AK, Wang E, Wang J, Leboeuf SE, Avrampou K, Papagiannakopoulos T, Tsirigos A, Aifantis I. Valine tRNA levels and availability regulate complex I assembly in leukaemia. Nature. [DOI: 10.1038/s41586-021-04244-1] [Reference Citation Analysis]
165 Shirzad R, Shahrabi S, Ahmadzadeh A, Kampen KR, Shahjahani M, Saki N. Signaling and molecular basis of bone marrow niche angiogenesis in leukemia. Clin Transl Oncol 2016;18:957-71. [PMID: 26742939 DOI: 10.1007/s12094-015-1477-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
166 Tasian SK, Loh ML, Hunger SP. Childhood acute lymphoblastic leukemia: Integrating genomics into therapy. Cancer 2015;121:3577-90. [PMID: 26194091 DOI: 10.1002/cncr.29573] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 4.6] [Reference Citation Analysis]
167 Tiemessen MM, Baert MR, Schonewille T, Brugman MH, Famili F, Salvatori DC, Meijerink JP, Ozbek U, Clevers H, van Dongen JJ, Staal FJ. The nuclear effector of Wnt-signaling, Tcf1, functions as a T-cell-specific tumor suppressor for development of lymphomas. PLoS Biol 2012;10:e1001430. [PMID: 23185135 DOI: 10.1371/journal.pbio.1001430] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 5.1] [Reference Citation Analysis]
168 Ileana Dumbrava EE, Mills GB, Yap TA. Targeting gamma secretase: has progress moved up a Notch? Ann Oncol 2018;29:1889-91. [PMID: 30084907 DOI: 10.1093/annonc/mdy307] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
169 Hefazi M, Litzow MR. Recent Advances in the Biology and Treatment of T Cell Acute Lymphoblastic Leukemia. Curr Hematol Malig Rep 2018;13:265-74. [PMID: 29948644 DOI: 10.1007/s11899-018-0455-9] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 6.3] [Reference Citation Analysis]
170 Heo J, Eki R, Abbas T. Deregulation of F-box proteins and its consequence on cancer development, progression and metastasis. Semin Cancer Biol 2016;36:33-51. [PMID: 26432751 DOI: 10.1016/j.semcancer.2015.09.015] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 4.6] [Reference Citation Analysis]
171 Baeten JT, de Jong JLO. Genetic Models of Leukemia in Zebrafish. Front Cell Dev Biol 2018;6:115. [PMID: 30294597 DOI: 10.3389/fcell.2018.00115] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
172 Huh HJ, Lee SH, Yoo KH, Sung KW, Koo HH, Jang JH, Kim K, Kim SJ, Kim WS, Jung CW, Lee KO, Kim SH, Kim HJ. Gene mutation profiles and prognostic implications in Korean patients with T-lymphoblastic leukemia. Ann Hematol 2013;92:635-44. [PMID: 23354995 DOI: 10.1007/s00277-012-1664-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
173 Klein-Hessling S, Rudolf R, Muhammad K, Knobeloch KP, Maqbool MA, Cauchy P, Andrau JC, Avots A, Talora C, Ellenrieder V, Screpanti I, Serfling E, Patra AK. A threshold level of NFATc1 activity facilitates thymocyte differentiation and opposes notch-driven leukaemia development. Nat Commun 2016;7:11841. [PMID: 27312418 DOI: 10.1038/ncomms11841] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
174 Sail V, Hadden MK. Notch Pathway Modulators as Anticancer Chemotherapeutics. Annual Reports in Medicinal Chemistry Volume 47. Elsevier; 2012. pp. 267-80. [DOI: 10.1016/b978-0-12-396492-2.00018-7] [Cited by in Crossref: 6] [Article Influence: 0.6] [Reference Citation Analysis]
175 Roos-Weil D, Nguyen-Khac F, Bernard OA. Chronic lymphocytic leukemia: Time to go past genomics? Am J Hematol 2016;91:518-28. [PMID: 26800490 DOI: 10.1002/ajh.24301] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
176 Kaveri D, Kastner P, Dembélé D, Nerlov C, Chan S, Kirstetter P. β-Catenin activation synergizes with Pten loss and Myc overexpression in Notch-independent T-ALL. Blood 2013;122:694-704. [DOI: 10.1182/blood-2012-12-471904] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 3.8] [Reference Citation Analysis]
177 Kałafut J, Czerwonka A, Anameriç A, Przybyszewska-Podstawka A, Misiorek JO, Rivero-Müller A, Nees M. Shooting at Moving and Hidden Targets-Tumour Cell Plasticity and the Notch Signalling Pathway in Head and Neck Squamous Cell Carcinomas. Cancers (Basel) 2021;13:6219. [PMID: 34944837 DOI: 10.3390/cancers13246219] [Reference Citation Analysis]
178 Beachy SH, Onozawa M, Silverman D, Chung YJ, Rivera MM, Aplan PD. Isolated Hoxa9 overexpression predisposes to the development of lymphoid but not myeloid leukemia. Exp Hematol 2013;41:518-529.e5. [PMID: 23435313 DOI: 10.1016/j.exphem.2013.02.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
179 Sandy AR, Jones M, Maillard I. Notch signaling and development of the hematopoietic system. Adv Exp Med Biol 2012;727:71-88. [PMID: 22399340 DOI: 10.1007/978-1-4614-0899-4_6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
180 Kox C, Zimmermann M, Stanulla M, Leible S, Schrappe M, Ludwig WD, Koehler R, Tolle G, Bandapalli OR, Breit S, Muckenthaler MU, Kulozik AE. The favorable effect of activating NOTCH1 receptor mutations on long-term outcome in T-ALL patients treated on the ALL-BFM 2000 protocol can be separated from FBXW7 loss of function. Leukemia 2010;24:2005-13. [PMID: 20944675 DOI: 10.1038/leu.2010.203] [Cited by in Crossref: 86] [Cited by in F6Publishing: 85] [Article Influence: 7.2] [Reference Citation Analysis]
181 Qin WD, Zhang F, Qin XJ, Wang J, Meng X, Wang H, Guo HP, Wu QZ, Wu DW, Zhang MX. Notch1 inhibition reduces low shear stress-induced plaque formation. Int J Biochem Cell Biol 2016;72:63-72. [PMID: 26783939 DOI: 10.1016/j.biocel.2016.01.007] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
182 Zheng L, Conner SD. Glycogen synthase kinase 3β inhibition enhances Notch1 recycling. Mol Biol Cell 2018;29:389-95. [PMID: 29237816 DOI: 10.1091/mbc.E17-07-0474] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
183 Suh Y, Amelio I, Guerrero Urbano T, Tavassoli M. Clinical update on cancer: molecular oncology of head and neck cancer. Cell Death Dis 2014;5:e1018. [PMID: 24457962 DOI: 10.1038/cddis.2013.548] [Cited by in Crossref: 104] [Cited by in F6Publishing: 97] [Article Influence: 13.0] [Reference Citation Analysis]
184 Hagemeijer A, Graux C. ABL1 rearrangements in T-cell acute lymphoblastic leukemia. Genes Chromosomes Cancer 2010;49:299-308. [PMID: 20073070 DOI: 10.1002/gcc.20743] [Cited by in Crossref: 5] [Cited by in F6Publishing: 21] [Article Influence: 0.4] [Reference Citation Analysis]
185 Colomer-Lahiguera S, Strehl S. Complexity of NOTCH1 juxtamembrane insertion mutations in T-cell acute lymphoblastic leukemia. Leuk Lymphoma 2016;57:1219-22. [PMID: 26292904 DOI: 10.3109/10428194.2015.1080366] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
186 Bonnet M, Loosveld M, Montpellier B, Navarro JM, Quilichini B, Picard C, Di Cristofaro J, Bagnis C, Fossat C, Hernandez L. Posttranscriptional deregulation of MYC via PTEN constitutes a major alternative pathway of MYC activation in T-cell acute lymphoblastic leukemia. Blood. 2011;117:6650-6659. [PMID: 21527520 DOI: 10.1182/blood-2011-02-336842] [Cited by in Crossref: 53] [Cited by in F6Publishing: 54] [Article Influence: 4.8] [Reference Citation Analysis]
187 Gerby B, Clappier E, Armstrong F, Deswarte C, Calvo J, Poglio S, Soulier J, Boissel N, Leblanc T, Baruchel A, Landman-Parker J, Roméo PH, Ballerini P, Pflumio F. Expression of CD34 and CD7 on human T-cell acute lymphoblastic leukemia discriminates functionally heterogeneous cell populations. Leukemia 2011;25:1249-58. [PMID: 21566655 DOI: 10.1038/leu.2011.93] [Cited by in Crossref: 48] [Cited by in F6Publishing: 39] [Article Influence: 4.4] [Reference Citation Analysis]
188 Li N, Fassl A, Chick J, Inuzuka H, Li X, Mansour MR, Liu L, Wang H, King B, Shaik S, Gutierrez A, Ordureau A, Otto T, Kreslavsky T, Baitsch L, Bury L, Meyer CA, Ke N, Mulry KA, Kluk MJ, Roy M, Kim S, Zhang X, Geng Y, Zagozdzon A, Jenkinson S, Gale RE, Linch DC, Zhao JJ, Mullighan CG, Harper JW, Aster JC, Aifantis I, von Boehmer H, Gygi SP, Wei W, Look AT, Sicinski P. Cyclin C is a haploinsufficient tumour suppressor. Nat Cell Biol 2014;16:1080-91. [PMID: 25344755 DOI: 10.1038/ncb3046] [Cited by in Crossref: 84] [Cited by in F6Publishing: 74] [Article Influence: 10.5] [Reference Citation Analysis]
189 Li X, Sanda T, Look AT, Novina CD, von Boehmer H. Repression of tumor suppressor miR-451 is essential for NOTCH1-induced oncogenesis in T-ALL. J Exp Med 2011;208:663-75. [PMID: 21464222 DOI: 10.1084/jem.20102384] [Cited by in Crossref: 87] [Cited by in F6Publishing: 81] [Article Influence: 7.9] [Reference Citation Analysis]
190 Wang S, Itoh M, Shiratori E, Ohtaka M, Tohda S. NOTCH activation promotes glycosyltransferase expression in human myeloid leukemia cells. Hematol Rep 2018;10:7576. [PMID: 30344988 DOI: 10.4081/hr.2018.7576] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
191 González-García S, Mosquera M, Fuentes P, Palumbo T, Escudero A, Pérez-Martínez A, Ramírez M, Corcoran AE, Toribio ML. IL-7R is essential for leukemia-initiating cell activity of T-cell acute lymphoblastic leukemia. Blood 2019;134:2171-82. [PMID: 31530562 DOI: 10.1182/blood.2019000982] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
192 Maurya SK, Khan P, Rehman AU, Kanchan RK, Perumal N, Mahapatra S, Chand HS, Santamaria-Barria JA, Batra SK, Nasser MW. Rethinking the chemokine cascade in brain metastasis: Preventive and therapeutic implications. Semin Cancer Biol 2021:S1044-579X(21)00302-3. [PMID: 34968667 DOI: 10.1016/j.semcancer.2021.12.009] [Reference Citation Analysis]
193 Silva A, Jotta PY, Silveira AB, Ribeiro D, Brandalise SR, Yunes JA, Barata JT. Regulation of PTEN by CK2 and Notch1 in primary T-cell acute lymphoblastic leukemia: rationale for combined use of CK2- and gamma-secretase inhibitors. Haematologica 2010;95:674-8. [PMID: 20015880 DOI: 10.3324/haematol.2009.011999] [Cited by in Crossref: 58] [Cited by in F6Publishing: 53] [Article Influence: 4.5] [Reference Citation Analysis]
194 De Smedt M, Taghon T, Van de Walle I, De Smet G, Leclercq G, Plum J. Notch signaling induces cytoplasmic CD3 epsilon expression in human differentiating NK cells. Blood 2007;110:2696-703. [PMID: 17630354 DOI: 10.1182/blood-2007-03-082206] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 2.4] [Reference Citation Analysis]
195 Mukherjee A, Veraksa A, Bauer A, Rosse C, Camonis J, Artavanis-Tsakonas S. Regulation of Notch signalling by non-visual beta-arrestin. Nat Cell Biol 2005;7:1191-201. [PMID: 16284625 DOI: 10.1038/ncb1327] [Cited by in Crossref: 161] [Cited by in F6Publishing: 149] [Article Influence: 9.5] [Reference Citation Analysis]
196 Matesic LE, Haines DC, Copeland NG, Jenkins NA. Itch genetically interacts with Notch1 in a mouse autoimmune disease model. Hum Mol Genet 2006;15:3485-97. [PMID: 17095521 DOI: 10.1093/hmg/ddl425] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 2.3] [Reference Citation Analysis]
197 Luo M, Zhang Q, Xia M, Hu F, Ma Z, Chen Z, Guo AY. Differential Co-expression and Regulatory Network Analysis Uncover the Relapse Factor and Mechanism of T Cell Acute Leukemia. Mol Ther Nucleic Acids 2018;12:184-94. [PMID: 30195757 DOI: 10.1016/j.omtn.2018.05.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
198 Lee S, Kumano K, Masuda S, Hangaishi A, Takita J, Nakazaki K, Kurokawa M, Hayashi Y, Ogawa S, Chiba S. Mutations of the Notch1 gene in T-cell acute lymphoblastic leukemia: analysis in adults and children. Leukemia 2005;19:1841-3. [DOI: 10.1038/sj.leu.2403896] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 2.6] [Reference Citation Analysis]
199 Zanotti S, Canalis E. Notch and the skeleton. Mol Cell Biol 2010;30:886-96. [PMID: 19995916 DOI: 10.1128/MCB.01285-09] [Cited by in Crossref: 112] [Cited by in F6Publishing: 80] [Article Influence: 8.6] [Reference Citation Analysis]
200 Hacein-Bey-Abina S, Garrigue A, Wang GP, Soulier J, Lim A, Morillon E, Clappier E, Caccavelli L, Delabesse E, Beldjord K, Asnafi V, MacIntyre E, Dal Cortivo L, Radford I, Brousse N, Sigaux F, Moshous D, Hauer J, Borkhardt A, Belohradsky BH, Wintergerst U, Velez MC, Leiva L, Sorensen R, Wulffraat N, Blanche S, Bushman FD, Fischer A, Cavazzana-Calvo M. Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. J Clin Invest. 2008;118:3132-3142. [PMID: 18688285 DOI: 10.1172/jci35700] [Cited by in Crossref: 1187] [Cited by in F6Publishing: 652] [Article Influence: 84.8] [Reference Citation Analysis]
201 Ding J, Cardoso AA, Yoshimoto M, Kobayashi M. The Earliest T-Precursors in the Mouse Embryo Are Susceptible to Leukemic Transformation. Front Cell Dev Biol 2021;9:634151. [PMID: 33996794 DOI: 10.3389/fcell.2021.634151] [Reference Citation Analysis]
202 Rota R, Ciarapica R, Miele L, Locatelli F. Notch signaling in pediatric soft tissue sarcomas. BMC Med 2012;10:141. [PMID: 23158439 DOI: 10.1186/1741-7015-10-141] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
203 Bellavia D, Mecarozzi M, Campese AF, Grazioli P, Talora C, Frati L, Gulino A, Screpanti I. Notch3 and the Notch3-upregulated RNA-binding protein HuD regulate Ikaros alternative splicing. EMBO J 2007;26:1670-80. [PMID: 17332745 DOI: 10.1038/sj.emboj.7601626] [Cited by in Crossref: 60] [Cited by in F6Publishing: 62] [Article Influence: 4.0] [Reference Citation Analysis]
204 Chen Y, Greenwald I. hecd-1 modulates notch activity in Caenorhabditis elegans. G3 (Bethesda) 2014;5:353-9. [PMID: 25552605 DOI: 10.1534/g3.114.015321] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
205 Brazel AJ, Vernimmen D. The complexity of epigenetic diseases. J Pathol 2016;238:333-44. [PMID: 26419725 DOI: 10.1002/path.4647] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 3.1] [Reference Citation Analysis]
206 Tammam J, Ware C, Efferson C, O'Neil J, Rao S, Qu X, Gorenstein J, Angagaw M, Kim H, Kenific C, Kunii K, Leach KJ, Nikov G, Zhao J, Dai X, Hardwick J, Scott M, Winter C, Bristow L, Elbi C, Reilly JF, Look T, Draetta G, Van der Ploeg L, Kohl NE, Strack PR, Majumder PK. Down-regulation of the Notch pathway mediated by a gamma-secretase inhibitor induces anti-tumour effects in mouse models of T-cell leukaemia. Br J Pharmacol 2009;158:1183-95. [PMID: 19775282 DOI: 10.1111/j.1476-5381.2009.00389.x] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 4.2] [Reference Citation Analysis]
207 Liu Z, Teng L, Bailey SK, Frost AR, Bland KI, LoBuglio AF, Ruppert JM, Lobo-Ruppert SM. Epithelial transformation by KLF4 requires Notch1 but not canonical Notch1 signaling. Cancer Biol Ther 2009;8:1840-51. [PMID: 19717984 DOI: 10.4161/cbt.8.19.9440] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
208 Cromm PM, Spiegel J, Grossmann TN. Hydrocarbon stapled peptides as modulators of biological function. ACS Chem Biol 2015;10:1362-75. [PMID: 25798993 DOI: 10.1021/cb501020r] [Cited by in Crossref: 175] [Cited by in F6Publishing: 151] [Article Influence: 25.0] [Reference Citation Analysis]
209 Yuan L, Ma L, Xue H, Song S. Relationship between the upregulation of Notch1 signaling and the clinical characteristics of patients with papillary thyroid carcinoma in East Asia: a systematic review and meta-analysis. Cancer Cell Int 2019;19:5. [PMID: 30622441 DOI: 10.1186/s12935-018-0723-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
210 Ntziachristos P, Lim JS, Sage J, Aifantis I. From fly wings to targeted cancer therapies: a centennial for notch signaling. Cancer Cell. 2014;25:318-334. [PMID: 24651013 DOI: 10.1016/j.ccr.2014.02.018] [Cited by in Crossref: 224] [Cited by in F6Publishing: 198] [Article Influence: 28.0] [Reference Citation Analysis]
211 Li W, Jiang Z, Li T, Wei X, Zheng Y, Wu D, Yang L, Chen S, Xu B, Zhong M, Jiang J, Hu Y, Su H, Zhang M, Huang X, Geng S, Weng J, Du X, Liu P, Li Y, Liu H, Yao Y, Li P. Genome-wide analyses identify KLF4 as an important negative regulator in T-cell acute lymphoblastic leukemia through directly inhibiting T-cell associated genes. Mol Cancer 2015;14:26. [PMID: 25644173 DOI: 10.1186/s12943-014-0285-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
212 Tesio M, Trinquand A, Macintyre E, Asnafi V. Oncogenic PTEN functions and models in T-cell malignancies. Oncogene 2016;35:3887-96. [PMID: 26616857 DOI: 10.1038/onc.2015.462] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
213 Martínez-Trillos A, Quesada V, Villamor N, Puente XS, López-Otín C, Campo E. Recurrent gene mutations in CLL. Adv Exp Med Biol 2013;792:87-107. [PMID: 24014293 DOI: 10.1007/978-1-4614-8051-8_4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
214 Fabbri G, Rasi S, Rossi D, Trifonov V, Khiabanian H, Ma J, Grunn A, Fangazio M, Capello D, Monti S, Cresta S, Gargiulo E, Forconi F, Guarini A, Arcaini L, Paulli M, Laurenti L, Larocca LM, Marasca R, Gattei V, Oscier D, Bertoni F, Mullighan CG, Foá R, Pasqualucci L, Rabadan R, Dalla-Favera R, Gaidano G. Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation. J Exp Med 2011;208:1389-401. [PMID: 21670202 DOI: 10.1084/jem.20110921] [Cited by in Crossref: 428] [Cited by in F6Publishing: 396] [Article Influence: 38.9] [Reference Citation Analysis]
215 McCaw TR, Inga E, Chen H, Jaskula-Sztul R, Dudeja V, Bibb JA, Ren B, Rose JB. Gamma Secretase Inhibitors in Cancer: A Current Perspective on Clinical Performance. Oncologist 2021;26:e608-21. [PMID: 33284507 DOI: 10.1002/onco.13627] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
216 Giaimo BD, Borggrefe T. Introduction to Molecular Mechanisms in Notch Signal Transduction and Disease Pathogenesis. In: Borggrefe T, Giaimo BD, editors. Molecular Mechanisms of Notch Signaling. Cham: Springer International Publishing; 2018. pp. 3-30. [DOI: 10.1007/978-3-319-89512-3_1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
217 Tottone L, Lancho O, Loh JW, Singh A, Kimura S, Roels J, Kuchmiy A, Strubbe S, Lawlor MA, da Silva-Diz V, Luo S, Gachet S, García-Prieto CA, Hagelaar R, Esteller M, Meijerink JPP, Soulier J, Taghon T, Van Vlierberghe P, Mullighan CG, Khiabanian H, Rocha PP, Herranz D. A Tumor Suppressor Enhancer of PTEN in T-cell development and leukemia. Blood Cancer Discov 2021;2:92-109. [PMID: 33458694 DOI: 10.1158/2643-3230.BCD-20-0201] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
218 Anekpuritanang T, Pongsapich W, Watcharadilokkul T, Ngaotepprutaram P, Pithuksurachai P, Bunbanjerdsuk S. Notch Intracellular Domain (NICD) Expression and Clinical Manifestations of Second Primary Tumor at Esophagus in Patients with Head and Neck Squamous Cell Carcinoma. Onco Targets Ther 2019;12:11175-81. [PMID: 31908484 DOI: 10.2147/OTT.S227745] [Reference Citation Analysis]
219 Azizidoost S, Asnafi AA, Saki N. Signaling-chemokine axis network in brain as a sanctuary site for metastasis. J Cell Physiol 2019;234:3376-82. [PMID: 30187487 DOI: 10.1002/jcp.27305] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
220 Wang NJ, Sanborn Z, Arnett KL, Bayston LJ, Liao W, Proby CM, Leigh IM, Collisson EA, Gordon PB, Jakkula L. Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma. Proc Natl Acad Sci USA. 2011;108:17761-17766. [PMID: 22006338 DOI: 10.1073/pnas.1114669108] [Cited by in Crossref: 301] [Cited by in F6Publishing: 274] [Article Influence: 27.4] [Reference Citation Analysis]
221 Durinck K, Wallaert A, Van de Walle I, Van Loocke W, Volders PJ, Vanhauwaert S, Geerdens E, Benoit Y, Van Roy N, Poppe B, Soulier J, Cools J, Mestdagh P, Vandesompele J, Rondou P, Van Vlierberghe P, Taghon T, Speleman F. The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia. Haematologica 2014;99:1808-16. [PMID: 25344525 DOI: 10.3324/haematol.2014.115683] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 3.9] [Reference Citation Analysis]
222 Ho C, Kluk MJ. Molecular Pathology: Predictive, Prognostic, and Diagnostic Markers in Lymphoid Neoplasms. Surg Pathol Clin 2016;9:489-521. [PMID: 27523974 DOI: 10.1016/j.path.2016.04.011] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
223 Wang J, Wakeman TP, Lathia JD, Hjelmeland AB, Wang XF, White RR, Rich JN, Sullenger BA. Notch promotes radioresistance of glioma stem cells. Stem Cells. 2010;28:17-28. [PMID: 19921751 DOI: 10.1002/stem.261] [Cited by in Crossref: 77] [Cited by in F6Publishing: 268] [Article Influence: 6.4] [Reference Citation Analysis]
224 Aggarwal V, Tuli HS, Varol M, Tuorkey M, Sak K, Parashar NC, Barwal TS, Sharma U, Iqubal A, Parashar G, Jain A. NOTCH signaling: Journey of an evolutionarily conserved pathway in driving tumor progression and its modulation as a therapeutic target. Crit Rev Oncol Hematol 2021;164:103403. [PMID: 34214610 DOI: 10.1016/j.critrevonc.2021.103403] [Reference Citation Analysis]
225 Du XL, Chen Q. Recent advancements of bortezomib in acute lymphocytic leukemia treatment. Acta Haematol 2013;129:207-14. [PMID: 23295437 DOI: 10.1159/000345260] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
226 Morin RD, Gascoyne RD. Newly Identified Mechanisms in B-Cell Non-Hodgkin Lymphomas Uncovered by Next-Generation Sequencing. Seminars in Hematology 2013;50:303-13. [DOI: 10.1053/j.seminhematol.2013.09.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
227 Cramer SD, Aplan PD, Durum SK. Therapeutic targeting of IL-7Rα signaling pathways in ALL treatment. Blood 2016;128:473-8. [PMID: 27268088 DOI: 10.1182/blood-2016-03-679209] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 4.3] [Reference Citation Analysis]
228 Mullighan CG. Genomic profiling of B-progenitor acute lymphoblastic leukemia. Best Pract Res Clin Haematol 2011;24:489-503. [PMID: 22127311 DOI: 10.1016/j.beha.2011.09.004] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 3.2] [Reference Citation Analysis]
229 Sayitoğlu M, Erbilgin Y, Hatırnaz Ng O, Yıldız I, Celkan T, Anak S, Devecioğlu O, Aydoğan G, Karaman S, Sarper N, Timur C, Ure U, Ozbek U. Upregulation of T-Cell-Specific Transcription Factor Expression in Pediatric T-Cell Acute Lymphoblastic Leukemia (T-ALL). Turk J Haematol 2012;29:325-33. [PMID: 24385720 DOI: 10.5505/tjh.2012.13540] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
230 Canté-Barrett K, Spijkers-Hagelstein JA, Buijs-Gladdines JG, Uitdehaag JC, Smits WK, van der Zwet J, Buijsman RC, Zaman GJ, Pieters R, Meijerink JP. MEK and PI3K-AKT inhibitors synergistically block activated IL7 receptor signaling in T-cell acute lymphoblastic leukemia. Leukemia 2016;30:1832-43. [PMID: 27174491 DOI: 10.1038/leu.2016.83] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 8.0] [Reference Citation Analysis]
231 Ho DM, Pallavi SK, Artavanis-Tsakonas S. The Notch-mediated hyperplasia circuitry in Drosophila reveals a Src-JNK signaling axis. Elife 2015;4:e05996. [PMID: 26222204 DOI: 10.7554/eLife.05996] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 3.1] [Reference Citation Analysis]
232 Demarest RM, Ratti F, Capobianco AJ. It's T-ALL about Notch. Oncogene 2008;27:5082-91. [DOI: 10.1038/onc.2008.222] [Cited by in Crossref: 78] [Cited by in F6Publishing: 76] [Article Influence: 5.6] [Reference Citation Analysis]
233 Belver L, Albero R, Ferrando AA. Deregulation of enhancer structure, function, and dynamics in acute lymphoblastic leukemia. Trends Immunol 2021;42:418-31. [PMID: 33858773 DOI: 10.1016/j.it.2021.03.005] [Reference Citation Analysis]
234 Allgood AG, Barrick D. Mapping the Deltex-binding surface on the notch ankyrin domain using analytical ultracentrifugation. J Mol Biol 2011;414:243-59. [PMID: 22001695 DOI: 10.1016/j.jmb.2011.09.050] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
235 Thompson BJ, Buonamici S, Sulis ML, Palomero T, Vilimas T, Basso G, Ferrando A, Aifantis I. The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia. J Exp Med 2007;204:1825-35. [PMID: 17646408 DOI: 10.1084/jem.20070872] [Cited by in Crossref: 336] [Cited by in F6Publishing: 317] [Article Influence: 22.4] [Reference Citation Analysis]
236 Shen Q, Reedijk M. Notch Signaling and the Breast Cancer Microenvironment. Adv Exp Med Biol 2021;1287:183-200. [PMID: 33034033 DOI: 10.1007/978-3-030-55031-8_12] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
237 Magee CN, Riella LV. Notch and its ligands in alloimmunity and rejection. Curr Opin Organ Transplant 2016;21:15-21. [PMID: 26626420 DOI: 10.1097/MOT.0000000000000266] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
238 Mendes RD, Canté-Barrett K, Pieters R, Meijerink JP. The relevance of PTEN-AKT in relation to NOTCH1-directed treatment strategies in T-cell acute lymphoblastic leukemia. Haematologica 2016;101:1010-7. [PMID: 27582570 DOI: 10.3324/haematol.2016.146381] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 6.8] [Reference Citation Analysis]
239 Pinnix CC, Lee JT, Liu ZJ, McDaid R, Balint K, Beverly LJ, Brafford PA, Xiao M, Himes B, Zabierowski SE. Active Notch1 confers a transformed phenotype to primary human melanocytes. Cancer Res. 2009;69:5312-5320. [PMID: 19549918 DOI: 10.1158/0008-5472.can-08-3767] [Cited by in Crossref: 83] [Cited by in F6Publishing: 49] [Article Influence: 6.4] [Reference Citation Analysis]
240 Braune EB, Tsoi YL, Phoon YP, Landor S, Silva Cascales H, Ramsköld D, Deng Q, Lindqvist A, Lian X, Sahlgren C, Jin SB, Lendahl U. Loss of CSL Unlocks a Hypoxic Response and Enhanced Tumor Growth Potential in Breast Cancer Cells. Stem Cell Reports 2016;6:643-51. [PMID: 27066863 DOI: 10.1016/j.stemcr.2016.03.004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
241 Vanden Bempt M, Demeyer S, Broux M, De Bie J, Bornschein S, Mentens N, Vandepoel R, Geerdens E, Radaelli E, Bornhauser BC, Kulozik AE, Meijerink JP, Bourquin JP, de Bock CE, Cools J. Cooperative Enhancer Activation by TLX1 and STAT5 Drives Development of NUP214-ABL1/TLX1-Positive T Cell Acute Lymphoblastic Leukemia. Cancer Cell 2018;34:271-285.e7. [PMID: 30107177 DOI: 10.1016/j.ccell.2018.07.007] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 8.0] [Reference Citation Analysis]
242 Neumann M, Coskun E, Fransecky L, Mochmann LH, Bartram I, Sartangi NF, Heesch S, Gökbuget N, Schwartz S, Brandts C, Schlee C, Haas R, Dührsen U, Griesshammer M, Döhner H, Ehninger G, Burmeister T, Blau O, Thiel E, Hoelzer D, Hofmann WK, Baldus CD. FLT3 mutations in early T-cell precursor ALL characterize a stem cell like leukemia and imply the clinical use of tyrosine kinase inhibitors. PLoS One 2013;8:e53190. [PMID: 23359050 DOI: 10.1371/journal.pone.0053190] [Cited by in Crossref: 59] [Cited by in F6Publishing: 48] [Article Influence: 6.6] [Reference Citation Analysis]
243 Tien AC, Rajan A, Bellen HJ. A Notch updated. J Cell Biol. 2009;184:621-629. [PMID: 19255248 DOI: 10.1083/jcb.200811141] [Cited by in Crossref: 130] [Cited by in F6Publishing: 125] [Article Influence: 10.0] [Reference Citation Analysis]
244 Levy DS, Kahana JA, Kumar R. AKT inhibitor, GSK690693, induces growth inhibition and apoptosis in acute lymphoblastic leukemia cell lines. Blood 2009;113:1723-9. [PMID: 19064730 DOI: 10.1182/blood-2008-02-137737] [Cited by in Crossref: 96] [Cited by in F6Publishing: 97] [Article Influence: 6.9] [Reference Citation Analysis]
245 Oswald F, Rodriguez P, Giaimo BD, Antonello ZA, Mira L, Mittler G, Thiel VN, Collins KJ, Tabaja N, Cizelsky W, Rothe M, Kühl SJ, Kühl M, Ferrante F, Hein K, Kovall RA, Dominguez M, Borggrefe T. A phospho-dependent mechanism involving NCoR and KMT2D controls a permissive chromatin state at Notch target genes. Nucleic Acids Res 2016;44:4703-20. [PMID: 26912830 DOI: 10.1093/nar/gkw105] [Cited by in Crossref: 51] [Cited by in F6Publishing: 40] [Article Influence: 8.5] [Reference Citation Analysis]
246 Bertrand FE. The cross-talk of NOTCH and GSK-3 signaling in colon and other cancers. Biochim Biophys Acta Mol Cell Res 2020;1867:118738. [PMID: 32389646 DOI: 10.1016/j.bbamcr.2020.118738] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
247 Dunn CD, Sulis ML, Ferrando AA, Greenwald I. A conserved tetraspanin subfamily promotes Notch signaling in Caenorhabditis elegans and in human cells. Proc Natl Acad Sci U S A 2010;107:5907-12. [PMID: 20220101 DOI: 10.1073/pnas.1001647107] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 3.8] [Reference Citation Analysis]
248 Yeh CH, Bellon M, Nicot C. FBXW7: a critical tumor suppressor of human cancers. Mol Cancer 2018;17:115. [PMID: 30086763 DOI: 10.1186/s12943-018-0857-2] [Cited by in Crossref: 132] [Cited by in F6Publishing: 135] [Article Influence: 33.0] [Reference Citation Analysis]
249 Schachter NF, Adams JR, Skowron P, Kozma KJ, Lee CA, Raghuram N, Yang J, Loch AJ, Wang W, Kucharczuk A, Wright KL, Quintana RM, An Y, Dotzko D, Gorman JL, Wojtal D, Shah JS, Leon-Gomez P, Pellecchia G, Dupuy AJ, Perou CM, Ben-Porath I, Karni R, Zacksenhaus E, Woodgett JR, Done SJ, Garzia L, Sorana Morrissy A, Reimand J, Taylor MD, Egan SE. Single allele loss-of-function mutations select and sculpt conditional cooperative networks in breast cancer. Nat Commun 2021;12:5238. [PMID: 34475389 DOI: 10.1038/s41467-021-25467-w] [Reference Citation Analysis]
250 Liau WS, Tan SH, Ngoc PCT, Wang CQ, Tergaonkar V, Feng H, Gong Z, Osato M, Look AT, Sanda T. Aberrant activation of the GIMAP enhancer by oncogenic transcription factors in T-cell acute lymphoblastic leukemia. Leukemia 2017;31:1798-807. [PMID: 28028313 DOI: 10.1038/leu.2016.392] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
251 Volk A. NOTCH-ing up nucleotide metabolism in T-cell acute lymphoblastic leukemia. Commun Biol 2021;4:809. [PMID: 34188174 DOI: 10.1038/s42003-021-02330-8] [Reference Citation Analysis]
252 Si-Tu J, Cai Y, Feng T, Yang D, Yuan S, Yang X, He S, Li Z, Wang Y, Tang Y, Ye C, Li Z. Upregulated circular RNA circ-102004 that promotes cell proliferation in prostate cancer. Int J Biol Macromol 2019;122:1235-43. [PMID: 30219508 DOI: 10.1016/j.ijbiomac.2018.09.076] [Cited by in Crossref: 19] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
253 Drobna M, Szarzyńska-Zawadzka B, Dawidowska M. T-cell acute lymphoblastic leukemia from miRNA perspective: Basic concepts, experimental approaches, and potential biomarkers. Blood Rev 2018;32:457-72. [PMID: 29703513 DOI: 10.1016/j.blre.2018.04.003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
254 Belver L, Ferrando A. The genetics and mechanisms of T cell acute lymphoblastic leukaemia. Nat Rev Cancer 2016;16:494-507. [DOI: 10.1038/nrc.2016.63] [Cited by in Crossref: 185] [Cited by in F6Publishing: 171] [Article Influence: 30.8] [Reference Citation Analysis]
255 Veeraraghavan J, Ma J, Hu Y, Wang XS. Recurrent and pathological gene fusions in breast cancer: current advances in genomic discovery and clinical implications. Breast Cancer Res Treat 2016;158:219-32. [PMID: 27372070 DOI: 10.1007/s10549-016-3876-y] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
256 Ryan RJH, Petrovic J, Rausch DM, Zhou Y, Lareau CA, Kluk MJ, Christie AL, Lee WY, Tarjan DR, Guo B, Donohue LKH, Gillespie SM, Nardi V, Hochberg EP, Blacklow SC, Weinstock DM, Faryabi RB, Bernstein BE, Aster JC, Pear WS. A B Cell Regulome Links Notch to Downstream Oncogenic Pathways in Small B Cell Lymphomas. Cell Rep 2017;21:784-97. [PMID: 29045844 DOI: 10.1016/j.celrep.2017.09.066] [Cited by in Crossref: 43] [Cited by in F6Publishing: 34] [Article Influence: 10.8] [Reference Citation Analysis]
257 Song JH, Schnittke N, Zaat A, Walsh CS, Miller CW. FBXW7 mutation in adult T-cell and B-cell acute lymphocytic leukemias. Leuk Res 2008;32:1751-5. [PMID: 18485478 DOI: 10.1016/j.leukres.2008.03.040] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
258 Del Bianco C, Aster JC, Blacklow SC. Mutational and energetic studies of Notch 1 transcription complexes. J Mol Biol 2008;376:131-40. [PMID: 18155729 DOI: 10.1016/j.jmb.2007.11.061] [Cited by in Crossref: 45] [Cited by in F6Publishing: 44] [Article Influence: 3.0] [Reference Citation Analysis]
259 Chen X, Thiaville MM, Chen L, Stoeck A, Xuan J, Gao M, Shih IeM, Wang TL. Defining NOTCH3 target genes in ovarian cancer. Cancer Res 2012;72:2294-303. [PMID: 22396495 DOI: 10.1158/0008-5472.CAN-11-2181] [Cited by in Crossref: 42] [Cited by in F6Publishing: 32] [Article Influence: 4.2] [Reference Citation Analysis]
260 Chen WP, Chiang WF, Chen HM, Chan JS, Hsiao PJ. Preventive Healthcare and Management for Acute Lymphoblastic Leukaemia in Adults: Case Report and Literature Review. Healthcare (Basel) 2021;9:531. [PMID: 34063253 DOI: 10.3390/healthcare9050531] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
261 Puissant A, Frumm SM, Alexe G, Bassil CF, Qi J, Chanthery YH, Nekritz EA, Zeid R, Gustafson WC, Greninger P. Targeting MYCN in neuroblastoma by BET bromodomain inhibition. Cancer Discov. 2013;3:308-323. [PMID: 23430699 DOI: 10.1158/2159-8290.cd-12-0418] [Cited by in Crossref: 407] [Cited by in F6Publishing: 276] [Article Influence: 45.2] [Reference Citation Analysis]
262 Kraszewska MD, Dawidowska M, Szczepański T, Witt M. T-cell acute lymphoblastic leukaemia: recent molecular biology findings. Br J Haematol 2012;156:303-15. [PMID: 22145858 DOI: 10.1111/j.1365-2141.2011.08957.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 3.7] [Reference Citation Analysis]
263 Hayward AN, Aird EJ, Gordon WR. A toolkit for studying cell surface shedding of diverse transmembrane receptors. Elife 2019;8:e46983. [PMID: 31172946 DOI: 10.7554/eLife.46983] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
264 Tien AC, Rajan A, Schulze KL, Ryoo HD, Acar M, Steller H, Bellen HJ. Ero1L, a thiol oxidase, is required for Notch signaling through cysteine bridge formation of the Lin12-Notch repeats in Drosophila melanogaster. J Cell Biol 2008;182:1113-25. [PMID: 18809725 DOI: 10.1083/jcb.200805001] [Cited by in Crossref: 58] [Cited by in F6Publishing: 55] [Article Influence: 4.1] [Reference Citation Analysis]
265 Borggrefe T, Lauth M, Zwijsen A, Huylebroeck D, Oswald F, Giaimo BD. The Notch intracellular domain integrates signals from Wnt, Hedgehog, TGFβ/BMP and hypoxia pathways. Biochim Biophys Acta 2016;1863:303-13. [PMID: 26592459 DOI: 10.1016/j.bbamcr.2015.11.020] [Cited by in Crossref: 103] [Cited by in F6Publishing: 108] [Article Influence: 14.7] [Reference Citation Analysis]
266 Michie AM, Chan AC, Ciofani M, Carleton M, Lefebvre JM, He Y, Allman DM, Wiest DL, Zúñiga-Pflücker JC, Izon DJ. Constitutive Notch signalling promotes CD4 CD8 thymocyte differentiation in the absence of the pre-TCR complex, by mimicking pre-TCR signals. Int Immunol 2007;19:1421-30. [PMID: 17981791 DOI: 10.1093/intimm/dxm113] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 1.6] [Reference Citation Analysis]
267 Nam Y, Sliz P, Song L, Aster JC, Blacklow SC. Structural basis for cooperativity in recruitment of MAML coactivators to Notch transcription complexes. Cell 2006;124:973-83. [PMID: 16530044 DOI: 10.1016/j.cell.2005.12.037] [Cited by in Crossref: 302] [Cited by in F6Publishing: 290] [Article Influence: 18.9] [Reference Citation Analysis]
268 Kang X, Lu Z, Cui C, Deng M, Fan Y, Dong B, Han X, Xie F, Tyner JW, Coligan JE, Collins RH, Xiao X, You MJ, Zhang CC. The ITIM-containing receptor LAIR1 is essential for acute myeloid leukaemia development. Nat Cell Biol 2015;17:665-77. [PMID: 25915125 DOI: 10.1038/ncb3158] [Cited by in Crossref: 66] [Cited by in F6Publishing: 68] [Article Influence: 9.4] [Reference Citation Analysis]
269 Nguyen TL, Nokin MJ, Terés S, Tomé M, Bodineau C, Galmar O, Pasquet JM, Rousseau B, van Liempd S, Falcon-Perez JM, Richard E, Muzotte E, Rezvani HR, Priault M, Bouchecareilh M, Redonnet-Vernhet I, Calvo J, Uzan B, Pflumio F, Fuentes P, Toribio ML, Khatib AM, Soubeyran P, Murdoch PDS, Durán RV. Downregulation of Glutamine Synthetase, not glutaminolysis, is responsible for glutamine addiction in Notch1-driven acute lymphoblastic leukemia. Mol Oncol 2021;15:1412-31. [PMID: 33314742 DOI: 10.1002/1878-0261.12877] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
270 Greene LM, Nathwani SM, Zisterer DM. Inhibition of γ-secretase activity synergistically enhances tumour necrosis factor-related apoptosis-inducing ligand induced apoptosis in T-cell acute lymphoblastic leukemia cells via upregulation of death receptor 5. Oncol Lett 2016;12:2900-5. [PMID: 27698877 DOI: 10.3892/ol.2016.5011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
271 Takebe N, Nguyen D, Yang SX. Targeting notch signaling pathway in cancer: clinical development advances and challenges. Pharmacol Ther. 2014;141:140-149. [PMID: 24076266 DOI: 10.1016/j.pharmthera.2013.09.005] [Cited by in Crossref: 240] [Cited by in F6Publishing: 229] [Article Influence: 26.7] [Reference Citation Analysis]
272 Doerrenberg M, Kloetgen A, Hezaveh K, Wössmann W, Bleckmann K, Stanulla M, Schrappe M, Mchardy AC, Borkhardt A, Hoell JI. T-cell acute lymphoblastic leukemia in infants has distinct genetic and epigenetic features compared to childhood cases: GENETIC AND EPIGENETIC FEATURES IN INFANT T-ALL. Genes Chromosomes Cancer 2017;56:159-67. [DOI: 10.1002/gcc.22423] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
273 Hounjet J, Vooijs M. The Role of Intracellular Trafficking of Notch Receptors in Ligand-Independent Notch Activation. Biomolecules 2021;11:1369. [PMID: 34572582 DOI: 10.3390/biom11091369] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
274 Yeh TC, Liang DC, Liu HC, Jaing TH, Chen SH, Hou JY, Yang CP, Huang YJ, Yao HW, Huang TY, Lin TH, Shih LY. Clinical and biological relevance of genetic alterations in pediatric T-cell acute lymphoblastic leukemia in Taiwan. Pediatr Blood Cancer 2019;66:e27496. [PMID: 30280491 DOI: 10.1002/pbc.27496] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
275 Neumann M, Heesch S, Gökbuget N, Schwartz S, Schlee C, Benlasfer O, Farhadi-Sartangi N, Thibaut J, Burmeister T, Hoelzer D, Hofmann WK, Thiel E, Baldus CD. Clinical and molecular characterization of early T-cell precursor leukemia: a high-risk subgroup in adult T-ALL with a high frequency of FLT3 mutations. Blood Cancer J 2012;2:e55. [PMID: 22829239 DOI: 10.1038/bcj.2011.49] [Cited by in Crossref: 65] [Cited by in F6Publishing: 64] [Article Influence: 6.5] [Reference Citation Analysis]
276 Tracey LJ, Brooke-Bisschop T, Jansen PWTC, Campos EI, Vermeulen M, Justice MJ. The Pluripotency Regulator PRDM14 Requires Hematopoietic Regulator CBFA2T3 to Initiate Leukemia in Mice. Mol Cancer Res 2019;17:1468-79. [PMID: 31015254 DOI: 10.1158/1541-7786.MCR-18-1327] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
277 Guo SS, Mi JQ, Wang J. [The role and research progress of NOTCH1 in T-cell acute lymphoblastic leukemia]. Zhonghua Xue Ye Xue Za Zhi 2021;42:165-70. [PMID: 33858050 DOI: 10.3760/cma.j.issn.0253-2727.2021.02.014] [Reference Citation Analysis]
278 Moeini A, Cornellà H, Villanueva A. Emerging signaling pathways in hepatocellular carcinoma. Liver Cancer. 2012;1:83-93. [PMID: 24159576 DOI: 10.1159/0003424-05] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
279 Olsauskas-Kuprys R, Zlobin A, Osipo C. Gamma secretase inhibitors of Notch signaling. Onco Targets Ther 2013;6:943-55. [PMID: 23901284 DOI: 10.2147/OTT.S33766] [Cited by in Crossref: 27] [Cited by in F6Publishing: 67] [Article Influence: 3.0] [Reference Citation Analysis]
280 Ohnuki H, Jiang K, Wang D, Salvucci O, Kwak H, Sánchez-Martín D, Maric D, Tosato G. Tumor-infiltrating myeloid cells activate Dll4/Notch/TGF-β signaling to drive malignant progression. Cancer Res 2014;74:2038-49. [PMID: 24520074 DOI: 10.1158/0008-5472.CAN-13-3118] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
281 Saito Y, Koya J, Kataoka K. Multiple mutations within individual oncogenes. Cancer Sci 2021;112:483-9. [PMID: 33073435 DOI: 10.1111/cas.14699] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
282 Chinen Y, Taki T, Nishida K, Shimizu D, Okuda T, Yoshida N, Kobayashi C, Koike K, Tsuchida M, Hayashi Y, Taniwaki M. Identification of the novel AML1 fusion partner gene, LAF4, a fusion partner of MLL, in childhood T-cell acute lymphoblastic leukemia with t(2;21)(q11;q22) by bubble PCR method for cDNA. Oncogene 2008;27:2249-56. [PMID: 17968322 DOI: 10.1038/sj.onc.1210857] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
283 Fleenor CJ, Higa K, Weil MM, DeGregori J. Evolved Cellular Mechanisms to Respond to Genotoxic Insults: Implications for Radiation-Induced Hematologic Malignancies. Radiat Res 2015;184:341-51. [PMID: 26414506 DOI: 10.1667/RR14147.1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
284 Chen CZ, Schaffert S, Fragoso R, Loh C. Regulation of immune responses and tolerance: the microRNA perspective. Immunol Rev 2013;253:112-28. [PMID: 23550642 DOI: 10.1111/imr.12060] [Cited by in Crossref: 112] [Cited by in F6Publishing: 105] [Article Influence: 12.4] [Reference Citation Analysis]
285 Schubbert S, Cardenas A, Chen H, Garcia C, Guo W, Bradner J, Wu H. Targeting the MYC and PI3K pathways eliminates leukemia-initiating cells in T-cell acute lymphoblastic leukemia. Cancer Res 2014;74:7048-59. [PMID: 25287161 DOI: 10.1158/0008-5472.CAN-14-1470] [Cited by in Crossref: 33] [Cited by in F6Publishing: 21] [Article Influence: 4.1] [Reference Citation Analysis]
286 Canté-Barrett K, Holtzer L, van Ooijen H, Hagelaar R, Cordo' V, Verhaegh W, van de Stolpe A, Meijerink JPP. A Molecular Test for Quantifying Functional Notch Signaling Pathway Activity in Human Cancer. Cancers (Basel) 2020;12:E3142. [PMID: 33120947 DOI: 10.3390/cancers12113142] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
287 Schnaiter A, Paschka P, Rossi M, Zenz T, Bühler A, Winkler D, Cazzola M, Döhner K, Edelmann J, Mertens D, Kless S, Mack S, Busch R, Hallek M, Döhner H, Stilgenbauer S. NOTCH1, SF3B1, and TP53 mutations in fludarabine-refractory CLL patients treated with alemtuzumab: results from the CLL2H trial of the GCLLSG. Blood 2013;122:1266-70. [PMID: 23821658 DOI: 10.1182/blood-2013-03-488197] [Cited by in Crossref: 46] [Cited by in F6Publishing: 52] [Article Influence: 5.1] [Reference Citation Analysis]
288 Jorissen E, De Strooper B. γ-Secretase and the Intramembrane Proteolysis of Notch. Notch Signaling. Elsevier; 2010. pp. 201-30. [DOI: 10.1016/s0070-2153(10)92006-1] [Cited by in Crossref: 36] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
289 Chen J, Zolkiewska A. Force-induced unfolding simulations of the human Notch1 negative regulatory region: possible roles of the heterodimerization domain in mechanosensing. PLoS One 2011;6:e22837. [PMID: 21829530 DOI: 10.1371/journal.pone.0022837] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
290 Rakowski LA, Lehotzky EA, Chiang MY. Transient responses to NOTCH and TLX1/HOX11 inhibition in T-cell acute lymphoblastic leukemia/lymphoma. PLoS One 2011;6:e16761. [PMID: 21326611 DOI: 10.1371/journal.pone.0016761] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
291 Chien WW, Catallo R, Chebel A, Baranger L, Thomas X, Béné M, Gerland LM, Schmidt A, Beldjord K, Klein N, Escoffre-barbe M, Leguay T, Huguet F, Larosa F, Hayette S, Plesa A, Ifrah N, Dombret H, Salles G, Chassevent A, Ffrench M. The p16INK4A/pRb pathway and telomerase activity define a subgroup of Ph+ adult Acute Lymphoblastic Leukemia associated with inferior outcome. Leukemia Research 2015;39:453-61. [DOI: 10.1016/j.leukres.2015.01.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
292 Kalender Atak Z, De Keersmaecker K, Gianfelici V, Geerdens E, Vandepoel R, Pauwels D, Porcu M, Lahortiga I, Brys V, Dirks WG, Quentmeier H, Cloos J, Cuppens H, Uyttebroeck A, Vandenberghe P, Cools J, Aerts S. High accuracy mutation detection in leukemia on a selected panel of cancer genes. PLoS One 2012;7:e38463. [PMID: 22675565 DOI: 10.1371/journal.pone.0038463] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 4.1] [Reference Citation Analysis]
293 Goossens S, Radaelli E, Blanchet O, Durinck K, Van der Meulen J, Peirs S, Taghon T, Tremblay CS, Costa M, Farhang Ghahremani M, De Medts J, Bartunkova S, Haigh K, Schwab C, Farla N, Pieters T, Matthijssens F, Van Roy N, Best JA, Deswarte K, Bogaert P, Carmichael C, Rickard A, Suryani S, Bracken LS, Alserihi R, Canté-Barrett K, Haenebalcke L, Clappier E, Rondou P, Slowicka K, Huylebroeck D, Goldrath AW, Janzen V, McCormack MP, Lock RB, Curtis DJ, Harrison C, Berx G, Speleman F, Meijerink JP, Soulier J, Van Vlierberghe P, Haigh JJ. ZEB2 drives immature T-cell lymphoblastic leukaemia development via enhanced tumour-initiating potential and IL-7 receptor signalling. Nat Commun 2015;6:5794. [PMID: 25565005 DOI: 10.1038/ncomms6794] [Cited by in Crossref: 51] [Cited by in F6Publishing: 54] [Article Influence: 7.3] [Reference Citation Analysis]
294 August KJ, Narendran A, Neville KA. Pediatric relapsed or refractory leukemia: new pharmacotherapeutic developments and future directions. Drugs 2013;73:439-61. [PMID: 23568274 DOI: 10.1007/s40265-013-0026-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
295 Bar Y, Efrat S. The NOTCH Pathway in β-Cell Growth and Differentiation. The Pancreatic Beta Cell. Elsevier; 2014. pp. 391-405. [DOI: 10.1016/b978-0-12-800174-5.00015-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
296 Uddin S, Bhat AA, Krishnankutty R, Mir F, Kulinski M, Mohammad RM. Involvement of F-BOX proteins in progression and development of human malignancies. Seminars in Cancer Biology 2016;36:18-32. [DOI: 10.1016/j.semcancer.2015.09.008] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 4.8] [Reference Citation Analysis]
297 Andersson ER, Sandberg R, Lendahl U. Notch signaling: Simplicity in design, versatility in function. Development. 2011;138:3593-3612. [PMID: 21828089 DOI: 10.1242/dev.063610] [Cited by in Crossref: 599] [Cited by in F6Publishing: 569] [Article Influence: 54.5] [Reference Citation Analysis]
298 Ding J, Fishel ML, Reed AM, McAdams E, Czader MB, Cardoso AA, Kelley MR. Ref-1/APE1 as a Transcriptional Regulator and Novel Therapeutic Target in Pediatric T-cell Leukemia. Mol Cancer Ther 2017;16:1401-11. [PMID: 28446640 DOI: 10.1158/1535-7163.MCT-17-0099] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 2.4] [Reference Citation Analysis]
299 Loosveld M, Bonnet M, Gon S, Montpellier B, Quilichini B, Navarro J, Crouzet T, Goujart M, Chasson L, Morgado E, Picard C, Hernandez L, Fossat C, Gabert J, Michel G, Nadel B, Payet-bornet D. MYC fails to efficiently shape malignant transformation in T-cell acute lymphoblastic leukemia: Inefficient Leukemia Initiation By MYC. Genes Chromosomes Cancer 2014;53:52-66. [DOI: 10.1002/gcc.22117] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
300 Ristorcelli E, Lombardo D. Targeting Notch signaling in pancreatic cancer. Expert Opin Ther Targets. 2010;14:541-552. [PMID: 20392166 DOI: 10.1517/14728221003769895] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 2.8] [Reference Citation Analysis]
301 Deniz E, Erman B. Long noncoding RNA (lincRNA), a new paradigm in gene expression control. Funct Integr Genomics. 2017;17:135-143. [PMID: 27681237 DOI: 10.1007/s10142-016-0524-x] [Cited by in Crossref: 108] [Cited by in F6Publishing: 113] [Article Influence: 18.0] [Reference Citation Analysis]
302 Shieh A, Ward AF, Donlan KL, Harding-Theobald ER, Xu J, Mullighan CG, Zhang C, Chen SC, Su X, Downing JR, Bollag GE, Shannon KM. Defective K-Ras oncoproteins overcome impaired effector activation to initiate leukemia in vivo. Blood 2013;121:4884-93. [PMID: 23637129 DOI: 10.1182/blood-2012-05-432252] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
303 Zheng L, Conner SD. PI5P4Kγ functions in DTX1-mediated Notch signaling. Proc Natl Acad Sci U S A 2018;115:E1983-90. [PMID: 29440432 DOI: 10.1073/pnas.1712142115] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
304 Kumamoto H, Ohki K. Detection of Notch signaling molecules in ameloblastomas: Notch signaling in ameloblastoma. Journal of Oral Pathology & Medicine 2008;37:228-34. [DOI: 10.1111/j.1600-0714.2007.00629.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
305 Chabanais J, Labrousse F, Chaunavel A, Germot A, Maftah A. POFUT1 as a Promising Novel Biomarker of Colorectal Cancer. Cancers (Basel) 2018;10:E411. [PMID: 30380753 DOI: 10.3390/cancers10110411] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
306 Huang BJ, Wandler AM, Meyer LK, Dail M, Daemen A, Sampath D, Li Q, Wang X, Wong JC, Nakitandwe J, Downing JR, Zhang J, Taylor BS, Shannon K. Convergent genetic aberrations in murine and human T lineage acute lymphoblastic leukemias. PLoS Genet 2019;15:e1008168. [PMID: 31199785 DOI: 10.1371/journal.pgen.1008168] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
307 Hubbard EJA, Schedl T. Biology of the Caenorhabditis elegans Germline Stem Cell System. Genetics 2019;213:1145-88. [PMID: 31796552 DOI: 10.1534/genetics.119.300238] [Cited by in Crossref: 33] [Cited by in F6Publishing: 19] [Article Influence: 16.5] [Reference Citation Analysis]
308 Chu Q, Liu L, Wang W. Overexpression of hCLP46 enhances Notch activation and regulates cell proliferation in a cell type-dependent manner. Cell Prolif 2013;46:254-62. [PMID: 23692084 DOI: 10.1111/cpr.12037] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
309 Guo Z, Jin X, Jia H. Inhibition of ADAM-17 more effectively down-regulates the Notch pathway than that of γ-secretase in renal carcinoma. J Exp Clin Cancer Res 2013;32:26. [PMID: 23659326 DOI: 10.1186/1756-9966-32-26] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
310 Gianfelici V, Chiaretti S, Demeyer S, Di Giacomo F, Messina M, La Starza R, Peragine N, Paoloni F, Geerdens E, Pierini V, Elia L, Mancini M, De Propris MS, Apicella V, Gaidano G, Testi AM, Vitale A, Vignetti M, Mecucci C, Guarini A, Cools J, Foà R. RNA sequencing unravels the genetics of refractory/relapsed T-cell acute lymphoblastic leukemia. Prognostic and therapeutic implications. Haematologica 2016;101:941-50. [PMID: 27151993 DOI: 10.3324/haematol.2015.139410] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
311 Nickoloff BJ, Hendrix MJ, Pollock PM, Trent JM, Miele L, Qin JZ. Notch and NOXA-related pathways in melanoma cells. J Investig Dermatol Symp Proc 2005;10:95-104. [PMID: 16363061 DOI: 10.1111/j.1087-0024.2005.200404.x] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 2.7] [Reference Citation Analysis]
312 Ohnuki H, Tosato G. Notch and TGFβ: Functional partners facilitating tumor progression. Oncoimmunology 2014;3:e29029. [PMID: 25114830 DOI: 10.4161/onci.29029] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
313 Gianni F, Belver L, Ferrando A. The Genetics and Mechanisms of T-Cell Acute Lymphoblastic Leukemia. Cold Spring Harb Perspect Med 2020;10:a035246. [PMID: 31570389 DOI: 10.1101/cshperspect.a035246] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
314 Milani L, Lundmark A, Nordlund J, Kiialainen A, Flaegstad T, Jonmundsson G, Kanerva J, Schmiegelow K, Gunderson KL, Lönnerholm G, Syvänen AC. Allele-specific gene expression patterns in primary leukemic cells reveal regulation of gene expression by CpG site methylation. Genome Res 2009;19:1-11. [PMID: 18997001 DOI: 10.1101/gr.083931.108] [Cited by in Crossref: 51] [Cited by in F6Publishing: 52] [Article Influence: 3.6] [Reference Citation Analysis]
315 Zhang C, Berndt-Paetz M, Neuhaus J. A Comprehensive Bioinformatics Analysis of Notch Pathways in Bladder Cancer. Cancers (Basel) 2021;13:3089. [PMID: 34205690 DOI: 10.3390/cancers13123089] [Reference Citation Analysis]
316 Willander K, Dutta RK, Ungerbäck J, Gunnarsson R, Juliusson G, Fredrikson M, Linderholm M, Söderkvist P. NOTCH1 mutations influence survival in chronic lymphocytic leukemia patients. BMC Cancer. 2013;13:274. [PMID: 23734977 DOI: 10.1186/1471-2407-13-274] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
317 Engin F, Bertin T, Ma O, Jiang MM, Wang L, Sutton RE, Donehower LA, Lee B. Notch signaling contributes to the pathogenesis of human osteosarcomas. Hum Mol Genet 2009;18:1464-70. [PMID: 19228774 DOI: 10.1093/hmg/ddp057] [Cited by in Crossref: 124] [Cited by in F6Publishing: 112] [Article Influence: 9.5] [Reference Citation Analysis]
318 Yang Y, Staudt LM. Protein ubiquitination in lymphoid malignancies. Immunol Rev 2015;263:240-56. [PMID: 25510281 DOI: 10.1111/imr.12247] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
319 Fleenor CJ, Marusyk A, DeGregori J. Ionizing radiation and hematopoietic malignancies: altering the adaptive landscape. Cell Cycle 2010;9:3005-11. [PMID: 20676038 DOI: 10.4161/cc.9.15.12311] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
320 Martelli AM, Paganelli F, Fazio A, Bazzichetto C, Conciatori F, McCubrey JA. The Key Roles of PTEN in T-Cell Acute Lymphoblastic Leukemia Development, Progression, and Therapeutic Response. Cancers (Basel) 2019;11:E629. [PMID: 31064074 DOI: 10.3390/cancers11050629] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
321 Callens C, Baleydier F, Lengline E, Ben Abdelali R, Petit A, Villarese P, Cieslak A, Minard-Colin V, Rullier A, Moreau A, Baruchel A, Schmitt C, Asnafi V, Bertrand Y, Macintyre E. Clinical impact of NOTCH1 and/or FBXW7 mutations, FLASH deletion, and TCR status in pediatric T-cell lymphoblastic lymphoma. J Clin Oncol 2012;30:1966-73. [PMID: 22547598 DOI: 10.1200/JCO.2011.39.7661] [Cited by in Crossref: 86] [Cited by in F6Publishing: 31] [Article Influence: 8.6] [Reference Citation Analysis]
322 Radojcic V, Maillard I. Notch Signaling and Alloreactivity. Transplantation 2016;100:2593-600. [PMID: 27607530 DOI: 10.1097/TP.0000000000001468] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
323 D'Altri T, Gonzalez J, Aifantis I, Espinosa L, Bigas A. Hes1 expression and CYLD repression are essential events downstream of Notch1 in T-cell leukemia. Cell Cycle 2011;10:1031-6. [PMID: 21389783 DOI: 10.4161/cc.10.7.15067] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
324 Purow B. Notch inhibitors as a new tool in the war on cancer: a pathway to watch. Curr Pharm Biotechnol. 2009;10:154-160. [PMID: 19199947 DOI: 10.2174/138920109787315060] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
325 Kamstrup M, Biskup E, Gniadecki R. Notch signalling in primary cutaneous CD30+ lymphoproliferative disorders: a new therapeutic approach?: Notch signalling in primary cutaneous ALCL. British Journal of Dermatology 2010;163:781-8. [DOI: 10.1111/j.1365-2133.2010.09915.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
326 Mazhar S, Taylor SE, Sangodkar J, Narla G. Targeting PP2A in cancer: Combination therapies. Biochim Biophys Acta Mol Cell Res 2019;1866:51-63. [PMID: 30401535 DOI: 10.1016/j.bbamcr.2018.08.020] [Cited by in Crossref: 41] [Cited by in F6Publishing: 33] [Article Influence: 10.3] [Reference Citation Analysis]
327 Guo D, Ye J, Li L, Dai J, Ma D, Ji C. Down-regulation of Notch-1 increases co-cultured Jurkat cell sensitivity to chemotherapy. Leukemia & Lymphoma 2009;50:270-8. [DOI: 10.1080/10428190802553257] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
328 Krutikov K, Zheng Y, Chesney A, Huang X, Vaags AK, Evdokimova V, Hough MR, Chen E. Ectopic TLX1 expression accelerates malignancies in mice deficient in DNA-PK. PLoS One 2014;9:e89649. [PMID: 24586935 DOI: 10.1371/journal.pone.0089649] [Reference Citation Analysis]
329 Yuan T, Yang Y, Chen J, Li W, Li W, Zhang Q, Mi Y, Goswami RS, You JQ, Lin D, Qian MD, Calin S, Liang Y, Miranda RN, Calin GA, Zhou X, Ma L, Zweidler-McKay PA, Liu B, Weng AP, Medeiros LJ, Zhang Y, You MJ. Regulation of PI3K signaling in T-cell acute lymphoblastic leukemia: a novel PTEN/Ikaros/miR-26b mechanism reveals a critical targetable role for PIK3CD. Leukemia 2017;31:2355-64. [PMID: 28280276 DOI: 10.1038/leu.2017.80] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 5.6] [Reference Citation Analysis]
330 Herranz D, Ambesi-Impiombato A, Palomero T, Schnell SA, Belver L, Wendorff AA, Xu L, Castillo-Martin M, Llobet-Navás D, Cordon-Cardo C, Clappier E, Soulier J, Ferrando AA. A NOTCH1-driven MYC enhancer promotes T cell development, transformation and acute lymphoblastic leukemia. Nat Med 2014;20:1130-7. [PMID: 25194570 DOI: 10.1038/nm.3665] [Cited by in Crossref: 228] [Cited by in F6Publishing: 213] [Article Influence: 28.5] [Reference Citation Analysis]
331 Fernandes MT, Dejardin E, dos Santos NR. Context-dependent roles for lymphotoxin-β receptor signaling in cancer development. Biochim Biophys Acta 2016;1865:204-19. [PMID: 26923876 DOI: 10.1016/j.bbcan.2016.02.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
332 Srivastava S, Sahu U, Zhou Y, Hogan AK, Sathyan KM, Bodner J, Huang J, Wong KA, Khalatyan N, Savas JN, Ntziachristos P, Ben-Sahra I, Foltz DR. NOTCH1-driven UBR7 stimulates nucleotide biosynthesis to promote T cell acute lymphoblastic leukemia. Sci Adv 2021;7:eabc9781. [PMID: 33571115 DOI: 10.1126/sciadv.abc9781] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
333 Kamstrup MR, Biskup E, Gjerdrum LM, Ralfkiaer E, Niazi O, Gniadecki R. The importance of Notch signaling in peripheral T-cell lymphomas. Leuk Lymphoma 2014;55:639-44. [PMID: 23697875 DOI: 10.3109/10428194.2013.807510] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
334 Zhang Y, Hua C, Cheng H, Wang W, Hao S, Xu J, Wang X, Gao Y, Zhu X, Cheng T, Yuan W. Distinct sensitivity of CD8+ CD4- and CD8+ CD4+ leukemic cell subpopulations to cyclophosphamide and rapamycin in Notch1-induced T-ALL mouse model. Leuk Res 2013;37:1592-601. [PMID: 24090996 DOI: 10.1016/j.leukres.2013.09.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
335 Tatarek J, Cullion K, Ashworth T, Gerstein R, Aster JC, Kelliher MA. Notch1 inhibition targets the leukemia-initiating cells in a Tal1/Lmo2 mouse model of T-ALL. Blood. 2011;118:1579-1590. [PMID: 21670468 DOI: 10.1182/blood-2010-08-300343] [Cited by in Crossref: 70] [Cited by in F6Publishing: 64] [Article Influence: 6.4] [Reference Citation Analysis]
336 Bhadri VA, Trahair TN, Lock RB. Glucocorticoid resistance in paediatric acute lymphoblastic leukaemia. J Paediatr Child Health. 2012;48:634-640. [PMID: 22050419 DOI: 10.1111/j.1440-1754.2011.02212.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 3.2] [Reference Citation Analysis]
337 Soulier J, Clappier E, Cayuela JM, Regnault A, García-Peydró M, Dombret H, Baruchel A, Toribio ML, Sigaux F. HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL). Blood 2005;106:274-86. [PMID: 15774621 DOI: 10.1182/blood-2004-10-3900] [Cited by in Crossref: 251] [Cited by in F6Publishing: 233] [Article Influence: 14.8] [Reference Citation Analysis]
338 Harris PJ, Speranza G, Dansky Ullmann C. Targeting embryonic signaling pathways in cancer therapy. Expert Opinion on Therapeutic Targets 2012;16:131-45. [DOI: 10.1517/14728222.2011.645808] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
339 Dotto GP. Crosstalk of Notch with p53 and p63 in cancer growth control. Nat Rev Cancer. 2009;9:587-595. [PMID: 19609265 DOI: 10.1038/nrc2675] [Cited by in Crossref: 127] [Cited by in F6Publishing: 118] [Article Influence: 9.8] [Reference Citation Analysis]
340 Gutierrez A, Sanda T, Grebliunaite R, Carracedo A, Salmena L, Ahn Y, Dahlberg S, Neuberg D, Moreau LA, Winter SS, Larson R, Zhang J, Protopopov A, Chin L, Pandolfi PP, Silverman LB, Hunger SP, Sallan SE, Look AT. High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia. Blood. 2009;114:647-650. [PMID: 19458356 DOI: 10.1182/blood-2009-02-206722] [Cited by in Crossref: 311] [Cited by in F6Publishing: 295] [Article Influence: 23.9] [Reference Citation Analysis]
341 Nakahara F, Sakata-Yanagimoto M, Komeno Y, Kato N, Uchida T, Haraguchi K, Kumano K, Harada Y, Harada H, Kitaura J, Ogawa S, Kurokawa M, Kitamura T, Chiba S. Hes1 immortalizes committed progenitors and plays a role in blast crisis transition in chronic myelogenous leukemia. Blood 2010;115:2872-81. [PMID: 19861684 DOI: 10.1182/blood-2009-05-222836] [Cited by in Crossref: 52] [Cited by in F6Publishing: 52] [Article Influence: 4.0] [Reference Citation Analysis]
342 Ramakrishnan V, Ansell S, Haug J, Grote D, Kimlinger T, Stenson M, Timm M, Wellik L, Halling T, Rajkumar SV. MRK003, a γ-secretase inhibitor exhibits promising in vitro pre-clinical activity in multiple myeloma and non-Hodgkin’s lymphoma. Leukemia. 2012;26:340-348. [PMID: 21826062 DOI: 10.1038/leu.2011.192] [Cited by in Crossref: 51] [Cited by in F6Publishing: 50] [Article Influence: 4.6] [Reference Citation Analysis]
343 Patel AA, Thomas J, Rojek AE, Stock W. Biology and Treatment Paradigms in T Cell Acute Lymphoblastic Leukemia in Older Adolescents and Adults. Curr Treat Options Oncol 2020;21:57. [PMID: 32468488 DOI: 10.1007/s11864-020-00757-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
344 Mansour MR, Sulis ML, Duke V, Foroni L, Jenkinson S, Koo K, Allen CG, Gale RE, Buck G, Richards S, Paietta E, Rowe JM, Tallman MS, Goldstone AH, Ferrando AA, Linch DC. Prognostic implications of NOTCH1 and FBXW7 mutations in adults with T-cell acute lymphoblastic leukemia treated on the MRC UKALLXII/ECOG E2993 protocol. J Clin Oncol 2009;27:4352-6. [PMID: 19635999 DOI: 10.1200/JCO.2009.22.0996] [Cited by in Crossref: 72] [Cited by in F6Publishing: 40] [Article Influence: 5.5] [Reference Citation Analysis]
345 Sakata-Yanagimoto M, Enami T, Yokoyama Y, Chiba S. Disease-specific mutations in mature lymphoid neoplasms: recent advances. Cancer Sci 2014;105:623-9. [PMID: 24689848 DOI: 10.1111/cas.12408] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
346 Dunsmore KP, Winter SS, Devidas M, Wood BL, Esiashvili N, Chen Z, Eisenberg N, Briegel N, Hayashi RJ, Gastier-Foster JM, Carroll AJ, Heerema NA, Asselin BL, Rabin KR, Zweidler-Mckay PA, Raetz EA, Loh ML, Schultz KR, Winick NJ, Carroll WL, Hunger SP. Children's Oncology Group AALL0434: A Phase III Randomized Clinical Trial Testing Nelarabine in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia. J Clin Oncol 2020;38:3282-93. [PMID: 32813610 DOI: 10.1200/JCO.20.00256] [Cited by in Crossref: 28] [Cited by in F6Publishing: 14] [Article Influence: 14.0] [Reference Citation Analysis]
347 Velaithan V, Okuda KS, Ng MF, Samat N, Leong SW, Faudzi SM, Abas F, Shaari K, Cheong SC, Tan PJ, Patel V. Zebrafish phenotypic screen identifies novel Notch antagonists. Invest New Drugs 2017;35:166-79. [PMID: 28058624 DOI: 10.1007/s10637-016-0423-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
348 Cuadrado M, Robles-Valero J. VAV Proteins as Double Agents in Cancer: Oncogenes with Tumor Suppressor Roles. Biology (Basel) 2021;10:888. [PMID: 34571765 DOI: 10.3390/biology10090888] [Reference Citation Analysis]
349 Chang MT, Asthana S, Gao SP, Lee BH, Chapman JS, Kandoth C, Gao J, Socci ND, Solit DB, Olshen AB. Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity. Nat Biotechnol. 2016;34:155-163. [PMID: 26619011 DOI: 10.1038/nbt.3391] [Cited by in Crossref: 416] [Cited by in F6Publishing: 368] [Article Influence: 59.4] [Reference Citation Analysis]
350 Fang QY, Hao QS, Gong XY, Wang J, Li QH, Yuan T, Tian Z, Liu KQ, Li Y, Liu YT, Gong BF, Wang Y, Wei H, Zhou CL, Lin D, Liu BC, Wei SN, Zhang GJ, Wang JX, Mi YC. [The characteristics and prognostic impact of NOTCH1/FBXW7 mutation and CDKN2A/B deletion in adult T-cell acute lymphoblastic leukemia patients]. Zhonghua Xue Ye Xue Za Zhi 2021;42:432-5. [PMID: 34218589 DOI: 10.3760/cma.j.issn.0253-2727.2021.05.015] [Reference Citation Analysis]
351 Staal FJ, van Dongen JJ, Langerak AW. Novel insights into the development of T-cell acute lymphoblastic leukemia. Curr Hematol Malig Rep 2007;2:176-82. [PMID: 20425367 DOI: 10.1007/s11899-007-0024-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
352 Pagliaro L, Marchesini M, Roti G. Targeting oncogenic Notch signaling with SERCA inhibitors. J Hematol Oncol 2021;14:8. [PMID: 33407740 DOI: 10.1186/s13045-020-01015-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
353 Smeets MF, Chan AC, Dagger S, Bradley CK, Wei A, Izon DJ. Fli-1 overexpression in hematopoietic progenitors deregulates T cell development and induces pre-T cell lymphoblastic leukaemia/lymphoma. PLoS One 2013;8:e62346. [PMID: 23667468 DOI: 10.1371/journal.pone.0062346] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
354 Heitzler P. Biodiversity and noncanonical Notch signaling. Curr Top Dev Biol. 2010;92:457-481. [PMID: 20816404 DOI: 10.1016/S0070-2153(10)92014-0] [Cited by in Crossref: 52] [Cited by in F6Publishing: 37] [Article Influence: 4.3] [Reference Citation Analysis]
355 Ferrando A. Can one target T-cell ALL? Best Pract Res Clin Haematol 2018;31:361-6. [PMID: 30466748 DOI: 10.1016/j.beha.2018.10.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
356 Pear WS, Simon MC. Lasting longer without oxygen: The influence of hypoxia on Notch signaling. Cancer Cell 2005;8:435-7. [PMID: 16338655 DOI: 10.1016/j.ccr.2005.11.016] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 1.9] [Reference Citation Analysis]
357 Stein SJ, Mack EA, Rome KS, Pajcini KV, Ohtani T, Xu L, Li Y, Meijerink JP, Faryabi RB, Pear WS. Trib2 Suppresses Tumor Initiation in Notch-Driven T-ALL. PLoS One 2016;11:e0155408. [PMID: 27191957 DOI: 10.1371/journal.pone.0155408] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
358 Rooney M, Devarakonda S, Govindan R. Genomics of squamous cell lung cancer. Oncologist 2013;18:707-16. [PMID: 23728941 DOI: 10.1634/theoncologist.2013-0063] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
359 Armstrong SA, Look AT. Molecular genetics of acute lymphoblastic leukemia. J Clin Oncol. 2005;23:6306-6315. [PMID: 16155013 DOI: 10.1200/jco.2005.05.047] [Cited by in Crossref: 253] [Cited by in F6Publishing: 104] [Article Influence: 14.9] [Reference Citation Analysis]
360 Firestone AJ, Chen JK. Controlling destiny through chemistry: small-molecule regulators of cell fate. ACS Chem Biol 2010;5:15-34. [PMID: 20000447 DOI: 10.1021/cb900249y] [Cited by in Crossref: 52] [Cited by in F6Publishing: 44] [Article Influence: 4.3] [Reference Citation Analysis]
361 Orkin SH, Zon LI. Hematopoiesis: an evolving paradigm for stem cell biology. Cell. 2008;132:631-644. [PMID: 18295580 DOI: 10.1016/j.cell.2008.01.025] [Cited by in Crossref: 1541] [Cited by in F6Publishing: 1412] [Article Influence: 110.1] [Reference Citation Analysis]
362 Zweidler-McKay PA, He Y, Xu L, Rodriguez CG, Karnell FG, Carpenter AC, Aster JC, Allman D, Pear WS. Notch signaling is a potent inducer of growth arrest and apoptosis in a wide range of B-cell malignancies. Blood. 2005;106:3898-3906. [PMID: 16118316 DOI: 10.1182/blood-2005-01-0355] [Cited by in Crossref: 143] [Cited by in F6Publishing: 139] [Article Influence: 8.4] [Reference Citation Analysis]
363 Wang T, Holt CM, Xu C, Ridley C, P O Jones R, Baron M, Trump D. Notch3 activation modulates cell growth behaviour and cross-talk to Wnt/TCF signalling pathway. Cellular Signalling 2007;19:2458-67. [DOI: 10.1016/j.cellsig.2007.07.019] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 2.2] [Reference Citation Analysis]
364 Cairo MS, Raetz E, Lim MS, Davenport V, Perkins SL. Childhood and adolescent non-Hodgkin lymphoma: new insights in biology and critical challenges for the future. Pediatr Blood Cancer 2005;45:753-69. [PMID: 15929129 DOI: 10.1002/pbc.20342] [Cited by in Crossref: 52] [Cited by in F6Publishing: 40] [Article Influence: 3.1] [Reference Citation Analysis]
365 Ural AU. Cancer Stem Cells: Current Concepts and Therapeutic Implications. In: Turksen K, editor. Adult and Embryonic Stem Cells. Totowa: Humana Press; 2012. pp. 227-35. [DOI: 10.1007/978-1-61779-630-2_15] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
366 Fielding AK, Banerjee L, Marks DI. Recent Developments in the Management of T-Cell Precursor Acute Lymphoblastic Leukemia/Lymphoma. Curr Hematol Malig Rep 2012;7:160-9. [DOI: 10.1007/s11899-012-0123-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
367 Zhang Y, Zeng F, Han X, Weng J, Gao Y. Lineage tracing: technology tool for exploring the development, regeneration, and disease of the digestive system. Stem Cell Res Ther 2020;11:438. [PMID: 33059752 DOI: 10.1186/s13287-020-01941-y] [Reference Citation Analysis]
368 Qian CJ, Yao J, Si JM. Nuclear JAK2: form and function in cancer. Anat Rec (Hoboken) 2011;294:1446-59. [PMID: 21809458 DOI: 10.1002/ar.21443] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
369 Shima N, Pederson KD. Dormant origins as a built-in safeguard in eukaryotic DNA replication against genome instability and disease development. DNA Repair (Amst) 2017;56:166-73. [PMID: 28641940 DOI: 10.1016/j.dnarep.2017.06.019] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.4] [Reference Citation Analysis]
370 Renneville A, Kaltenbach S, Clappier E, Collette S, Micol JB, Nelken B, Lepelley P, Dastugue N, Benoît Y, Bertrand Y, Preudhomme C, Cavé H. Wilms tumor 1 (WT1) gene mutations in pediatric T-cell malignancies. Leukemia 2010;24:476-80. [PMID: 19847202 DOI: 10.1038/leu.2009.221] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
371 Arslanova D, Yang T, Xu X, Wong ST, Augelli-Szafran CE, Xia W. Phenotypic analysis of images of zebrafish treated with Alzheimer's gamma-secretase inhibitors. BMC Biotechnol 2010;10:24. [PMID: 20307292 DOI: 10.1186/1472-6750-10-24] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 2.7] [Reference Citation Analysis]
372 Guan Y, Wang G, Fails D, Nagarajan P, Ge Y. Unraveling cancer lineage drivers in squamous cell carcinomas. Pharmacol Ther. 2020;206:107448. [PMID: 31836455 DOI: 10.1016/j.pharmthera.2019.107448] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
373 Mazurkiewicz M, Hillert EK, Wang X, Pellegrini P, Olofsson MH, Selvaraju K, D'Arcy P, Linder S. Acute lymphoblastic leukemia cells are sensitive to disturbances in protein homeostasis induced by proteasome deubiquitinase inhibition. Oncotarget 2017;8:21115-27. [PMID: 28423502 DOI: 10.18632/oncotarget.15501] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
374 Zhang M, Biswas S, Qin X, Gong W, Deng W, Yu H. Does Notch play a tumor suppressor role across diverse squamous cell carcinomas? Cancer Med 2016;5:2048-60. [PMID: 27228302 DOI: 10.1002/cam4.731] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 4.3] [Reference Citation Analysis]
375 Chen H, Lu Q, Zhang Y, Zhang C, Zhang H, Xu H. Overexpression of SLC25A38 protein on acute lymphoblastic leukemia cells. Oncol Lett 2014;7:1422-6. [PMID: 24765149 DOI: 10.3892/ol.2014.1947] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
376 Rubin LL, de Sauvage FJ. Targeting the Hedgehog pathway in cancer. Nat Rev Drug Discov. 2006;5:1026-1033. [PMID: 17139287 DOI: 10.1038/nrd2086] [Cited by in Crossref: 556] [Cited by in F6Publishing: 515] [Article Influence: 37.1] [Reference Citation Analysis]
377 Ouyang K, Leandro Gomez-Amaro R, Stachura DL, Tang H, Peng X, Fang X, Traver D, Evans SM, Chen J. Loss of IP3R-dependent Ca2+ signalling in thymocytes leads to aberrant development and acute lymphoblastic leukemia. Nat Commun 2014;5:4814. [PMID: 25215520 DOI: 10.1038/ncomms5814] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 4.8] [Reference Citation Analysis]
378 Locatelli M, Curigliano G. Notch inhibitors and their role in the treatment of triple negative breast cancer: promises and failures. Current Opinion in Oncology 2017;29:411-27. [DOI: 10.1097/cco.0000000000000406] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 4.2] [Reference Citation Analysis]
379 Bao B, Azmi AS, Ali S, Ahmad A, Li Y, Banerjee S, Kong D, Sarkar FH. The biological kinship of hypoxia with CSC and EMT and their relationship with deregulated expression of miRNAs and tumor aggressiveness. Biochim Biophys Acta. 2012;1826:272-296. [PMID: 22579961 DOI: 10.1016/j.bbcan.2012.04.008] [Cited by in Crossref: 38] [Cited by in F6Publishing: 80] [Article Influence: 3.8] [Reference Citation Analysis]
380 Barata JT. The impact of PTEN regulation by CK2 on PI3K-dependent signaling and leukemia cell survival. Adv Enzyme Regul 2011;51:37-49. [PMID: 21035501 DOI: 10.1016/j.advenzreg.2010.09.012] [Cited by in Crossref: 53] [Cited by in F6Publishing: 51] [Article Influence: 4.4] [Reference Citation Analysis]
381 Arai MA, Akamine R, Hayashi N, Koyano T, Kowithayakorn T, Ishibashi M. The Notch Inhibitors Isolated from Nerium indicum. J Nat Prod 2018;81:1235-40. [DOI: 10.1021/acs.jnatprod.7b01031] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
382 Sjölund J, Manetopoulos C, Stockhausen MT, Axelson H. The Notch pathway in cancer: differentiation gone awry. Eur J Cancer. 2005;41:2620-2629. [PMID: 16239105 DOI: 10.1016/j.ejca.2005.06.025] [Cited by in Crossref: 89] [Cited by in F6Publishing: 81] [Article Influence: 5.2] [Reference Citation Analysis]
383 Matsui WH. Cancer stem cell signaling pathways. Medicine (Baltimore) 2016;95:S8-S19. [PMID: 27611937 DOI: 10.1097/MD.0000000000004765] [Cited by in Crossref: 113] [Cited by in F6Publishing: 77] [Article Influence: 22.6] [Reference Citation Analysis]
384 Thomas X. Emerging drugs for adult acute lymphoblastic leukaemia. Expert Opin Emerg Drugs. 2005;10:591-617. [PMID: 16083331 DOI: 10.1517/14728214.10.3.591] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
385 Zhong W, Yi Q, Xu B, Li S, Wang T, Liu F, Zhu B, Hoffmann PR, Ji G, Lei P, Li G, Li J, Li J, Olkkonen VM, Yan D. ORP4L is essential for T-cell acute lymphoblastic leukemia cell survival. Nat Commun. 2016;7:12702. [PMID: 27581363 DOI: 10.1038/ncomms12702] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 7.2] [Reference Citation Analysis]
386 Yang G, Zhou R, Zhou Q, Guo X, Yan C, Ke M, Lei J, Shi Y. Structural basis of Notch recognition by human γ-secretase. Nature 2019;565:192-7. [PMID: 30598546 DOI: 10.1038/s41586-018-0813-8] [Cited by in Crossref: 103] [Cited by in F6Publishing: 85] [Article Influence: 25.8] [Reference Citation Analysis]
387 Roti G, Qi J, Kitara S, Sanchez-Martin M, Saur Conway A, Varca AC, Su A, Wu L, Kung AL, Ferrando AA, Bradner JE, Stegmaier K. Leukemia-specific delivery of mutant NOTCH1 targeted therapy. J Exp Med 2018;215:197-216. [PMID: 29158376 DOI: 10.1084/jem.20151778] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
388 Pui C. Quest for effective agents to combat T-cell acute lymphoblastic leukemia. European Journal of Cancer 2005;41:1243-5. [DOI: 10.1016/j.ejca.2005.03.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
389 Inder S, O'Rourke S, McDermott N, Manecksha R, Finn S, Lynch T, Marignol L. The Notch-3 receptor: A molecular switch to tumorigenesis? Cancer Treat Rev 2017;60:69-76. [PMID: 28889086 DOI: 10.1016/j.ctrv.2017.08.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
390 Hodson DJ, Janas ML, Galloway A, Bell SE, Andrews S, Li CM, Pannell R, Siebel CW, MacDonald HR, De Keersmaecker K, Ferrando AA, Grutz G, Turner M. Deletion of the RNA-binding proteins ZFP36L1 and ZFP36L2 leads to perturbed thymic development and T lymphoblastic leukemia. Nat Immunol 2010;11:717-24. [PMID: 20622884 DOI: 10.1038/ni.1901] [Cited by in Crossref: 123] [Cited by in F6Publishing: 120] [Article Influence: 10.3] [Reference Citation Analysis]
391 Liu WH, Hsiao HW, Tsou WI, Lai MZ. Notch inhibits apoptosis by direct interference with XIAP ubiquitination and degradation. EMBO J 2007;26:1660-9. [PMID: 17318174 DOI: 10.1038/sj.emboj.7601611] [Cited by in Crossref: 45] [Cited by in F6Publishing: 37] [Article Influence: 3.0] [Reference Citation Analysis]
392 Kudryavtsev GY, Kudryavtseva LV, Mikhaleva LM, Solovieva NA, Babichenko II. [Immunohistochemical study of Ki-67, p53 and Notch1 expressions in prostate cancer of different grades]. Arkh Patol 2020;82:42-9. [PMID: 33054031 DOI: 10.17116/patol20208205142] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
393 Cartledge Wolf DM, Langhans SA. Moving Myeloid Leukemia Drug Discovery Into the Third Dimension. Front Pediatr 2019;7:314. [PMID: 31417884 DOI: 10.3389/fped.2019.00314] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
394 Tiyanont K, Wales TE, Siebel CW, Engen JR, Blacklow SC. Insights into Notch3 activation and inhibition mediated by antibodies directed against its negative regulatory region. J Mol Biol 2013;425:3192-204. [PMID: 23747483 DOI: 10.1016/j.jmb.2013.05.025] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
395 Fre S, Bardin A, Robine S, Louvard D. Notch signaling in intestinal homeostasis across species: the cases of Drosophila, Zebrafish and the mouse. Exp Cell Res 2011;317:2740-7. [PMID: 21745469 DOI: 10.1016/j.yexcr.2011.06.012] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 3.5] [Reference Citation Analysis]
396 Sanghvi VR, Mavrakis KJ, Van der Meulen J, Boice M, Wolfe AL, Carty M, Mohan P, Rondou P, Socci ND, Benoit Y, Taghon T, Van Vlierberghe P, Leslie CS, Speleman F, Wendel HG. Characterization of a set of tumor suppressor microRNAs in T cell acute lymphoblastic leukemia. Sci Signal 2014;7:ra111. [PMID: 25406379 DOI: 10.1126/scisignal.2005500] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
397 Choi SH, Severson E, Pear WS, Liu XS, Aster JC, Blacklow SC. The common oncogenomic program of NOTCH1 and NOTCH3 signaling in T-cell acute lymphoblastic leukemia. PLoS One 2017;12:e0185762. [PMID: 29023469 DOI: 10.1371/journal.pone.0185762] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
398 Zeronian MR, Klykov O, Portell I de Montserrat J, Konijnenberg MJ, Gaur A, Scheltema RA, Janssen BJC. Notch-Jagged signaling complex defined by an interaction mosaic. Proc Natl Acad Sci U S A 2021;118:e2102502118. [PMID: 34301900 DOI: 10.1073/pnas.2102502118] [Reference Citation Analysis]
399 Ma J, Wu M. The indicative effect of Notch1 expression for the prognosis of T-cell acute lymphocytic leukemia: a systematic review. Mol Biol Rep 2012;39:6095-100. [PMID: 22311010 DOI: 10.1007/s11033-011-1424-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
400 Tan Y, Sementino E, Liu Z, Cai KQ, Testa JR. Wnt signaling mediates oncogenic synergy between Akt and Dlx5 in T-cell lymphomagenesis by enhancing cholesterol synthesis. Sci Rep 2020;10:15837. [PMID: 32985581 DOI: 10.1038/s41598-020-72822-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
401 Taki T, Taniwaki M. Chromosomal translocations in cancer and their relevance for therapy. Curr Opin Oncol 2006;18:62-8. [PMID: 16357566 DOI: 10.1097/01.cco.0000198972.69541.04] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
402 Lin L, Mernaugh R, Yi F, Blum D, Carbone DP, Dang TP. Targeting specific regions of the Notch3 ligand-binding domain induces apoptosis and inhibits tumor growth in lung cancer. Cancer Res 2010;70:632-8. [PMID: 20068176 DOI: 10.1158/0008-5472.CAN-09-3293] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 3.3] [Reference Citation Analysis]
403 Sulis ML, Saftig P, Ferrando AA. Redundancy and specificity of the metalloprotease system mediating oncogenic NOTCH1 activation in T-ALL. Leukemia 2011;25:1564-9. [PMID: 21625236 DOI: 10.1038/leu.2011.130] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
404 Koch U, Radtke F. Notch signaling in solid tumors. Curr Top Dev Biol. 2010;92:411-455. [PMID: 20816403 DOI: 10.1016/s0070-2153(10)92013-9] [Cited by in Crossref: 82] [Cited by in F6Publishing: 57] [Article Influence: 6.8] [Reference Citation Analysis]
405 Lee LA, Farris AD. Photosensitivity Diseases: Cutaneous Lupus Erythematosus. Journal of Investigative Dermatology Symposium Proceedings 1999;4:73-8. [DOI: 10.1038/sj.jidsp.5640186] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
406 Yin C, Ye J, Zou J, Lu T, Du Y, Liu Z, Fan R, Lu F, Li P, Ma D, Ji C. RETRACTED: Role of stromal cells-mediated Notch-1 in the invasion of T-ALL cells. Experimental Cell Research 2015;332:39-46. [DOI: 10.1016/j.yexcr.2015.01.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
407 Morell CM, Strazzabosco M. Notch signaling and new therapeutic options in liver disease. J Hepatol. 2014;60:885-890. [PMID: 24308992 DOI: 10.1016/j.jhep.2013.11.028] [Cited by in Crossref: 68] [Cited by in F6Publishing: 69] [Article Influence: 7.6] [Reference Citation Analysis]
408 Dobranowski P, Ban F, Contreras-Sanz A, Cherkasov A, Black PC. Perspectives on the discovery of NOTCH2-specific inhibitors. Chem Biol Drug Des 2018;91:691-706. [PMID: 29078041 DOI: 10.1111/cbdd.13132] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
409 Lobry C, Ntziachristos P, Ndiaye-Lobry D, Oh P, Cimmino L, Zhu N, Araldi E, Hu W, Freund J, Abdel-Wahab O, Ibrahim S, Skokos D, Armstrong SA, Levine RL, Park CY, Aifantis I. Notch pathway activation targets AML-initiating cell homeostasis and differentiation. J Exp Med 2013;210:301-19. [PMID: 23359070 DOI: 10.1084/jem.20121484] [Cited by in Crossref: 103] [Cited by in F6Publishing: 101] [Article Influence: 11.4] [Reference Citation Analysis]
410 Benelli D, Cialfi S, Pinzaglia M, Talora C, Londei P. The translation factor eIF6 is a Notch-dependent regulator of cell migration and invasion. PLoS One 2012;7:e32047. [PMID: 22348144 DOI: 10.1371/journal.pone.0032047] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
411 Lee SM, Moon J, Redman BG, Chidiac T, Flaherty LE, Zha Y, Othus M, Ribas A, Sondak VK, Gajewski TF, Margolin KA. Phase 2 study of RO4929097, a gamma-secretase inhibitor, in metastatic melanoma: SWOG 0933. Cancer. 2015;121:432-440. [PMID: 25250858 DOI: 10.1002/cncr.29055] [Cited by in Crossref: 53] [Cited by in F6Publishing: 52] [Article Influence: 6.6] [Reference Citation Analysis]
412 Heesch S, Goekbuget N, Stroux A, Tanchez JO, Schlee C, Burmeister T, Schwartz S, Blau O, Keilholz U, Busse A, Hoelzer D, Thiel E, Hofmann WK, Baldus CD. Prognostic implications of mutations and expression of the Wilms tumor 1 (WT1) gene in adult acute T-lymphoblastic leukemia. Haematologica 2010;95:942-9. [PMID: 20435628 DOI: 10.3324/haematol.2009.016386] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 2.4] [Reference Citation Analysis]
413 Yashiro-Ohtani Y, He Y, Ohtani T, Jones ME, Shestova O, Xu L, Fang TC, Chiang MY, Intlekofer AM, Blacklow SC, Zhuang Y, Pear WS. Pre-TCR signaling inactivates Notch1 transcription by antagonizing E2A. Genes Dev 2009;23:1665-76. [PMID: 19605688 DOI: 10.1101/gad.1793709] [Cited by in Crossref: 116] [Cited by in F6Publishing: 114] [Article Influence: 8.9] [Reference Citation Analysis]
414 Meng H, Zhang X, Hankenson KD, Wang MM. Thrombospondin 2 potentiates notch3/jagged1 signaling. J Biol Chem. 2009;284:7866-7874. [PMID: 19147503 DOI: 10.1074/jbc.m803650200] [Cited by in Crossref: 43] [Cited by in F6Publishing: 32] [Article Influence: 3.3] [Reference Citation Analysis]
415 You X, Wen Z, Chang YI, Ranheim EA, Zhou Y, Zhou L, Kong G, Zhang J. Systemic Notch downregulation promotes KrasG12D -induced myeloproliferative neoplasm. Br J Haematol 2019;186:e52-6. [PMID: 30931528 DOI: 10.1111/bjh.15893] [Reference Citation Analysis]
416 Onciu M. Acute Lymphoblastic Leukemia. Hematology/Oncology Clinics of North America 2009;23:655-74. [DOI: 10.1016/j.hoc.2009.04.009] [Cited by in Crossref: 83] [Cited by in F6Publishing: 64] [Article Influence: 6.4] [Reference Citation Analysis]
417 Hiroki CH, Amarante MK, Petenuci DL, Sakaguchi AY, Trigo FC, Watanabe MAE, de Oliveira CEC. IL-10 gene polymorphism and influence of chemotherapy on cytokine plasma levels in childhood acute lymphoblastic leukemia patients. Blood Cells, Molecules, and Diseases 2015;55:168-72. [DOI: 10.1016/j.bcmd.2015.06.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
418 DeAngelo DJ. The treatment of adolescents and young adults with acute lymphoblastic leukemia. Hematology Am Soc Hematol Educ Program 2005;:123-30. [PMID: 16304369 DOI: 10.1182/asheducation-2005.1.123] [Cited by in Crossref: 40] [Cited by in F6Publishing: 30] [Article Influence: 3.1] [Reference Citation Analysis]
419 Dong F, Bai H, Wang X, Zhang S, Wang Z, Xie M, Zhang S, Wang J, Hao S, Cheng T, Ema H. Mouse acute leukemia develops independent of self-renewal and differentiation potentials in hematopoietic stem and progenitor cells. Blood Adv 2019;3:419-31. [PMID: 30733302 DOI: 10.1182/bloodadvances.2018022400] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
420 Moreira MA, Bagni C, de Pinho MB, Mac-Cormick TM, dos Santos Mota M, Pinto-Silva FE, Daflon-Yunes N, Rumjanek VM. Changes in gene expression profile in two multidrug resistant cell lines derived from a same drug sensitive cell line. Leuk Res 2014;38:983-7. [PMID: 24996974 DOI: 10.1016/j.leukres.2014.06.001] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
421 Verma R, Sattar RSA, Nimisha, Apurva, Kumar A, Sharma AK, Sumi MP, Ahmad E, Ali A, Mahajan B, Saluja SS. Cross-talk between next generation sequencing methodologies to identify genomic signatures of esophageal cancer. Crit Rev Oncol Hematol 2021;162:103348. [PMID: 33961993 DOI: 10.1016/j.critrevonc.2021.103348] [Reference Citation Analysis]
422 Medinger M, Mross K. Clinical trials with anti-angiogenic agents in hematological malignancies. J Angiogenes Res 2010;2:10. [PMID: 20569499 DOI: 10.1186/2040-2384-2-10] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
423 Schajnovitz A, Scadden DT. Bone's dark side: mutated osteoblasts implicated in leukemia. Cell Res 2014;24:383-4. [PMID: 24589711 DOI: 10.1038/cr.2014.26] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
424 Saffie R, Zhou N, Rolland D, Önder Ö, Basrur V, Campbell S, Wellen KE, Elenitoba-Johnson KSJ, Capell BC, Busino L. FBXW7 Triggers Degradation of KMT2D to Favor Growth of Diffuse Large B-cell Lymphoma Cells. Cancer Res 2020;80:2498-511. [PMID: 32350066 DOI: 10.1158/0008-5472.CAN-19-2247] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
425 Bian W, Tang M, Jiang H, Xu W, Hao W, Sui Y, Hou Y, Nie L, Zhang H, Wang C, Li N, Wang J, Qin J, Wu L, Ma X, Chen J, Wang W, Li X. Low-density-lipoprotein-receptor-related protein 1 mediates Notch pathway activation. Dev Cell 2021;56:2902-2919.e8. [PMID: 34626540 DOI: 10.1016/j.devcel.2021.09.015] [Reference Citation Analysis]
426 Zuurbier L, Petricoin EF 3rd, Vuerhard MJ, Calvert V, Kooi C, Buijs-Gladdines JG, Smits WK, Sonneveld E, Veerman AJ, Kamps WA, Horstmann M, Pieters R, Meijerink JP. The significance of PTEN and AKT aberrations in pediatric T-cell acute lymphoblastic leukemia. Haematologica 2012;97:1405-13. [PMID: 22491738 DOI: 10.3324/haematol.2011.059030] [Cited by in Crossref: 79] [Cited by in F6Publishing: 78] [Article Influence: 7.9] [Reference Citation Analysis]
427 Martínez-climent JA, Andreu EJ, Prosper F. Somatic stem cells and the origin of cancer. Clin Transl Oncol 2006;8:647-63. [DOI: 10.1007/s12094-006-0035-7] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 1.9] [Reference Citation Analysis]
428 Li XJ, Luo XQ, Han BW, Duan FT, Wei PP, Chen YQ. MicroRNA-100/99a, deregulated in acute lymphoblastic leukaemia, suppress proliferation and promote apoptosis by regulating the FKBP51 and IGF1R/mTOR signalling pathways. Br J Cancer. 2013;109:2189-2198. [PMID: 24030073 DOI: 10.1038/bjc.2013.562] [Cited by in Crossref: 71] [Cited by in F6Publishing: 69] [Article Influence: 7.9] [Reference Citation Analysis]
429 Licciulli S, Avila JL, Hanlon L, Troutman S, Cesaroni M, Kota S, Keith B, Simon MC, Puré E, Radtke F, Capobianco AJ, Kissil JL. Notch1 is required for Kras-induced lung adenocarcinoma and controls tumor cell survival via p53. Cancer Res 2013;73:5974-84. [PMID: 23943799 DOI: 10.1158/0008-5472.CAN-13-1384] [Cited by in Crossref: 76] [Cited by in F6Publishing: 54] [Article Influence: 8.4] [Reference Citation Analysis]
430 Kobayashi M, Bai Y, Chen S, Gao R, Yao C, Cai W, Cardoso AA, Croop J, Zhang ZY, Liu Y. Phosphatase PRL2 promotes oncogenic NOTCH1-Induced T-cell leukemia. Leukemia 2017;31:751-4. [PMID: 27872499 DOI: 10.1038/leu.2016.340] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
431 Clappier E, Collette S, Grardel N, Girard S, Suarez L, Brunie G, Kaltenbach S, Yakouben K, Mazingue F, Robert A, Boutard P, Plantaz D, Rohrlich P, van Vlierberghe P, Preudhomme C, Otten J, Speleman F, Dastugue N, Suciu S, Benoit Y, Bertrand Y, Cavé H; EORTC-CLG. NOTCH1 and FBXW7 mutations have a favorable impact on early response to treatment, but not on outcome, in children with T-cell acute lymphoblastic leukemia (T-ALL) treated on EORTC trials 58881 and 58951. Leukemia 2010;24:2023-31. [PMID: 20861920 DOI: 10.1038/leu.2010.205] [Cited by in Crossref: 90] [Cited by in F6Publishing: 86] [Article Influence: 7.5] [Reference Citation Analysis]
432 Fasseu M, Aplan PD, Chopin M, Boissel N, Bories JC, Soulier J, von Boehmer H, Sigaux F, Regnault A. p16INK4A tumor suppressor gene expression and CD3epsilon deficiency but not pre-TCR deficiency inhibit TAL1-linked T-lineage leukemogenesis. Blood 2007;110:2610-9. [PMID: 17507663 DOI: 10.1182/blood-2007-01-066209] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
433 Iacobucci I, Kimura S, Mullighan CG. Biologic and Therapeutic Implications of Genomic Alterations in Acute Lymphoblastic Leukemia. J Clin Med 2021;10:3792. [PMID: 34501239 DOI: 10.3390/jcm10173792] [Reference Citation Analysis]
434 Bentley VL, Veinotte CJ, Corkery DP, Pinder JB, LeBlanc MA, Bedard K, Weng AP, Berman JN, Dellaire G. Focused chemical genomics using zebrafish xenotransplantation as a pre-clinical therapeutic platform for T-cell acute lymphoblastic leukemia. Haematologica. 2015;100:70-76. [PMID: 25281505 DOI: 10.3324/haematol.2014.110742] [Cited by in Crossref: 58] [Cited by in F6Publishing: 51] [Article Influence: 7.3] [Reference Citation Analysis]
435 Roper N, Velez MJ, Chiappori A, Kim YS, Wei JS, Sindiri S, Takahashi N, Mulford D, Kumar S, Ylaya K, Trindade C, Manukyan I, Brown AL, Trepel JB, Lee JM, Hewitt S, Khan J, Thomas A. Notch signaling and efficacy of PD-1/PD-L1 blockade in relapsed small cell lung cancer. Nat Commun 2021;12:3880. [PMID: 34162872 DOI: 10.1038/s41467-021-24164-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
436 Zhang J, Ding L, Holmfeldt L, Wu G, Heatley SL, Payne-Turner D, Easton J, Chen X, Wang J, Rusch M, Lu C, Chen SC, Wei L, Collins-Underwood JR, Ma J, Roberts KG, Pounds SB, Ulyanov A, Becksfort J, Gupta P, Huether R, Kriwacki RW, Parker M, McGoldrick DJ, Zhao D, Alford D, Espy S, Bobba KC, Song G, Pei D, Cheng C, Roberts S, Barbato MI, Campana D, Coustan-Smith E, Shurtleff SA, Raimondi SC, Kleppe M, Cools J, Shimano KA, Hermiston ML, Doulatov S, Eppert K, Laurenti E, Notta F, Dick JE, Basso G, Hunger SP, Loh ML, Devidas M, Wood B, Winter S, Dunsmore KP, Fulton RS, Fulton LL, Hong X, Harris CC, Dooling DJ, Ochoa K, Johnson KJ, Obenauer JC, Evans WE, Pui CH, Naeve CW, Ley TJ, Mardis ER, Wilson RK, Downing JR, Mullighan CG. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature 2012;481:157-63. [PMID: 22237106 DOI: 10.1038/nature10725] [Cited by in Crossref: 1032] [Cited by in F6Publishing: 984] [Article Influence: 103.2] [Reference Citation Analysis]
437 Wu J, Bresnick EH. Bare rudiments of notch signaling: how receptor levels are regulated. Trends in Biochemical Sciences 2007;32:477-85. [DOI: 10.1016/j.tibs.2007.09.002] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 2.1] [Reference Citation Analysis]
438 Mets E, Van der Meulen J, Van Peer G, Boice M, Mestdagh P, Van de Walle I, Lammens T, Goossens S, De Moerloose B, Benoit Y, Van Roy N, Clappier E, Poppe B, Vandesompele J, Wendel HG, Taghon T, Rondou P, Soulier J, Van Vlierberghe P, Speleman F. MicroRNA-193b-3p acts as a tumor suppressor by targeting the MYB oncogene in T-cell acute lymphoblastic leukemia. Leukemia 2015;29:798-806. [PMID: 25231743 DOI: 10.1038/leu.2014.276] [Cited by in Crossref: 63] [Cited by in F6Publishing: 67] [Article Influence: 7.9] [Reference Citation Analysis]
439 Morgan KM, Fischer BS, Lee FY, Shah JJ, Bertino JR, Rosenfeld J, Singh A, Khiabanian H, Pine SR. Gamma Secretase Inhibition by BMS-906024 Enhances Efficacy of Paclitaxel in Lung Adenocarcinoma. Mol Cancer Ther. 2017;16:2759-2769. [PMID: 28978720 DOI: 10.1158/1535-7163.mct-17-0439] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 5.4] [Reference Citation Analysis]
440 Yang X, Feng W, Wang R, Yang F, Wang L, Chen S, Chen C, Ren Q, Zheng G. Hepatic leukemia-associated macrophages exhibit a pro-inflammatory phenotype in Notch1-induced acute T cell leukemia. Immunobiology 2018;223:73-80. [PMID: 29030004 DOI: 10.1016/j.imbio.2017.10.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
441 Hales EC, Orr SM, Larson Gedman A, Taub JW, Matherly LH. Notch1 receptor regulates AKT protein activation loop (Thr308) dephosphorylation through modulation of the PP2A phosphatase in phosphatase and tensin homolog (PTEN)-null T-cell acute lymphoblastic leukemia cells. J Biol Chem 2013;288:22836-48. [PMID: 23788636 DOI: 10.1074/jbc.M113.451625] [Cited by in Crossref: 33] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
442 Kefas B, Comeau L, Floyd DH, Seleverstov O, Godlewski J, Schmittgen T, Jiang J, diPierro CG, Li Y, Chiocca EA, Lee J, Fine H, Abounader R, Lawler S, Purow B. The neuronal microRNA miR-326 acts in a feedback loop with notch and has therapeutic potential against brain tumors. J Neurosci 2009;29:15161-8. [PMID: 19955368 DOI: 10.1523/JNEUROSCI.4966-09.2009] [Cited by in Crossref: 158] [Cited by in F6Publishing: 106] [Article Influence: 12.2] [Reference Citation Analysis]
443 Longville BAC, Anderson D, Welch MD, Kees UR, Greene WK. Aberrant expression of aldehyde dehydrogenase 1A (ALDH1A) subfamily genes in acute lymphoblastic leukaemia is a common feature of T-lineage tumours. Br J Haematol 2015;168:246-57. [DOI: 10.1111/bjh.13120] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
444 Qiu M, Peng Q, Jiang I, Carroll C, Han G, Rymer I, Lippincott J, Zachwieja J, Gajiwala K, Kraynov E, Thibault S, Stone D, Gao Y, Sofia S, Gallo J, Li G, Yang J, Li K, Wei P. Specific inhibition of Notch1 signaling enhances the antitumor efficacy of chemotherapy in triple negative breast cancer through reduction of cancer stem cells. Cancer Letters 2013;328:261-70. [DOI: 10.1016/j.canlet.2012.09.023] [Cited by in Crossref: 82] [Cited by in F6Publishing: 75] [Article Influence: 9.1] [Reference Citation Analysis]
445 Lynch JT, McEwen R, Crafter C, McDermott U, Garnett MJ, Barry ST, Davies BR. Identification of differential PI3K pathway target dependencies in T-cell acute lymphoblastic leukemia through a large cancer cell panel screen. Oncotarget 2016;7:22128-39. [PMID: 26989080 DOI: 10.18632/oncotarget.8031] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
446 Razumilava N, Gores GJ. Notch-driven carcinogenesis: the merging of hepatocellular cancer and cholangiocarcinoma into a common molecular liver cancer subtype. J Hepatol. 2013;58:1244-1245. [PMID: 23352938 DOI: 10.1016/j.jhep.2013.01.017] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
447 Rivina L, Davoren MJ, Schiestl RH. Mouse models for radiation-induced cancers. Mutagenesis 2016;31:491-509. [PMID: 27209205 DOI: 10.1093/mutage/gew019] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
448 Garg V, Muth AN, Ransom JF, Schluterman MK, Barnes R, King IN, Grossfeld PD, Srivastava D. Mutations in NOTCH1 cause aortic valve disease. Nature. 2005;437:270-274. [PMID: 16025100 DOI: 10.1038/nature03940] [Cited by in Crossref: 959] [Cited by in F6Publishing: 846] [Article Influence: 56.4] [Reference Citation Analysis]
449 Fang-Fang Z, You Y, Wen-Jun L. Progress in research on childhood T-cell acute lymphocytic leukemia, Notch1 signaling pathway, and its inhibitors: A review. Bosn J Basic Med Sci 2021;21:136-44. [PMID: 32415821 DOI: 10.17305/bjbms.2020.4687] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
450 Zhou W, Wang G, Guo S. Regulation of angiogenesis via Notch signaling in breast cancer and cancer stem cells. Biochim Biophys Acta. 2013;1836:304-320. [PMID: 24183943 DOI: 10.1016/j.bbcan.2013.10.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 23] [Article Influence: 1.3] [Reference Citation Analysis]
451 Waegemans E, Van de Walle I, De Medts J, De Smedt M, Kerre T, Vandekerckhove B, Leclercq G, Wang T, Plum J, Taghon T. Notch3 activation is sufficient but not required for inducing human T-lineage specification. J Immunol 2014;193:5997-6004. [PMID: 25381438 DOI: 10.4049/jimmunol.1400764] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
452 Jiao X, Wood LD, Lindman M, Jones S, Buckhaults P, Polyak K, Sukumar S, Carter H, Kim D, Karchin R. Somatic mutations in the Notch, NF-KB, PIK3CA, and Hedgehog pathways in human breast cancers. Genes Chromosomes Cancer. 2012;51:480-489. [PMID: 22302350 DOI: 10.1002/gcc.21935] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 4.5] [Reference Citation Analysis]
453 Fu W, Wang K, Zhao JL, Yu HC, Li SZ, Lin Y, Liang L, Huang SY, Liang YM, Han H, Qin HY. FHL1C induces apoptosis in Notch1-dependent T-ALL cells through an interaction with RBP-J. BMC Cancer 2014;14:463. [PMID: 24952875 DOI: 10.1186/1471-2407-14-463] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
454 Malecki MJ, Sanchez-Irizarry C, Mitchell JL, Histen G, Xu ML, Aster JC, Blacklow SC. Leukemia-associated mutations within the NOTCH1 heterodimerization domain fall into at least two distinct mechanistic classes. Mol Cell Biol 2006;26:4642-51. [PMID: 16738328 DOI: 10.1128/MCB.01655-05] [Cited by in Crossref: 182] [Cited by in F6Publishing: 122] [Article Influence: 11.4] [Reference Citation Analysis]
455 Chumsri S, Matsui W, Burger AM. Therapeutic implications of leukemic stem cell pathways. Clin Cancer Res 2007;13:6549-54. [PMID: 18006753 DOI: 10.1158/1078-0432.CCR-07-1088] [Cited by in Crossref: 16] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
456 Evans AG, Calvi LM. Notch signaling in the malignant bone marrow microenvironment: implications for a niche-based model of oncogenesis. Ann N Y Acad Sci 2015;1335:63-77. [PMID: 25351294 DOI: 10.1111/nyas.12562] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
457 Kannan S, Fang W, Song G, Mullighan CG, Hammitt R, McMurray J, Zweidler-McKay PA. Notch/HES1-mediated PARP1 activation: a cell type-specific mechanism for tumor suppression. Blood 2011;117:2891-900. [PMID: 21224467 DOI: 10.1182/blood-2009-12-253419] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 3.5] [Reference Citation Analysis]
458 Xi Y, Li YS, Tang HB. High mobility group A1 protein acts as a new target of Notch1 signaling and regulates cell proliferation in T leukemia cells. Mol Cell Biochem 2013;374:173-80. [PMID: 23229232 DOI: 10.1007/s11010-012-1517-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
459 Jamil K, Jayaraman A, Rao R, Raju S. In silico evidence of signaling pathways of notch mediated networks in leukemia. Comput Struct Biotechnol J 2012;1:e201207005. [PMID: 24688641 DOI: 10.5936/csbj.201207005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
460 Grzes KM, Swamy M, Hukelmann JL, Emslie E, Sinclair LV, Cantrell DA. Control of amino acid transport coordinates metabolic reprogramming in T-cell malignancy. Leukemia 2017;31:2771-9. [PMID: 28546582 DOI: 10.1038/leu.2017.160] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
461 Daakour S, Hajingabo LJ, Kerselidou D, Devresse A, Kettmann R, Simonis N, Dequiedt F, Twizere JC. Systematic interactome mapping of acute lymphoblastic leukemia cancer gene products reveals EXT-1 tumor suppressor as a Notch1 and FBWX7 common interactor. BMC Cancer 2016;16:335. [PMID: 27229929 DOI: 10.1186/s12885-016-2374-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
462 Anjum S, Sen S, Pushker N, Bajaj MS, Kashyap S, Bakhshi S, Chosdol K, Meel R, Sharma MC. Prognostic impact of Notch1 receptor and clinicopathological High-Risk Predictors in lacrimal gland adenoid cystic carcinoma. Acta Ophthalmol 2021. [PMID: 33675181 DOI: 10.1111/aos.14812] [Reference Citation Analysis]
463 Sanda T. Transcription Factors as Therapeutic Targets in Lymphoid Malignancies. International Reviews of Immunology 2009;26:305-32. [DOI: 10.1080/08830180701655945] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
464 Martincorena I, Roshan A, Gerstung M, Ellis P, Van Loo P, McLaren S, Wedge DC, Fullam A, Alexandrov LB, Tubio JM. Tumor evolution. High burden and pervasive positive selection of somatic mutations in normal human skin. Science. 2015;348:880-886. [PMID: 25999502 DOI: 10.1126/science.aaa6806] [Cited by in Crossref: 913] [Cited by in F6Publishing: 737] [Article Influence: 130.4] [Reference Citation Analysis]
465 Mandinova A, Lefort K, Tommasi di Vignano A, Stonely W, Ostano P, Chiorino G, Iwaki H, Nakanishi J, Dotto GP. The FoxO3a gene is a key negative target of canonical Notch signalling in the keratinocyte UVB response. EMBO J 2008;27:1243-54. [PMID: 18388864 DOI: 10.1038/emboj.2008.45] [Cited by in Crossref: 57] [Cited by in F6Publishing: 54] [Article Influence: 4.1] [Reference Citation Analysis]
466 Kumar R, Juillerat-jeanneret L, Golshayan D. Notch Antagonists: Potential Modulators of Cancer and Inflammatory Diseases. J Med Chem 2016;59:7719-37. [DOI: 10.1021/acs.jmedchem.5b01516] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
467 Kalén M, Heikura T, Karvinen H, Nitzsche A, Weber H, Esser N, Ylä-Herttuala S, Hellström M. Gamma-secretase inhibitor treatment promotes VEGF-A-driven blood vessel growth and vascular leakage but disrupts neovascular perfusion. PLoS One 2011;6:e18709. [PMID: 21533193 DOI: 10.1371/journal.pone.0018709] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
468 Homminga I, Pieters R, Langerak AW, de Rooi JJ, Stubbs A, Verstegen M, Vuerhard M, Buijs-Gladdines J, Kooi C, Klous P, van Vlierberghe P, Ferrando AA, Cayuela JM, Verhaaf B, Beverloo HB, Horstmann M, de Haas V, Wiekmeijer AS, Pike-Overzet K, Staal FJ, de Laat W, Soulier J, Sigaux F, Meijerink JP. Integrated transcript and genome analyses reveal NKX2-1 and MEF2C as potential oncogenes in T cell acute lymphoblastic leukemia. Cancer Cell 2011;19:484-97. [PMID: 21481790 DOI: 10.1016/j.ccr.2011.02.008] [Cited by in Crossref: 236] [Cited by in F6Publishing: 227] [Article Influence: 21.5] [Reference Citation Analysis]
469 Bai F, Tagen M, Colotta C, Miller L, Fouladi M, Stewart CF. Determination of the gamma-secretase inhibitor MK-0752 in human plasma by online extraction and electrospray tandem mass spectrometry (HTLC-ESI-MS/MS). J Chromatogr B Analyt Technol Biomed Life Sci 2010;878:2348-52. [PMID: 20702149 DOI: 10.1016/j.jchromb.2010.07.019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
470 Carroll KD, Bu W, Palmeri D, Spadavecchia S, Lynch SJ, Marras SA, Tyagi S, Lukac DM. Kaposi's Sarcoma-associated herpesvirus lytic switch protein stimulates DNA binding of RBP-Jk/CSL to activate the Notch pathway. J Virol 2006;80:9697-709. [PMID: 16973574 DOI: 10.1128/JVI.00746-06] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 2.8] [Reference Citation Analysis]
471 Hurtado C, Safarova A, Smith M, Chung R, Bruyneel AAN, Gomez-Galeno J, Oswald F, Larson CJ, Cashman JR, Ruiz-Lozano P, Janiak P, Suzuki T, Mercola M. Disruption of NOTCH signaling by a small molecule inhibitor of the transcription factor RBPJ. Sci Rep 2019;9:10811. [PMID: 31346210 DOI: 10.1038/s41598-019-46948-5] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
472 Wang Q, Qiu H, Jiang H, Wu L, Dong S, Pan J, Wang W, Ping N, Xia J, Sun A, Wu D, Xue Y, Drexler HG, Macleod RA, Chen S. Mutations of PHF6 are associated with mutations of NOTCH1, JAK1 and rearrangement of SET-NUP214 in T-cell acute lymphoblastic leukemia. Haematologica 2011;96:1808-14. [PMID: 21880637 DOI: 10.3324/haematol.2011.043083] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 4.1] [Reference Citation Analysis]
473 Weaver KL, Alves-Guerra MC, Jin K, Wang Z, Han X, Ranganathan P, Zhu X, DaSilva T, Liu W, Ratti F, Demarest RM, Tzimas C, Rice M, Vasquez-Del Carpio R, Dahmane N, Robbins DJ, Capobianco AJ. NACK is an integral component of the Notch transcriptional activation complex and is critical for development and tumorigenesis. Cancer Res 2014;74:4741-51. [PMID: 25038227 DOI: 10.1158/0008-5472.CAN-14-1547] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
474 Gutierrez A, Pan L, Groen RW, Baleydier F, Kentsis A, Marineau J, Grebliunaite R, Kozakewich E, Reed C, Pflumio F, Poglio S, Uzan B, Clemons P, VerPlank L, An F, Burbank J, Norton S, Tolliday N, Steen H, Weng AP, Yuan H, Bradner JE, Mitsiades C, Look AT, Aster JC. Phenothiazines induce PP2A-mediated apoptosis in T cell acute lymphoblastic leukemia. J Clin Invest 2014;124:644-55. [PMID: 24401270 DOI: 10.1172/JCI65093] [Cited by in Crossref: 132] [Cited by in F6Publishing: 88] [Article Influence: 16.5] [Reference Citation Analysis]
475 Jennings BH, Pickles LM, Wainwright SM, Roe SM, Pearl LH, Ish-Horowicz D. Molecular recognition of transcriptional repressor motifs by the WD domain of the Groucho/TLE corepressor. Mol Cell 2006;22:645-55. [PMID: 16762837 DOI: 10.1016/j.molcel.2006.04.024] [Cited by in Crossref: 104] [Cited by in F6Publishing: 108] [Article Influence: 6.5] [Reference Citation Analysis]
476 Jegalian AG, Bodo J, Hsi ED. NOTCH1 Intracellular Domain Immunohistochemistry as a Diagnostic Tool to Distinguish T-Lymphoblastic Lymphoma From Thymoma. American Journal of Surgical Pathology 2015;39:565-72. [DOI: 10.1097/pas.0000000000000358] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 1.9] [Reference Citation Analysis]
477 Hua C, Guo H, Bu J, Zhou M, Cheng H, He F, Wang J, Wang X, Zhang Y, Wang Q, Zhou J, Cheng T, Xu M, Yuan W. Rictor/mammalian target of rapamycin 2 regulates the development of Notch1 induced murine T-cell acute lymphoblastic leukemia via forkhead box O3. Exp Hematol 2014;42:1031-40.e1-4. [PMID: 25201756 DOI: 10.1016/j.exphem.2014.08.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
478 Macieira-coelho A. Neoplastic Growth Through the Developmental Stages of the Organism. In: Macieira-coelho A, editor. Developmental Biology of Neoplastic Growth. Berlin/Heidelberg: Springer-Verlag; 2005. pp. 217-50. [DOI: 10.1007/3-540-27671-8_9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
479 Purow B. Notch inhibition as a promising new approach to cancer therapy. Adv Exp Med Biol. 2012;727:305-319. [PMID: 22399357 DOI: 10.1007/978-1-4614-0899-4_23] [Cited by in Crossref: 102] [Cited by in F6Publishing: 92] [Article Influence: 10.2] [Reference Citation Analysis]
480 Neumann M, Vosberg S, Schlee C, Heesch S, Schwartz S, Gökbuget N, Hoelzer D, Graf A, Krebs S, Bartram I, Blum H, Brüggemann M, Hecht J, Bohlander SK, Greif PA, Baldus CD. Mutational spectrum of adult T-ALL. Oncotarget 2015;6:2754-66. [PMID: 25595890 DOI: 10.18632/oncotarget.2218] [Cited by in Crossref: 73] [Cited by in F6Publishing: 70] [Article Influence: 10.4] [Reference Citation Analysis]
481 Fasoulakis Z, Daskalakis G, Theodora M, Antsaklis P, Sindos M, Diakosavvas M, Angelou K, Loutradis D, Kontomanolis EN. The Relevance of Notch Signaling in Cancer Progression. Adv Exp Med Biol 2021;1287:169-81. [PMID: 33034032 DOI: 10.1007/978-3-030-55031-8_11] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
482 Jun HT, Stevens J, Kaplan-lefko P. Top NOTCH targets: notch signaling in cancer. Drug Dev Res 2008;69:319-28. [DOI: 10.1002/ddr.20264] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
483 Osanyingbemi-Obidi J, Dobromilskaya I, Illei PB, Hann CL, Rudin CM. Notch signaling contributes to lung cancer clonogenic capacity in vitro but may be circumvented in tumorigenesis in vivo. Mol Cancer Res. 2011;9:1746-1754. [PMID: 21994468 DOI: 10.1158/1541-7786.mcr-11-0286] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
484 Zhou MH, Yang QM. NUP214 fusion genes in acute leukemia (Review). Oncol Lett 2014;8:959-62. [PMID: 25120641 DOI: 10.3892/ol.2014.2263] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
485 Deng X, Michaelson D, Tchieu J, Cheng J, Rothenstein D, Feldman R, Lee SG, Fuller J, Haimovitz-Friedman A, Studer L, Powell S, Fuks Z, Hubbard EJ, Kolesnick R. Targeting Homologous Recombination in Notch-Driven C. elegans Stem Cell and Human Tumors. PLoS One 2015;10:e0127862. [PMID: 26120834 DOI: 10.1371/journal.pone.0127862] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
486 Lee D, Sykes SM, Kalaitzidis D, Lane AA, Kfoury Y, Raaijmakers MH, Wang YH, Armstrong SA, Scadden DT. Transmembrane Inhibitor of RICTOR/mTORC2 in Hematopoietic Progenitors. Stem Cell Reports 2014;3:832-40. [PMID: 25418727 DOI: 10.1016/j.stemcr.2014.08.011] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
487 Tremblay CS, Hoang T, Hoang T. Early T cell differentiation lessons from T-cell acute lymphoblastic leukemia. Prog Mol Biol Transl Sci 2010;92:121-56. [PMID: 20800819 DOI: 10.1016/S1877-1173(10)92006-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
488 Wang J, Sullenger BA, Rich JN. Notch Signaling in Cancer Stem Cells. In: Reichrath J, Reichrath S, editors. Notch Signaling in Embryology and Cancer. New York: Springer US; 2012. pp. 174-85. [DOI: 10.1007/978-1-4614-0899-4_13] [Cited by in Crossref: 68] [Cited by in F6Publishing: 54] [Article Influence: 6.8] [Reference Citation Analysis]
489 Yahyanejad S, Theys J, Vooijs M. Targeting Notch to overcome radiation resistance. Oncotarget 2016;7:7610-28. [PMID: 26713603 DOI: 10.18632/oncotarget.6714] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 5.3] [Reference Citation Analysis]
490 Wakabayashi T, De Strooper B. Presenilins: members of the gamma-secretase quartets, but part-time soloists too. Physiology (Bethesda) 2008;23:194-204. [PMID: 18697993 DOI: 10.1152/physiol.00009.2008] [Cited by in Crossref: 86] [Cited by in F6Publishing: 86] [Article Influence: 6.1] [Reference Citation Analysis]
491 Makita Y, Saito S, Tsuchiya A, Ishibashi M, Arai MA. Identification of 1β,2α-epoxytagitinin C as a Notch inhibitor, oxidative stress mechanism and its anti-leukemia activity. J Nat Med 2021. [PMID: 34779991 DOI: 10.1007/s11418-021-01584-0] [Reference Citation Analysis]
492 White EA. Manipulation of Epithelial Differentiation by HPV Oncoproteins. Viruses 2019;11:E369. [PMID: 31013597 DOI: 10.3390/v11040369] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 5.3] [Reference Citation Analysis]
493 Chiang MY, Xu L, Shestova O, Histen G, L'heureux S, Romany C, Childs ME, Gimotty PA, Aster JC, Pear WS. Leukemia-associated NOTCH1 alleles are weak tumor initiators but accelerate K-ras-initiated leukemia. J Clin Invest 2008;118:3181-94. [PMID: 18677410 DOI: 10.1172/JCI35090] [Cited by in Crossref: 166] [Cited by in F6Publishing: 121] [Article Influence: 11.9] [Reference Citation Analysis]
494 Jin X, Jin X, Kim H. Cancer stem cells and differentiation therapy. Tumour Biol 2017;39:1010428317729933. [PMID: 29072131 DOI: 10.1177/1010428317729933] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 6.2] [Reference Citation Analysis]
495 Deng Y, Luo KL, Shaye DD, Greenwald I. A Screen of the Conserved Kinome for Negative Regulators of LIN-12 Negative Regulatory Region ("NRR")-Missense Activity in Caenorhabditis elegans. G3 (Bethesda) 2019;9:3567-74. [PMID: 31519743 DOI: 10.1534/g3.119.400471] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
496 Karrman K, Kjeldsen E, Lassen C, Isaksson M, Davidsson J, Andersson A, Hasle H, Fioretos T, Johansson B. The t(X;7)(q22;q34) in paediatric T-cell acute lymphoblastic leukaemia results in overexpression of the insulin receptor substrate 4 gene through illegitimate recombination with the T-cell receptor beta locus. Br J Haematol 2009;144:546-51. [PMID: 19055661 DOI: 10.1111/j.1365-2141.2008.07453.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
497 Park MJ, Taki T, Oda M, Watanabe T, Yumura-Yagi K, Kobayashi R, Suzuki N, Hara J, Horibe K, Hayashi Y. FBXW7 and NOTCH1 mutations in childhood T cell acute lymphoblastic leukaemia and T cell non-Hodgkin lymphoma. Br J Haematol 2009;145:198-206. [PMID: 19245433 DOI: 10.1111/j.1365-2141.2009.07607.x] [Cited by in Crossref: 86] [Cited by in F6Publishing: 79] [Article Influence: 6.6] [Reference Citation Analysis]
498 Tung JJ, Tattersall IW, Kitajewski J. Tips, stalks, tubes: notch-mediated cell fate determination and mechanisms of tubulogenesis during angiogenesis. Cold Spring Harb Perspect Med 2012;2:a006601. [PMID: 22355796 DOI: 10.1101/cshperspect.a006601] [Cited by in Crossref: 57] [Cited by in F6Publishing: 66] [Article Influence: 6.3] [Reference Citation Analysis]
499 Shi W, Harris AL. Notch signaling in breast cancer and tumor angiogenesis: cross-talk and therapeutic potentials. J Mammary Gland Biol Neoplasia. 2006;11:41-52. [PMID: 16947085 DOI: 10.1007/s10911-006-9011-7] [Cited by in Crossref: 51] [Cited by in F6Publishing: 54] [Article Influence: 3.4] [Reference Citation Analysis]
500 Hoare M, Narita M. Notch and Senescence. Adv Exp Med Biol 2018;1066:299-318. [PMID: 30030833 DOI: 10.1007/978-3-319-89512-3_15] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
501 Weisberg SP, Smith-Raska MR, Esquilin JM, Zhang J, Arenzana TL, Lau CM, Churchill M, Pan H, Klinakis A, Dixon JE, Mirny LA, Mukherjee S, Reizis B. ZFX controls propagation and prevents differentiation of acute T-lymphoblastic and myeloid leukemia. Cell Rep 2014;6:528-40. [PMID: 24485662 DOI: 10.1016/j.celrep.2014.01.007] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
502 Beher D, Graham SL. Protease inhibitors as potential disease-modifying therapeutics for Alzheimer’s disease. Expert Opinion on Investigational Drugs 2005;14:1385-409. [DOI: 10.1517/13543784.14.11.1385] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 2.7] [Reference Citation Analysis]
503 Kummar S, O'Sullivan Coyne G, Do KT, Turkbey B, Meltzer PS, Polley E, Choyke PL, Meehan R, Vilimas R, Horneffer Y, Juwara L, Lih A, Choudhary A, Mitchell SA, Helman LJ, Doroshow JH, Chen AP. Clinical Activity of the γ-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors (Aggressive Fibromatosis). J Clin Oncol 2017;35:1561-9. [PMID: 28350521 DOI: 10.1200/JCO.2016.71.1994] [Cited by in Crossref: 69] [Cited by in F6Publishing: 37] [Article Influence: 13.8] [Reference Citation Analysis]
504 Huntly BJ, Gilliland DG. Leukaemia stem cells and the evolution of cancer-stem-cell research. Nat Rev Cancer. 2005;5:311-321. [PMID: 15803157 DOI: 10.1038/nrc1592] [Cited by in Crossref: 400] [Cited by in F6Publishing: 357] [Article Influence: 23.5] [Reference Citation Analysis]
505 Murakami N, Maillard I, Riella LV. Notch Signaling and Immune Regulation in Alloimmunity. Curr Transplant Rep 2016;3:294-302. [PMID: 29977738 DOI: 10.1007/s40472-016-0126-5] [Reference Citation Analysis]
506 Giebel S, Krawczyk-kulis M, Adamczyk-cioch M, Jakubas B, Palynyczko G, Lewandowski K, Dmoszynska A, Skotnicki A, Nowak K, Holowiecki J; On behalf of the Polish Adult Leukemia Group. Fludarabine, cytarabine, and mitoxantrone (FLAM) for the treatment of relapsed and refractory adult acute lymphoblastic leukemia. A phase study by the Polish Adult Leukemia Group (PALG). Ann Hematol 2006;85:717-22. [DOI: 10.1007/s00277-006-0121-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
507 Balint K, Xiao M, Pinnix CC, Soma A, Veres I, Juhasz I, Brown EJ, Capobianco AJ, Herlyn M, Liu ZJ. Activation of Notch1 signaling is required for beta-catenin-mediated human primary melanoma progression. J Clin Invest 2005;115:3166-76. [PMID: 16239965 DOI: 10.1172/JCI25001] [Cited by in Crossref: 244] [Cited by in F6Publishing: 135] [Article Influence: 14.4] [Reference Citation Analysis]
508 . Cancer therapy resistance: chasing epigenetics. Nat Med 2014;20:340-1. [PMID: 24710376 DOI: 10.1038/nm.3528] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
509 Fabbri G, Khiabanian H, Holmes AB, Wang J, Messina M, Mullighan CG, Pasqualucci L, Rabadan R, Dalla-Favera R. Genetic lesions associated with chronic lymphocytic leukemia transformation to Richter syndrome. J Exp Med 2013;210:2273-88. [PMID: 24127483 DOI: 10.1084/jem.20131448] [Cited by in Crossref: 169] [Cited by in F6Publishing: 154] [Article Influence: 18.8] [Reference Citation Analysis]
510 Bornschein S, Demeyer S, Stirparo R, Gielen O, Vicente C, Geerdens E, Ghesquière B, Aerts S, Cools J, de Bock CE. Defining the molecular basis of oncogenic cooperation between TAL1 expression and Pten deletion in T-ALL using a novel pro-T-cell model system. Leukemia 2018;32:941-51. [PMID: 29151585 DOI: 10.1038/leu.2017.328] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
511 Tan TK, Zhang C, Sanda T. Oncogenic transcriptional program driven by TAL1 in T-cell acute lymphoblastic leukemia. Int J Hematol 2019;109:5-17. [PMID: 30145780 DOI: 10.1007/s12185-018-2518-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
512 Sherry KP, Johnson SE, Hatem CL, Majumdar A, Barrick D. Effects of Linker Length and Transient Secondary Structure Elements in the Intrinsically Disordered Notch RAM Region on Notch Signaling. J Mol Biol 2015;427:3587-97. [PMID: 26344835 DOI: 10.1016/j.jmb.2015.09.001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
513 Kool J, Berns A. High-throughput insertional mutagenesis screens in mice to identify oncogenic networks. Nat Rev Cancer 2009;9:389-99. [DOI: 10.1038/nrc2647] [Cited by in Crossref: 94] [Cited by in F6Publishing: 86] [Article Influence: 7.2] [Reference Citation Analysis]
514 Gordon WR, Zimmerman B, He L, Miles LJ, Huang J, Tiyanont K, McArthur DG, Aster JC, Perrimon N, Loparo JJ, Blacklow SC. Mechanical Allostery: Evidence for a Force Requirement in the Proteolytic Activation of Notch. Dev Cell 2015;33:729-36. [PMID: 26051539 DOI: 10.1016/j.devcel.2015.05.004] [Cited by in Crossref: 179] [Cited by in F6Publishing: 153] [Article Influence: 25.6] [Reference Citation Analysis]
515 Zha S, Bassing CH, Sanda T, Brush JW, Patel H, Goff PH, Murphy MM, Tepsuporn S, Gatti RA, Look AT, Alt FW. ATM-deficient thymic lymphoma is associated with aberrant tcrd rearrangement and gene amplification. J Exp Med 2010;207:1369-80. [PMID: 20566716 DOI: 10.1084/jem.20100285] [Cited by in Crossref: 67] [Cited by in F6Publishing: 61] [Article Influence: 5.6] [Reference Citation Analysis]
516 Pérez-Benavente B, Nasresfahani AF, Farràs R. Ubiquitin-Regulated Cell Proliferation and Cancer. Adv Exp Med Biol 2020;1233:3-28. [PMID: 32274751 DOI: 10.1007/978-3-030-38266-7_1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
517 Borssén M, Palmqvist L, Karrman K, Abrahamsson J, Behrendtz M, Heldrup J, Forestier E, Roos G, Degerman S. Promoter DNA methylation pattern identifies prognostic subgroups in childhood T-cell acute lymphoblastic leukemia. PLoS One 2013;8:e65373. [PMID: 23762353 DOI: 10.1371/journal.pone.0065373] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 4.2] [Reference Citation Analysis]
518 Vega-García N, Perez-Jaume S, Esperanza-Cebollada E, Vicente-Garcés C, Torrebadell M, Jiménez-Velasco A, Ortega M, Llop M, Abad L, Vagace JM, Minguela A, Pratcorona M, Sánchez-Garcia J, García-Calderón CB, Gómez-Casares MT, Martín-Clavero E, Escudero A, Riñón Martinez-Gallo M, Muñoz L, Velasco MR, García-Morin M, Català A, Pascual A, Velasco P, Fernández JM, Lassaletta A, Fuster JL, Badell I, Molinos-Quintana Á, Molinés A, Guerra-García P, Pérez-Martínez A, García-Abós M, Robles Ortiz R, Pisa S, Adán R, Díaz de Heredia C, Dapena JL, Rives S, Ramírez-Orellana M, Camós M. Measurable Residual Disease Assessed by Flow-Cytometry Is a Stable Prognostic Factor for Pediatric T-Cell Acute Lymphoblastic Leukemia in Consecutive SEHOP Protocols Whereas the Impact of Oncogenetics Depends on Treatment. Front Pediatr 2020;8:614521. [PMID: 33614543 DOI: 10.3389/fped.2020.614521] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
519 Rice KN, Jamieson CHM. Molecular pathways to CML stem cells. Int J Hematol 2010;91:748-52. [DOI: 10.1007/s12185-010-0615-8] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
520 Anand P, Guillaumet-Adkins A, Dimitrova V, Yun H, Drier Y, Sotudeh N, Rogers A, Ouseph MM, Nair M, Potdar S, Isenhart R, Kloeber JA, Vijaykumar T, Niu L, Vincent T, Guo G, Frede J, Harris MH, Place AE, Silverman LB, Teachey DT, Lane AA, DeAngelo DJ, Aster JC, Bernstein BE, Lohr JG, Knoechel B. Single-cell RNA-seq reveals developmental plasticity with coexisting oncogenic states and immune evasion programs in ETP-ALL. Blood 2021;137:2463-80. [PMID: 33227818 DOI: 10.1182/blood.2019004547] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
521 Maser RS, Choudhury B, Campbell PJ, Feng B, Wong KK, Protopopov A, O'Neil J, Gutierrez A, Ivanova E, Perna I, Lin E, Mani V, Jiang S, McNamara K, Zaghlul S, Edkins S, Stevens C, Brennan C, Martin ES, Wiedemeyer R, Kabbarah O, Nogueira C, Histen G, Aster J, Mansour M, Duke V, Foroni L, Fielding AK, Goldstone AH, Rowe JM, Wang YA, Look AT, Stratton MR, Chin L, Futreal PA, DePinho RA. Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancers. Nature 2007;447:966-71. [PMID: 17515920 DOI: 10.1038/nature05886] [Cited by in Crossref: 274] [Cited by in F6Publishing: 284] [Article Influence: 18.3] [Reference Citation Analysis]
522 Tal N, Shochat C, Geron I, Bercovich D, Izraeli S. Interleukin 7 and thymic stromal lymphopoietin: from immunity to leukemia. Cell Mol Life Sci 2014;71:365-78. [PMID: 23625073 DOI: 10.1007/s00018-013-1337-x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
523 Shaik JP, Alanazi IO, Pathan AAK, Parine NR, Almadi MA, Azzam NA, Aljebreen AM, Alharbi O, Alanazi MS, Khan Z. Frequent Activation of Notch Signaling Pathway in Colorectal Cancers and Its Implication in Patient Survival Outcome. J Oncol 2020;2020:6768942. [PMID: 32211044 DOI: 10.1155/2020/6768942] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
524 Belver L, Yang AY, Albero R, Herranz D, Brundu FG, Quinn SA, Pérez-Durán P, Álvarez S, Gianni F, Rashkovan M, Gurung D, Rocha PP, Raviram R, Reglero C, Cortés JR, Cooke AJ, Wendorff AA, Cordó V, Meijerink JP, Rabadan R, Ferrando AA. GATA3-Controlled Nucleosome Eviction Drives MYC Enhancer Activity in T-cell Development and Leukemia. Cancer Discov 2019;9:1774-91. [PMID: 31519704 DOI: 10.1158/2159-8290.CD-19-0471] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
525 Xu Z, Huang B, Zhang Q, He X, Wei H, Zhang D. NOTCH1 regulates the proliferation and migration of bladder cancer cells by cooperating with long non-coding RNA HCG18 and microRNA-34c-5p. J Cell Biochem 2019;120:6596-604. [PMID: 30426533 DOI: 10.1002/jcb.27954] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 5.5] [Reference Citation Analysis]
526 Popko-Scibor AE, Lindberg MJ, Hansson ML, Holmlund T, Wallberg AE. Ubiquitination of Notch1 is regulated by MAML1-mediated p300 acetylation of Notch1. Biochem Biophys Res Commun 2011;416:300-6. [PMID: 22100894 DOI: 10.1016/j.bbrc.2011.11.030] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
527 Guo D, Teng Q, Ji C. NOTCH and phosphatidylinositide 3-kinase/phosphatase and tensin homolog deleted on chromosome ten/AKT/mammalian target of rapamycin (mTOR) signaling in T-cell development and T-cell acute lymphoblastic leukemia. Leuk Lymphoma 2011;52:1200-10. [PMID: 21463127 DOI: 10.3109/10428194.2011.564696] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
528 Nowell CS, Radtke F. Notch as a tumour suppressor. Nat Rev Cancer 2017;17:145-59. [PMID: 28154375 DOI: 10.1038/nrc.2016.145] [Cited by in Crossref: 173] [Cited by in F6Publishing: 163] [Article Influence: 34.6] [Reference Citation Analysis]
529 Kwon OJ, Zhang L, Wang J, Su Q, Feng Q, Zhang XH, Mani SA, Paulter R, Creighton CJ, Ittmann MM, Xin L. Notch promotes tumor metastasis in a prostate-specific Pten-null mouse model. J Clin Invest 2016;126:2626-41. [PMID: 27294523 DOI: 10.1172/JCI84637] [Cited by in Crossref: 37] [Cited by in F6Publishing: 23] [Article Influence: 6.2] [Reference Citation Analysis]
530 Hsu PJ, Yan K, Shi H, Izumchenko E, Agrawal N. Molecular biology of oral cavity squamous cell carcinoma. Oral Oncol 2020;102:104552. [PMID: 31918173 DOI: 10.1016/j.oraloncology.2019.104552] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
531 Yamagishi M, Kubokawa M, Kuze Y, Suzuki A, Yokomizo A, Kobayashi S, Nakashima M, Makiyama J, Iwanaga M, Fukuda T, Watanabe T, Suzuki Y, Uchimaru K. Chronological genome and single-cell transcriptome integration characterizes the evolutionary process of adult T cell leukemia-lymphoma. Nat Commun 2021;12:4821. [PMID: 34376672 DOI: 10.1038/s41467-021-25101-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
532 Ying M, Tilghman J, Wei Y, Guerrero-Cazares H, Quinones-Hinojosa A, Ji H, Laterra J. Kruppel-like factor-9 (KLF9) inhibits glioblastoma stemness through global transcription repression and integrin α6 inhibition. J Biol Chem 2014;289:32742-56. [PMID: 25288800 DOI: 10.1074/jbc.M114.588988] [Cited by in Crossref: 37] [Cited by in F6Publishing: 20] [Article Influence: 4.6] [Reference Citation Analysis]
533 Lu M, Muers MR, Lu X. Introducing STRaNDs: shuttling transcriptional regulators that are non-DNA binding. Nat Rev Mol Cell Biol 2016;17:523-32. [PMID: 27220640 DOI: 10.1038/nrm.2016.41] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
534 Wang MM. Notch signaling and Notch signaling modifiers. Int J Biochem Cell Biol 2011;43:1550-62. [PMID: 21854867 DOI: 10.1016/j.biocel.2011.08.005] [Cited by in Crossref: 61] [Cited by in F6Publishing: 64] [Article Influence: 5.5] [Reference Citation Analysis]
535 Groth C, Fortini ME. Therapeutic approaches to modulating Notch signaling: current challenges and future prospects. Semin Cell Dev Biol 2012;23:465-72. [PMID: 22309842 DOI: 10.1016/j.semcdb.2012.01.016] [Cited by in Crossref: 86] [Cited by in F6Publishing: 79] [Article Influence: 8.6] [Reference Citation Analysis]
536 Khandelwal A, Chandu D, Roe CM, Kopan R, Quatrano RS. Moonlighting activity of presenilin in plants is independent of gamma-secretase and evolutionarily conserved. Proc Natl Acad Sci U S A 2007;104:13337-42. [PMID: 17684101 DOI: 10.1073/pnas.0702038104] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 3.1] [Reference Citation Analysis]
537 Hunger SP, Mullighan CG. Redefining ALL classification: toward detecting high-risk ALL and implementing precision medicine. Blood 2015;125:3977-87. [PMID: 25999453 DOI: 10.1182/blood-2015-02-580043] [Cited by in Crossref: 155] [Cited by in F6Publishing: 143] [Article Influence: 22.1] [Reference Citation Analysis]
538 Steinbuck MP, Winandy S. A Review of Notch Processing With New Insights Into Ligand-Independent Notch Signaling in T-Cells. Front Immunol 2018;9:1230. [PMID: 29910816 DOI: 10.3389/fimmu.2018.01230] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 8.0] [Reference Citation Analysis]
539 Riaz N, Morris LG, Lee W, Chan TA. Unraveling the molecular genetics of head and neck cancer through genome-wide approaches. Genes Dis. 2014;1:75-86. [PMID: 25642447 DOI: 10.1016/j.gendis.2014.07.002] [Cited by in Crossref: 62] [Cited by in F6Publishing: 50] [Article Influence: 7.8] [Reference Citation Analysis]
540 Speleman F, Cauwelier B, Dastugue N, Cools J, Verhasselt B, Poppe B, Van Roy N, Vandesompele J, Graux C, Uyttebroeck A, Boogaerts M, De Moerloose B, Benoit Y, Selleslag D, Billiet J, Robert A, Huguet F, Vandenberghe P, De Paepe A, Marynen P, Hagemeijer A. A new recurrent inversion, inv(7)(p15q34), leads to transcriptional activation of HOXA10 and HOXA11 in a subset of T-cell acute lymphoblastic leukemias. Leukemia 2005;19:358-66. [DOI: 10.1038/sj.leu.2403657] [Cited by in Crossref: 77] [Cited by in F6Publishing: 69] [Article Influence: 4.5] [Reference Citation Analysis]
541 Wang F, Li Z, Zhou J, Wang G, Zhang W, Xu J, Liang A. SIRT1 regulates the phosphorylation and degradation of P27 by deacetylating CDK2 to promote T-cell acute lymphoblastic leukemia progression. J Exp Clin Cancer Res 2021;40:259. [PMID: 34407842 DOI: 10.1186/s13046-021-02071-w] [Reference Citation Analysis]
542 Kataoka K, Ogawa S. Variegated RHOA mutations in human cancers. Experimental Hematology 2016;44:1123-9. [DOI: 10.1016/j.exphem.2016.09.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
543 Chari S, Umetsu SE, Winandy S. Notch target gene deregulation and maintenance of the leukemogenic phenotype do not require RBP-J kappa in Ikaros null mice. J Immunol 2010;185:410-7. [PMID: 20511547 DOI: 10.4049/jimmunol.0903688] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
544 Dumortier A, Jeannet R, Kirstetter P, Kleinmann E, Sellars M, dos Santos NR, Thibault C, Barths J, Ghysdael J, Punt JA, Kastner P, Chan S. Notch activation is an early and critical event during T-Cell leukemogenesis in Ikaros-deficient mice. Mol Cell Biol 2006;26:209-20. [PMID: 16354692 DOI: 10.1128/MCB.26.1.209-220.2006] [Cited by in Crossref: 120] [Cited by in F6Publishing: 71] [Article Influence: 7.5] [Reference Citation Analysis]
545 van der Zwet JCG, Cordo' V, Canté-Barrett K, Meijerink JPP. Multi-omic approaches to improve outcome for T-cell acute lymphoblastic leukemia patients. Adv Biol Regul 2019;74:100647. [PMID: 31523030 DOI: 10.1016/j.jbior.2019.100647] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
546 Haydu JE, De Keersmaecker K, Duff MK, Paietta E, Racevskis J, Wiernik PH, Rowe JM, Ferrando A. An activating intragenic deletion in NOTCH1 in human T-ALL. Blood 2012;119:5211-4. [PMID: 22510873 DOI: 10.1182/blood-2011-10-388504] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
547 Butzmann A, Sridhar K, Jangam D, Song H, Singh A, Kumar J, Chisholm KM, Pinsky B, Huang F, Ohgami RS. Mutations in JAK/STAT and NOTCH1 Genes Are Enriched in Post-Transplant Lymphoproliferative Disorders. Front Oncol 2022;11:790481. [DOI: 10.3389/fonc.2021.790481] [Reference Citation Analysis]
548 de Leval L, Bisig B, Thielen C, Boniver J, Gaulard P. Molecular classification of T-cell lymphomas. Critical Reviews in Oncology/Hematology 2009;72:125-43. [DOI: 10.1016/j.critrevonc.2009.01.002] [Cited by in Crossref: 50] [Cited by in F6Publishing: 44] [Article Influence: 3.8] [Reference Citation Analysis]
549 van den Brand M, Scheijen B, Hess CJ, van Krieken JHJ, Groenen PJTA. Pathways towards indolent B-cell lymphoma - Etiology and therapeutic strategies. Blood Rev 2017;31:426-35. [PMID: 28802906 DOI: 10.1016/j.blre.2017.08.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
550 Armstrong F, Brunet de la Grange P, Gerby B, Rouyez MC, Calvo J, Fontenay M, Boissel N, Dombret H, Baruchel A, Landman-Parker J, Roméo PH, Ballerini P, Pflumio F. NOTCH is a key regulator of human T-cell acute leukemia initiating cell activity. Blood 2009;113:1730-40. [PMID: 18984862 DOI: 10.1182/blood-2008-02-138172] [Cited by in Crossref: 118] [Cited by in F6Publishing: 108] [Article Influence: 8.4] [Reference Citation Analysis]
551 Sosa Iglesias V, Giuranno L, Dubois LJ, Theys J, Vooijs M. Drug Resistance in Non-Small Cell Lung Cancer: A Potential for NOTCH Targeting? Front Oncol 2018;8:267. [PMID: 30087852 DOI: 10.3389/fonc.2018.00267] [Cited by in Crossref: 54] [Cited by in F6Publishing: 54] [Article Influence: 13.5] [Reference Citation Analysis]
552 De Keersmaecker K, Michaux L, Bosly A, Graux C, Ferreiro JF, Vandenberghe P, Cools J, Wlodarska I. Rearrangement of NOTCH1 or BCL3 can independently trigger progression of CLL. Blood 2012;119:3864-6. [PMID: 22517878 DOI: 10.1182/blood-2011-10-388124] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
553 Stockhausen MT, Kristoffersen K, Poulsen HS. The functional role of Notch signaling in human gliomas. Neuro Oncol 2010;12:199-211. [PMID: 20150387 DOI: 10.1093/neuonc/nop022] [Cited by in Crossref: 75] [Cited by in F6Publishing: 72] [Article Influence: 5.8] [Reference Citation Analysis]
554 Bhagat TD, Zou Y, Huang S, Park J, Palmer MB, Hu C, Li W, Shenoy N, Giricz O, Choudhary G, Yu Y, Ko YA, Izquierdo MC, Park AS, Vallumsetla N, Laurence R, Lopez R, Suzuki M, Pullman J, Kaner J, Gartrell B, Hakimi AA, Greally JM, Patel B, Benhadji K, Pradhan K, Verma A, Susztak K. Notch Pathway Is Activated via Genetic and Epigenetic Alterations and Is a Therapeutic Target in Clear Cell Renal Cancer. J Biol Chem 2017;292:837-46. [PMID: 27909050 DOI: 10.1074/jbc.M116.745208] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
555 Wang X, Lou K, Song X, Ma H, Zhou X, Xu H, Wang W. Mebendazole is a potent inhibitor to chemoresistant T cell acute lymphoblastic leukemia cells. Toxicol Appl Pharmacol 2020;396:115001. [PMID: 32277947 DOI: 10.1016/j.taap.2020.115001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
556 Miller ML, Reznik E, Gauthier NP, Aksoy BA, Korkut A, Gao J, Ciriello G, Schultz N, Sander C. Pan-Cancer Analysis of Mutation Hotspots in Protein Domains. Cell Syst 2015;1:197-209. [PMID: 27135912 DOI: 10.1016/j.cels.2015.08.014] [Cited by in Crossref: 73] [Cited by in F6Publishing: 61] [Article Influence: 10.4] [Reference Citation Analysis]
557 Cui Y, Onozawa M, Garber HR, Samsel L, Wang Z, McCoy JP, Burkett S, Wu X, Aplan PD, Mackall CL. Thymic expression of a T-cell receptor targeting a tumor-associated antigen coexpressed in the thymus induces T-ALL. Blood 2015;125:2958-67. [PMID: 25814528 DOI: 10.1182/blood-2014-10-609271] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
558 Gómez-del Arco P, Kashiwagi M, Jackson AF, Naito T, Zhang J, Liu F, Kee B, Vooijs M, Radtke F, Redondo JM, Georgopoulos K. Alternative promoter usage at the Notch1 locus supports ligand-independent signaling in T cell development and leukemogenesis. Immunity 2010;33:685-98. [PMID: 21093322 DOI: 10.1016/j.immuni.2010.11.008] [Cited by in Crossref: 65] [Cited by in F6Publishing: 64] [Article Influence: 5.4] [Reference Citation Analysis]
559 Mori A, Masuda K, Ohtsuka H, Shijo M, Ariake K, Fukase K, Sakata N, Mizuma M, Morikawa T, Hayashi H, Nakagawa K, Motoi F, Naitoh T, Fujishima F, Unno M. FBXW7 modulates malignant potential and cisplatin-induced apoptosis in cholangiocarcinoma through NOTCH1 and MCL1. Cancer Sci 2018;109:3883-95. [PMID: 30302867 DOI: 10.1111/cas.13829] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
560 Jour G, Andeen NK, al-Rohil R, Aung PP, Mehrotra M, Duose D, Hoch B, Argenyi Z, Luthra R, Wistuba II, Prieto VG. Novel enriched pathways in superficial malignant peripheral nerve sheath tumours and spindle/desmoplastic melanomas: Perturbed immune pathways in MPNST and SDM. J Pathol 2018;244:97-106. [DOI: 10.1002/path.4996] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
561 Yashiro-Ohtani Y, Ohtani T, Pear WS. Notch regulation of early thymocyte development. Semin Immunol. 2010;22:261-269. [PMID: 20630772 DOI: 10.1016/j.smim.2010.04.015] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]
562 O'Neil J, Look AT. Mechanisms of transcription factor deregulation in lymphoid cell transformation. Oncogene 2007;26:6838-49. [PMID: 17934490 DOI: 10.1038/sj.onc.1210766] [Cited by in Crossref: 89] [Cited by in F6Publishing: 82] [Article Influence: 5.9] [Reference Citation Analysis]
563 Su Q, Zhang B, Zhang L, Dang T, Rowley D, Ittmann M, Xin L. Jagged1 upregulation in prostate epithelial cells promotes formation of reactive stroma in the Pten null mouse model for prostate cancer. Oncogene 2017;36:618-27. [PMID: 27345403 DOI: 10.1038/onc.2016.232] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
564 Li L, Tang P, Li S, Qin X, Yang H, Wu C, Liu Y. Notch signaling pathway networks in cancer metastasis: a new target for cancer therapy. Med Oncol 2017;34. [DOI: 10.1007/s12032-017-1039-6] [Cited by in Crossref: 62] [Cited by in F6Publishing: 73] [Article Influence: 12.4] [Reference Citation Analysis]
565 Mullighan CG. Mutations of NOTCH1, FBXW7, and prognosis in T-lineage acute lymphoblastic leukemia. Haematologica 2009;94:1338-40. [PMID: 19794079 DOI: 10.3324/haematol.2009.012047] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
566 Gal H, Amariglio N, Trakhtenbrot L, Jacob-Hirsh J, Margalit O, Avigdor A, Nagler A, Tavor S, Ein-Dor L, Lapidot T. Gene expression profiles of AML derived stem cells; similarity to hematopoietic stem cells. Leukemia. 2006;20:2147-2154. [PMID: 17039238 DOI: 10.1038/sj.leu.2404401] [Cited by in Crossref: 105] [Cited by in F6Publishing: 103] [Article Influence: 6.6] [Reference Citation Analysis]
567 Grazioli P, Orlando A, Giordano N, Noce C, Peruzzi G, Scafetta G, Screpanti I, Campese AF. NF-κB1 Regulates Immune Environment and Outcome of Notch-Dependent T-Cell Acute Lymphoblastic Leukemia. Front Immunol 2020;11:541. [PMID: 32346377 DOI: 10.3389/fimmu.2020.00541] [Reference Citation Analysis]
568 Regan J, Long F. Notch signaling and bone remodeling. Curr Osteoporos Rep 2013;11:126-9. [PMID: 23519781 DOI: 10.1007/s11914-013-0145-4] [Cited by in Crossref: 48] [Cited by in F6Publishing: 42] [Article Influence: 6.0] [Reference Citation Analysis]
569 Jen KY, Song IY, Banta KL, Wu D, Mao JH, Balmain A. Sequential mutations in Notch1, Fbxw7, and Tp53 in radiation-induced mouse thymic lymphomas. Blood 2012;119:805-9. [PMID: 22117044 DOI: 10.1182/blood-2011-01-327619] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
570 Bae Y, Yang T, Zeng HC, Campeau PM, Chen Y, Bertin T, Dawson BC, Munivez E, Tao J, Lee BH. miRNA-34c regulates Notch signaling during bone development. Hum Mol Genet 2012;21:2991-3000. [PMID: 22498974 DOI: 10.1093/hmg/dds129] [Cited by in Crossref: 162] [Cited by in F6Publishing: 151] [Article Influence: 16.2] [Reference Citation Analysis]
571 Brandstadter JD, Maillard I. Notch signalling in T cell homeostasis and differentiation. Open Biol 2019;9:190187. [PMID: 31690218 DOI: 10.1098/rsob.190187] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
572 Packham G. The role of NF-kappaB in lymphoid malignancies. Br J Haematol 2008;143:3-15. [PMID: 18573107 DOI: 10.1111/j.1365-2141.2008.07284.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 2.8] [Reference Citation Analysis]
573 Liu X, Karnell JL, Yin B, Zhang R, Zhang J, Li P, Choi Y, Maltzman JS, Pear WS, Bassing CH, Turka LA. Distinct roles for PTEN in prevention of T cell lymphoma and autoimmunity in mice. J Clin Invest 2010;120:2497-507. [PMID: 20516645 DOI: 10.1172/JCI42382] [Cited by in Crossref: 54] [Cited by in F6Publishing: 46] [Article Influence: 4.5] [Reference Citation Analysis]
574 Wendorff AA, Ferrando AA. Modeling NOTCH1 driven T-cell Acute Lymphoblastic Leukemia in Mice. Bio Protoc 2020;10:e3620. [PMID: 33659293 DOI: 10.21769/BioProtoc.3620] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
575 Hurlbut GD, Kankel MW, Lake RJ, Artavanis-Tsakonas S. Crossing paths with Notch in the hyper-network. Curr Opin Cell Biol 2007;19:166-75. [PMID: 17317139 DOI: 10.1016/j.ceb.2007.02.012] [Cited by in Crossref: 161] [Cited by in F6Publishing: 155] [Article Influence: 10.7] [Reference Citation Analysis]
576 Li K, Li Y, Wu W, Gordon WR, Chang DW, Lu M, Scoggin S, Fu T, Vien L, Histen G, Zheng J, Martin-Hollister R, Duensing T, Singh S, Blacklow SC, Yao Z, Aster JC, Zhou BB. Modulation of Notch signaling by antibodies specific for the extracellular negative regulatory region of NOTCH3. J Biol Chem 2008;283:8046-54. [PMID: 18182388 DOI: 10.1074/jbc.M800170200] [Cited by in Crossref: 147] [Cited by in F6Publishing: 92] [Article Influence: 10.5] [Reference Citation Analysis]
577 Batista A, Barata JT, Raderschall E, Sallan SE, Carlesso N, Nadler LM, Cardoso AA. Targeting of active mTOR inhibits primary leukemia T cells and synergizes with cytotoxic drugs and signaling inhibitors. Exp Hematol 2011;39:457-472.e3. [PMID: 21277936 DOI: 10.1016/j.exphem.2011.01.005] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 3.4] [Reference Citation Analysis]
578 Aste-Amézaga M, Zhang N, Lineberger JE, Arnold BA, Toner TJ, Gu M, Huang L, Vitelli S, Vo KT, Haytko P, Zhao JZ, Baleydier F, L'Heureux S, Wang H, Gordon WR, Thoryk E, Andrawes MB, Tiyanont K, Stegmaier K, Roti G, Ross KN, Franlin LL, Wang H, Wang F, Chastain M, Bett AJ, Audoly LP, Aster JC, Blacklow SC, Huber HE. Characterization of Notch1 antibodies that inhibit signaling of both normal and mutated Notch1 receptors. PLoS One 2010;5:e9094. [PMID: 20161710 DOI: 10.1371/journal.pone.0009094] [Cited by in Crossref: 127] [Cited by in F6Publishing: 114] [Article Influence: 10.6] [Reference Citation Analysis]
579 Xu H, Yu H, Jin R, Wu X, Chen H. Genetic and Epigenetic Targeting Therapy for Pediatric Acute Lymphoblastic Leukemia. Cells 2021;10:3349. [PMID: 34943855 DOI: 10.3390/cells10123349] [Reference Citation Analysis]
580 Wang HC, Peng V, Zhao Y, Sun XH. Enhanced Notch activation is advantageous but not essential for T cell lymphomagenesis in Id1 transgenic mice. PLoS One 2012;7:e32944. [PMID: 22393458 DOI: 10.1371/journal.pone.0032944] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
581 Otsubo K, Kanegane H, Eguchi M, Eguchi-Ishimae M, Tamura K, Nomura K, Abe A, Ishii E, Miyawaki T. ETV6-ARNT fusion in a patient with childhood T lymphoblastic leukemia. Cancer Genet Cytogenet 2010;202:22-6. [PMID: 20804916 DOI: 10.1016/j.cancergencyto.2010.07.121] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
582 Yugawa T, Nishino K, Ohno S, Nakahara T, Fujita M, Goshima N, Umezawa A, Kiyono T. Noncanonical NOTCH signaling limits self-renewal of human epithelial and induced pluripotent stem cells through ROCK activation. Mol Cell Biol 2013;33:4434-47. [PMID: 24019071 DOI: 10.1128/MCB.00577-13] [Cited by in Crossref: 34] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
583 van Grotel M, van den Heuvel-eibrink MM, van Wering ER, van Noesel MM, Kamps WA, Veerman AJ, Pieters R, Meijerink JP. CD34 expression is associated with poor survival in pediatric T-cell acute lymphoblastic leukemia. Pediatr Blood Cancer 2008;51:737-40. [DOI: 10.1002/pbc.21707] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
584 Gerby B, Hoang T. Modelling acute leukemias in mice: clonal evolution and the emergence of leukemic stem cells. BMC Proc 2013;7 Suppl 2:K1. [PMID: 24764466 DOI: 10.1186/1753-6561-7-S2-K1] [Reference Citation Analysis]
585 Tosello V, Ferrando AA. The NOTCH signaling pathway: role in the pathogenesis of T-cell acute lymphoblastic leukemia and implication for therapy. Ther Adv Hematol 2013;4:199-210. [PMID: 23730497 DOI: 10.1177/2040620712471368] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 5.4] [Reference Citation Analysis]
586 Miyamoto A, Lau R, Hein PW, Shipley JM, Weinmaster G. Microfibrillar Proteins MAGP-1 and MAGP-2 Induce Notch1 Extracellular Domain Dissociation and Receptor Activation. Journal of Biological Chemistry 2006;281:10089-97. [DOI: 10.1074/jbc.m600298200] [Cited by in Crossref: 91] [Cited by in F6Publishing: 52] [Article Influence: 5.7] [Reference Citation Analysis]
587 Farshbaf M, Lindberg MJ, Truong A, Bevens Z, Chambers E, Pournara A, Wallberg AE, White JB. Mastermind-Like 1 Is Ubiquitinated: Functional Consequences for Notch Signaling. PLoS One 2015;10:e0134013. [PMID: 26225565 DOI: 10.1371/journal.pone.0134013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
588 Luca VC, Jude KM, Pierce NW, Nachury MV, Fischer S, Garcia KC. Structural biology. Structural basis for Notch1 engagement of Delta-like 4. Science. 2015;347:847-853. [PMID: 25700513 DOI: 10.1126/science.1261093] [Cited by in Crossref: 153] [Cited by in F6Publishing: 139] [Article Influence: 21.9] [Reference Citation Analysis]
589 Bongiovanni D, Saccomani V, Piovan E. Aberrant Signaling Pathways in T-Cell Acute Lymphoblastic Leukemia. Int J Mol Sci 2017;18:E1904. [PMID: 28872614 DOI: 10.3390/ijms18091904] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 7.0] [Reference Citation Analysis]
590 Andersson ER, Lendahl U. Therapeutic modulation of Notch signalling--are we there yet? Nat Rev Drug Discov. 2014;13:357-378. [PMID: 24781550 DOI: 10.1038/nrd4252] [Cited by in Crossref: 304] [Cited by in F6Publishing: 273] [Article Influence: 38.0] [Reference Citation Analysis]
591 Trinquand A, Tanguy-Schmidt A, Ben Abdelali R, Lambert J, Beldjord K, Lengliné E, De Gunzburg N, Payet-Bornet D, Lhermitte L, Mossafa H, Lhéritier V, Bond J, Huguet F, Buzyn A, Leguay T, Cahn JY, Thomas X, Chalandon Y, Delannoy A, Bonmati C, Maury S, Nadel B, Macintyre E, Ifrah N, Dombret H, Asnafi V. Toward a NOTCH1/FBXW7/RAS/PTEN-based oncogenetic risk classification of adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study. J Clin Oncol 2013;31:4333-42. [PMID: 24166518 DOI: 10.1200/JCO.2012.48.5292] [Cited by in Crossref: 140] [Cited by in F6Publishing: 68] [Article Influence: 15.6] [Reference Citation Analysis]
592 Winter SS, Dunsmore KP, Devidas M, Wood BL, Esiashvili N, Chen Z, Eisenberg N, Briegel N, Hayashi RJ, Gastier-Foster JM, Carroll AJ, Heerema NA, Asselin BL, Gaynon PS, Borowitz MJ, Loh ML, Rabin KR, Raetz EA, Zweidler-Mckay PA, Winick NJ, Carroll WL, Hunger SP. Improved Survival for Children and Young Adults With T-Lineage Acute Lymphoblastic Leukemia: Results From the Children's Oncology Group AALL0434 Methotrexate Randomization. J Clin Oncol 2018;36:2926-34. [PMID: 30138085 DOI: 10.1200/JCO.2018.77.7250] [Cited by in Crossref: 73] [Cited by in F6Publishing: 36] [Article Influence: 18.3] [Reference Citation Analysis]
593 Natarajan V, Bandapalli OR, Rajkumar T, Sagar TG, Karunakaran N. NOTCH1 and FBXW7 mutations favor better outcome in pediatric South Indian T-cell acute lymphoblastic leukemia. J Pediatr Hematol Oncol 2015;37:e23-30. [PMID: 25493453 DOI: 10.1097/MPH.0000000000000290] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
594 Litzow MR. Therapy of Philadelphia chromosome-negative acute lymphoblastic leukemia in adults: new paradigms. Future Oncol 2009;5:1039-50. [PMID: 19792972 DOI: 10.2217/fon.09.74] [Reference Citation Analysis]
595 Luo YY, Wang ZH, Yu Q, Yuan LL, Peng HL, Xu YX. LncRNA-NEAT1 promotes proliferation of T-ALL cells via miR-146b-5p/NOTCH1 signaling pathway. Pathol Res Pract 2020;216:153212. [PMID: 33010698 DOI: 10.1016/j.prp.2020.153212] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
596 Lukenbill J, Advani AS. The treatment of adolescents and young adults with acute lymphoblastic leukemia. Curr Hematol Malig Rep 2013;8:91-7. [PMID: 23559026 DOI: 10.1007/s11899-013-0159-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
597 Khandanpour C, Phelan JD, Vassen L, Schütte J, Chen R, Horman SR, Gaudreau MC, Krongold J, Zhu J, Paul WE, Dührsen U, Göttgens B, Grimes HL, Möröy T. Growth factor independence 1 antagonizes a p53-induced DNA damage response pathway in lymphoblastic leukemia. Cancer Cell 2013;23:200-14. [PMID: 23410974 DOI: 10.1016/j.ccr.2013.01.011] [Cited by in Crossref: 52] [Cited by in F6Publishing: 52] [Article Influence: 5.8] [Reference Citation Analysis]
598 Cai Q, Medeiros LJ, Xu X, Young KH. MYC-driven aggressive B-cell lymphomas: biology, entity, differential diagnosis and clinical management. Oncotarget 2015;6:38591-616. [PMID: 26416427 DOI: 10.18632/oncotarget.5774] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 5.5] [Reference Citation Analysis]
599 Li C, Xie J, Lu Z, Chen C, Yin Y, Zhan R, Fang Y, Hu X, Zhang CC. ADCY7 supports development of acute myeloid leukemia. Biochem Biophys Res Commun 2015;465:47-52. [PMID: 26220344 DOI: 10.1016/j.bbrc.2015.07.123] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
600 Afkhami M, Ally F, Pullarkat V, Pillai RK. Genetics and Diagnostic Approach to Lymphoblastic Leukemia/Lymphoma. Cancer Treat Res 2021;181:17-43. [PMID: 34626353 DOI: 10.1007/978-3-030-78311-2_2] [Reference Citation Analysis]
601 Yu S, Zhou X, Steinke FC, Liu C, Chen SC, Zagorodna O, Jing X, Yokota Y, Meyerholz DK, Mullighan CG, Knudson CM, Zhao DM, Xue HH. The TCF-1 and LEF-1 transcription factors have cooperative and opposing roles in T cell development and malignancy. Immunity 2012;37:813-26. [PMID: 23103132 DOI: 10.1016/j.immuni.2012.08.009] [Cited by in Crossref: 117] [Cited by in F6Publishing: 111] [Article Influence: 11.7] [Reference Citation Analysis]
602 Lee JW, Kim YJ, Kang J, Shin TJ, Hyun HK, Kim YJ, Lee SH, Lee ZH, Kim JW. Dental implications in Hajdu-Cheney syndrome: A novel case report and review of the literature. Oral Dis 2018;24:1037-41. [PMID: 29566451 DOI: 10.1111/odi.12859] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
603 Locati LD, Cavalieri S, Bergamini C, Resteghini C, Alfieri S, Calareso G, Bossi P, Perrone F, Tamborini E, Quattrone P, Granata R, Galbiati D, Platini F, Orlandi E, Mariani L, Licitra L. Phase II trial with axitinib in recurrent and/or metastatic salivary gland cancers of the upper aerodigestive tract. Head & Neck 2019;41:3670-6. [DOI: 10.1002/hed.25891] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
604 Sahlgren C, Gustafsson MV, Jin S, Poellinger L, Lendahl U. Notch signaling mediates hypoxia-induced tumor cell migration and invasion. Proc Natl Acad Sci U S A. 2008;105:6392-6397. [PMID: 18427106 DOI: 10.1073/pnas.0802047105] [Cited by in Crossref: 530] [Cited by in F6Publishing: 502] [Article Influence: 37.9] [Reference Citation Analysis]
605 Yuan Y, Lu X, Chen X, Shao H, Huang S. Jagged1 contributes to the drug resistance of Jurkat cells in contact with human umbilical cord-derived mesenchymal stem cells. Oncol Lett 2013;6:1000-6. [PMID: 24137453 DOI: 10.3892/ol.2013.1523] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
606 Thurston G, Noguera-Troise I, Yancopoulos GD. The Delta paradox: DLL4 blockade leads to more tumour vessels but less tumour growth. Nat Rev Cancer. 2007;7:327-331. [PMID: 17457300 DOI: 10.1038/nrc2130] [Cited by in Crossref: 211] [Cited by in F6Publishing: 205] [Article Influence: 14.1] [Reference Citation Analysis]
607 Geissler K. Translational hematology. Wien Med Wochenschr 2014;164:487-96. [PMID: 25205187 DOI: 10.1007/s10354-014-0306-9] [Reference Citation Analysis]
608 Becker S, Vermeulin T, Cottereau AS, Boissel N, Vera P, Lepretre S. Predictive value of 18F-FDG PET/CT in adults with T-cell lymphoblastic lymphoma: post hoc analysis of results from the GRAALL-LYSA LLO3 trial. Eur J Nucl Med Mol Imaging 2017;44:2034-41. [PMID: 28733763 DOI: 10.1007/s00259-017-3776-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
609 Mensah AA, Rinaldi A, Ponzoni M, Canzonieri V, Uccella S, Rossi D, Bhagat G, Gaidano G, Zucca E, Bertoni F. Absence of NOTCH1 gene mutations in MALT lymphomas: Correspondence. Br J Haematol 2012;157:382-4. [DOI: 10.1111/j.1365-2141.2011.08980.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
610 McGirt LY, Jia P, Baerenwald DA, Duszynski RJ, Dahlman KB, Zic JA, Zwerner JP, Hucks D, Dave U, Zhao Z, Eischen CM. Whole-genome sequencing reveals oncogenic mutations in mycosis fungoides. Blood 2015;126:508-19. [PMID: 26082451 DOI: 10.1182/blood-2014-11-611194] [Cited by in Crossref: 125] [Cited by in F6Publishing: 104] [Article Influence: 17.9] [Reference Citation Analysis]
611 Nagel S, Pommerenke C, Meyer C, Kaufmann M, MacLeod RAF, Drexler HG. Identification of a tumor suppressor network in T-cell leukemia. Leuk Lymphoma 2017;58:2196–2207. [PMID: 28142295 DOI: 10.1080/10428194.2017.1283029] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
612 Xie J, Zhang C. Ex vivo expansion of hematopoietic stem cells. Sci China Life Sci 2015;58:839-53. [PMID: 26246379 DOI: 10.1007/s11427-015-4895-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
613 Asnafi V, Buzyn A, Le Noir S, Baleydier F, Simon A, Beldjord K, Reman O, Witz F, Fagot T, Tavernier E, Turlure P, Leguay T, Huguet F, Vernant JP, Daniel F, Béné MC, Ifrah N, Thomas X, Dombret H, Macintyre E. NOTCH1/FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): a Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) study. Blood 2009;113:3918-24. [PMID: 19109228 DOI: 10.1182/blood-2008-10-184069] [Cited by in Crossref: 144] [Cited by in F6Publishing: 136] [Article Influence: 10.3] [Reference Citation Analysis]
614 Mavrakis KJ, Van Der Meulen J, Wolfe AL, Liu X, Mets E, Taghon T, Khan AA, Setty M, Rondou P, Vandenberghe P. A cooperative microRNA-tumor suppressor gene network in acute T-cell lymphoblastic leukemia (T-ALL). Nat Genet. 2011;43:673-678. [PMID: 21642990 DOI: 10.1038/ng.858] [Cited by in Crossref: 179] [Cited by in F6Publishing: 189] [Article Influence: 16.3] [Reference Citation Analysis]
615 Sethi N, Kang Y. Notch signaling: mediator and therapeutic target of bone metastasis. Bonekey Rep 2012;1:3. [PMID: 23951415 DOI: 10.1038/bonekey.2012.2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
616 Rodig SJ, Payne EG, Degar BA, Rollins B, Feldman AL, Jaffe ES, Androkites A, Silverman LB, Longtine JA, Kutok JL, Fleming MD, Aster JC. Aggressive Langerhans cell histiocytosis following T-ALL: clonally related neoplasms with persistent expression of constitutively active NOTCH1. Am J Hematol 2008;83:116-21. [PMID: 17874453 DOI: 10.1002/ajh.21044] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 2.9] [Reference Citation Analysis]
617 Majewski J, Schwartzentruber JA, Caqueret A, Patry L, Marcadier J, Fryns JP, Boycott KM, Ste-Marie LG, McKiernan FE, Marik I, Van Esch H, Michaud JL, Samuels ME; FORGE Canada Consortium. Mutations in NOTCH2 in families with Hajdu-Cheney syndrome. Hum Mutat 2011;32:1114-7. [PMID: 21681853 DOI: 10.1002/humu.21546] [Cited by in Crossref: 73] [Cited by in F6Publishing: 63] [Article Influence: 6.6] [Reference Citation Analysis]
618 Sportoletti P, Baldoni S, Del Papa B, Aureli P, Dorillo E, Ruggeri L, Plebani S, Amico V, Di Tommaso A, Rosati E, Marconi P, Di Ianni M, Falzetti F. A revised NOTCH1 mutation frequency still impacts survival while the allele burden predicts early progression in chronic lymphocytic leukemia. Leukemia 2014;28:436-9. [PMID: 24177259 DOI: 10.1038/leu.2013.289] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
619 Trede NS, Heaton W, Ridges S, Sofla H, Cusick M, Bearss D, Jones D, Fujinami RS. Discovery of Biologically Active Oncologic and Immunologic Small Molecule Therapies using Zebrafish: Overview and Example of Modulation of T Cell Activation. Current Protocols in Pharmacology 2013;60. [DOI: 10.1002/0471141755.ph1424s60] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
620 Jena N, Sheng J, Hu JK, Li W, Zhou W, Lee G, Tsichlis N, Pathak A, Brown N, Deshpande A, Luo C, Hu GF, Hinds PW, Van Etten RA, Hu MG. CDK6-mediated repression of CD25 is required for induction and maintenance of Notch1-induced T-cell acute lymphoblastic leukemia. Leukemia 2016;30:1033-43. [PMID: 26707936 DOI: 10.1038/leu.2015.353] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
621 Blain J, Bédard J, Thompson M, Boisvert FM, Boucher MJ. C-terminal deletion of NOTCH1 intracellular domain (N1ICD) increases its stability but does not amplify and recapitulate N1ICD-dependent signalling. Sci Rep 2017;7:5034. [PMID: 28698562 DOI: 10.1038/s41598-017-05119-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
622 Grabher C, von Boehmer H, Look AT. Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia. Nat Rev Cancer 2006;6:347-59. [DOI: 10.1038/nrc1880] [Cited by in Crossref: 292] [Cited by in F6Publishing: 267] [Article Influence: 18.3] [Reference Citation Analysis]
623 Oki T, Kitaura J, Watanabe-Okochi N, Nishimura K, Maehara A, Uchida T, Komeno Y, Nakahara F, Harada Y, Sonoki T, Harada H, Kitamura T. Aberrant expression of RasGRP1 cooperates with gain-of-function NOTCH1 mutations in T-cell leukemogenesis. Leukemia 2012;26:1038-45. [PMID: 22116551 DOI: 10.1038/leu.2011.328] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
624 Hayashi I, Takatori S, Urano Y, Miyake Y, Takagi J, Sakata-Yanagimoto M, Iwanari H, Osawa S, Morohashi Y, Li T, Wong PC, Chiba S, Kodama T, Hamakubo T, Tomita T, Iwatsubo T. Neutralization of the γ-secretase activity by monoclonal antibody against extracellular domain of nicastrin. Oncogene 2012;31:787-98. [PMID: 21725355 DOI: 10.1038/onc.2011.265] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 4.5] [Reference Citation Analysis]
625 Howe SJ, Mansour MR, Schwarzwaelder K, Bartholomae C, Hubank M, Kempski H, Brugman MH, Pike-Overzet K, Chatters SJ, de Ridder D. Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients. J Clin Invest. 2008;118:3143-3150. [PMID: 18688286 DOI: 10.1172/jci35798ds1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
626 Nemir M, Pedrazzini T. Functional role of Notch signaling in the developing and postnatal heart. J Mol Cell Cardiol. 2008;45:495-504. [PMID: 18410944 DOI: 10.1016/j.yjmcc.2008.02.273] [Cited by in Crossref: 53] [Cited by in F6Publishing: 56] [Article Influence: 3.8] [Reference Citation Analysis]
627 Kim Y, Koo B, Jeong H, Yoon M, Song R, Shin J, Jeong D, Kim S, Kong Y. Defective Notch activation in microenvironment leads to myeloproliferative disease. Blood 2008;112:4628-38. [DOI: 10.1182/blood-2008-03-148999] [Cited by in Crossref: 113] [Cited by in F6Publishing: 108] [Article Influence: 8.1] [Reference Citation Analysis]
628 Cullion K, Draheim KM, Hermance N, Tammam J, Sharma VM, Ware C, Nikov G, Krishnamoorthy V, Majumder PK, Kelliher MA. Targeting the Notch1 and mTOR pathways in a mouse T-ALL model. Blood 2009;113:6172-81. [PMID: 19246562 DOI: 10.1182/blood-2008-02-136762] [Cited by in Crossref: 110] [Cited by in F6Publishing: 103] [Article Influence: 8.5] [Reference Citation Analysis]
629 Yamashita AS, Geraldo MV, Fuziwara CS, Kulcsar MA, Friguglietti CU, da Costa RB, Baia GS, Kimura ET. Notch pathway is activated by MAPK signaling and influences papillary thyroid cancer proliferation. Transl Oncol 2013;6:197-205. [PMID: 23544172 DOI: 10.1593/tlo.12442] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 5.6] [Reference Citation Analysis]
630 Kim JH, Penson AV, Taylor BS, Petrini JHJ. Nbn-Mre11 interaction is required for tumor suppression and genomic integrity. Proc Natl Acad Sci U S A 2019;116:15178-83. [PMID: 31285322 DOI: 10.1073/pnas.1905305116] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
631 van der Sligte NE, Kampen KR, ter Elst A, Scherpen FJ, Meeuwsen-de Boer TG, Guryev V, van Leeuwen FN, Kornblau SM, de Bont ES. Essential role for cyclic-AMP responsive element binding protein 1 (CREB) in the survival of acute lymphoblastic leukemia. Oncotarget 2015;6:14970-81. [PMID: 26008971 DOI: 10.18632/oncotarget.3911] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
632 Lin YW, Deveney R, Barbara M, Iscove NN, Nimer SD, Slape C, Aplan PD. OLIG2 (BHLHB1), a bHLH transcription factor, contributes to leukemogenesis in concert with LMO1. Cancer Res 2005;65:7151-8. [PMID: 16103065 DOI: 10.1158/0008-5472.CAN-05-1400] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
633 Baldus CD, Thibaut J, Goekbuget N, Stroux A, Schlee C, Mossner M, Burmeister T, Schwartz S, Bloomfield CD, Hoelzer D, Thiel E, Hofmann WK. Prognostic implications of NOTCH1 and FBXW7 mutations in adult acute T-lymphoblastic leukemia. Haematologica 2009;94:1383-90. [PMID: 19794083 DOI: 10.3324/haematol.2008.005272] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 4.4] [Reference Citation Analysis]
634 Minuzzo S, Agnusdei V, Pusceddu I, Pinazza M, Moserle L, Masiero M, Rossi E, Crescenzi M, Hoey T, Ponzoni M, Amadori A, Indraccolo S. DLL4 regulates NOTCH signaling and growth of T acute lymphoblastic leukemia cells in NOD/SCID mice. Carcinogenesis 2015;36:115-21. [PMID: 25355291 DOI: 10.1093/carcin/bgu223] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
635 Lee SH, Jeong EG, Yoo NJ, Lee SH. Mutational analysis of NOTCH1, 2, 3 and 4 genes in common solid cancers and acute leukemias. APMIS. 2007;115:1357-1363. [PMID: 18184405 DOI: 10.1111/j.1600-0463.2007.00751.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 2.7] [Reference Citation Analysis]
636 Lones MA, Heerema NA, Le Beau MM, Sposto R, Perkins SL, Kadin ME, Kjeldsberg CR, Meadows A, Siegel S, Buckley J, Abromowitch M, Kersey J, Bergeron S, Cairo MS, Sanger WG. Chromosome abnormalities in advanced stage lymphoblastic lymphoma of children and adolescents: a report from CCG-E08. Cancer Genet Cytogenet 2007;172:1-11. [PMID: 17175373 DOI: 10.1016/j.cancergencyto.2006.07.011] [Cited by in Crossref: 46] [Cited by in F6Publishing: 37] [Article Influence: 3.1] [Reference Citation Analysis]
637 Fukushima H, Shimizu K, Watahiki A, Hoshikawa S, Kosho T, Oba D, Sakano S, Arakaki M, Yamada A, Nagashima K, Okabe K, Fukumoto S, Jimi E, Bigas A, Nakayama KI, Nakayama K, Aoki Y, Wei W, Inuzuka H. NOTCH2 Hajdu-Cheney Mutations Escape SCFFBW7-Dependent Proteolysis to Promote Osteoporosis. Mol Cell 2017;68:645-658.e5. [PMID: 29149593 DOI: 10.1016/j.molcel.2017.10.018] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 4.2] [Reference Citation Analysis]
638 Dikic I, Schmidt MHH. Notch: Implications of endogenous inhibitors for therapy. Bioessays 2010;32:481-7. [PMID: 20486134 DOI: 10.1002/bies.200900140] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
639 Langenau DM, Feng H, Berghmans S, Kanki JP, Kutok JL, Look AT. Cre/lox-regulated transgenic zebrafish model with conditional myc-induced T cell acute lymphoblastic leukemia. Proc Natl Acad Sci U S A 2005;102:6068-73. [PMID: 15827121 DOI: 10.1073/pnas.0408708102] [Cited by in Crossref: 196] [Cited by in F6Publishing: 173] [Article Influence: 11.5] [Reference Citation Analysis]
640 Urech-varenne C, Radtke F, Heinis C. Phage Selection of Bicyclic Peptide Ligands of the Notch1 Receptor. ChemMedChem 2015;10:1754-61. [DOI: 10.1002/cmdc.201500261] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
641 Wang F, Qi Z, Yao Y, Yu G, Feng T, Zhao T, Xue HH, Zhao Y, Jiang P, Bao L, Yu S. Exploring the stage-specific roles of Tcf-1 in T cell development and malignancy at single-cell resolution. Cell Mol Immunol 2021;18:644-59. [PMID: 32868912 DOI: 10.1038/s41423-020-00527-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
642 South AP, Cho RJ, Aster JC. The double-edged sword of Notch signaling in cancer. Semin Cell Dev Biol. 2012;23:458-464. [PMID: 22309843 DOI: 10.1016/j.semcdb.2012.01.017] [Cited by in Crossref: 109] [Cited by in F6Publishing: 102] [Article Influence: 10.9] [Reference Citation Analysis]
643 Liu S, Mitra R, Zhao MM, Fan W, Eischen CM, Yin F, Zhao Z. The Potential Roles of Long Noncoding RNAs (lncRNA) in Glioblastoma Development. Mol Cancer Ther 2016;15:2977-86. [PMID: 27784795 DOI: 10.1158/1535-7163.MCT-16-0320] [Cited by in Crossref: 32] [Cited by in F6Publishing: 23] [Article Influence: 5.3] [Reference Citation Analysis]
644 Pi H, Huang YC, Chen IC, Lin CD, Yeh HF, Pai LM. Identification of 11-amino acid peptides that disrupt Notch-mediated processes in Drosophila. J Biomed Sci 2011;18:42. [PMID: 21682860 DOI: 10.1186/1423-0127-18-42] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
645 Jaekel R, Klein T. The Drosophila Notch Inhibitor and Tumor Suppressor Gene lethal (2) giant discs Encodes a Conserved Regulator of Endosomal Trafficking. Developmental Cell 2006;11:655-69. [DOI: 10.1016/j.devcel.2006.09.019] [Cited by in Crossref: 91] [Cited by in F6Publishing: 84] [Article Influence: 5.7] [Reference Citation Analysis]
646 Dreesen O, Brivanlou AH. Signaling pathways in cancer and embryonic stem cells. Stem Cell Rev. 2007;3:7-17. [PMID: 17873377 DOI: 10.1007/s12015-007-0004-8] [Cited by in Crossref: 242] [Cited by in F6Publishing: 218] [Article Influence: 16.1] [Reference Citation Analysis]
647 Isidor B, Lindenbaum P, Pichon O, Bézieau S, Dina C, Jacquemont S, Martin-Coignard D, Thauvin-Robinet C, Le Merrer M, Mandel JL, David A, Faivre L, Cormier-Daire V, Redon R, Le Caignec C. Truncating mutations in the last exon of NOTCH2 cause a rare skeletal disorder with osteoporosis. Nat Genet 2011;43:306-8. [PMID: 21378989 DOI: 10.1038/ng.778] [Cited by in Crossref: 143] [Cited by in F6Publishing: 120] [Article Influence: 13.0] [Reference Citation Analysis]
648 Hajdu M, Sebestyén A, Barna G, Reiniger L, Jánosi J, Sréter L, Várkonyi J, Demeter J, Kopper L. Activity of the notch-signalling pathway in circulating human chronic lymphocytic leukaemia cells. Scand J Immunol 2007;65:271-5. [PMID: 17309782 DOI: 10.1111/j.1365-3083.2006.01897.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
649 Hamidi H, Gustafason D, Pellegrini M, Gasson J. Identification of novel targets of CSL-dependent Notch signaling in hematopoiesis. PLoS One 2011;6:e20022. [PMID: 21637838 DOI: 10.1371/journal.pone.0020022] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 2.9] [Reference Citation Analysis]
650 Gallo Llorente L, Luther H, Schneppenheim R, Zimmermann M, Felice M, Horstmann MA. Identification of novel NOTCH1 mutations: increasing our knowledge of the NOTCH signaling pathway. Pediatr Blood Cancer 2014;61:788-96. [PMID: 24249312 DOI: 10.1002/pbc.24852] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
651 Minervini A, Coccaro N, Anelli L, Zagaria A, Specchia G, Albano F. HMGA Proteins in Hematological Malignancies. Cancers (Basel) 2020;12:E1456. [PMID: 32503270 DOI: 10.3390/cancers12061456] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
652 Hang BI, Thorne CA, Robbins DJ, Huppert SS, Lee LA, Lee E. Screening for small molecule inhibitors of embryonic pathways: sometimes you gotta crack a few eggs. Bioorg Med Chem 2012;20:1869-77. [PMID: 22261025 DOI: 10.1016/j.bmc.2011.12.044] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
653 Dumortier A, Wilson A, Macdonald HR, Radtke F. Paradigms of Notch Signaling in Mammals. International Journal of Hematology 2005;82:277-84. [DOI: 10.1532/ijh97.05099] [Cited by in Crossref: 22] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
654 Leong KG, Niessen K, Kulic I, Raouf A, Eaves C, Pollet I, Karsan A. Jagged1-mediated Notch activation induces epithelial-to-mesenchymal transition through Slug-induced repression of E-cadherin. J Exp Med 2007;204:2935-48. [PMID: 17984306 DOI: 10.1084/jem.20071082] [Cited by in Crossref: 321] [Cited by in F6Publishing: 303] [Article Influence: 21.4] [Reference Citation Analysis]
655 Hu Y, Su H, Liu C, Wang Z, Huang L, Wang Q, Liu S, Chen S, Zhou J, Li P, Chen Z, Liu H, Qing G. DEPTOR is a direct NOTCH1 target that promotes cell proliferation and survival in T-cell leukemia. Oncogene 2017;36:1038-47. [PMID: 27593934 DOI: 10.1038/onc.2016.275] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 4.5] [Reference Citation Analysis]
656 Dokmanovic L. Biomarkers in childhood non-Hodgkin's lymphomas. Biomark Med 2013;7:791-801. [PMID: 24044571 DOI: 10.2217/bmm.13.84] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
657 Ribeiro D, Melão A, Barata JT. IL-7R-mediated signaling in T-cell acute lymphoblastic leukemia. Advances in Biological Regulation 2013;53:211-22. [DOI: 10.1016/j.jbior.2012.10.005] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 5.4] [Reference Citation Analysis]
658 Franciosa G, Diluvio G, Gaudio FD, Giuli MV, Palermo R, Grazioli P, Campese AF, Talora C, Bellavia D, D'Amati G, Besharat ZM, Nicoletti C, Siebel CW, Choy L, Rustighi A, Sal GD, Screpanti I, Checquolo S. Prolyl-isomerase Pin1 controls Notch3 protein expression and regulates T-ALL progression. Oncogene 2016;35:4741-51. [PMID: 26876201 DOI: 10.1038/onc.2016.5] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 6.0] [Reference Citation Analysis]
659 Ma W, Gutierrez A, Goff DJ, Geron I, Sadarangani A, Jamieson CA, Court AC, Shih AY, Jiang Q, Wu CC, Li K, Smith KM, Crews LA, Gibson NW, Deichaite I, Morris SR, Wei P, Carson DA, Look AT, Jamieson CH. NOTCH1 signaling promotes human T-cell acute lymphoblastic leukemia initiating cell regeneration in supportive niches. PLoS One 2012;7:e39725. [PMID: 22768113 DOI: 10.1371/journal.pone.0039725] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
660 Herranz D, Ferrando AA. Targeting NOTCH1 in T-ALL: Starving the dragon. Cell Cycle 2016;15:483-4. [PMID: 26864725 DOI: 10.1080/15384101.2015.1128191] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
661 Egloff AM, Grandis JR. Molecular pathways: context-dependent approaches to Notch targeting as cancer therapy. Clin Cancer Res 2012;18:5188-95. [PMID: 22773520 DOI: 10.1158/1078-0432.CCR-11-2258] [Cited by in Crossref: 45] [Cited by in F6Publishing: 27] [Article Influence: 4.5] [Reference Citation Analysis]
662 Lampreia FP, Carmelo JG, Anjos-Afonso F. Notch Signaling in the Regulation of Hematopoietic Stem Cell. Curr Stem Cell Rep 2017;3:202-9. [PMID: 28845387 DOI: 10.1007/s40778-017-0090-8] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 6.6] [Reference Citation Analysis]
663 Schmidt E, Burkhardt B. Lymphoblastic Lymphoma in Childhood and Adolescence. Pediatric Hematology and Oncology 2013;30:484-508. [DOI: 10.3109/08880018.2013.789574] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
664 Alonso-Alonso R, Mondéjar R, Martínez N, García-Diaz N, Pérez C, Merino D, Rodríguez M, Esteve-Codina A, Fuste B, Gut M, Burrows F, Scholz C, Vaqué JP, Gualberto A, Piris MÁ. Identification of tipifarnib sensitivity biomarkers in T-cell acute lymphoblastic leukemia and T-cell lymphoma. Sci Rep 2020;10:6721. [PMID: 32317694 DOI: 10.1038/s41598-020-63434-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
665 Demarest RM, Dahmane N, Capobianco AJ. Notch is oncogenic dominant in T-cell acute lymphoblastic leukemia. Blood 2011;117:2901-9. [PMID: 21217079 DOI: 10.1182/blood-2010-05-286351] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.6] [Reference Citation Analysis]
666 Lefort K, Ostano P, Mello-Grand M, Calpini V, Scatolini M, Farsetti A, Dotto GP, Chiorino G. Dual tumor suppressing and promoting function of Notch1 signaling in human prostate cancer. Oncotarget 2016;7:48011-26. [PMID: 27384993 DOI: 10.18632/oncotarget.10333] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 3.5] [Reference Citation Analysis]
667 Zhou Y, Han C, Wang E, Lorch AH, Serafin V, Cho BK, Gutierrez Diaz BT, Calvo J, Fang C, Khodadadi-Jamayran A, Tabaglio T, Marier C, Kuchmiy A, Sun L, Yacu G, Filip SK, Jin Q, Takahashi YH, Amici DR, Rendleman EJ, Rawat R, Bresolin S, Paganin M, Zhang C, Li H, Kandela I, Politanska Y, Abdala-Valencia H, Mendillo ML, Zhu P, Palhais B, Van Vlierberghe P, Taghon T, Aifantis I, Goo YA, Guccione E, Heguy A, Tsirigos A, Wee KB, Mishra RK, Pflumio F, Accordi B, Basso G, Ntziachristos P. Posttranslational Regulation of the Exon Skipping Machinery Controls Aberrant Splicing in Leukemia. Cancer Discov 2020;10:1388-409. [PMID: 32444465 DOI: 10.1158/2159-8290.CD-19-1436] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
668 D'amato G, Luxán G, de la Pompa JL. Notch signalling in ventricular chamber development and cardiomyopathy. FEBS J 2016;283:4223-37. [DOI: 10.1111/febs.13773] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 5.5] [Reference Citation Analysis]
669 Morrow K, Hernandez CP, Raber P, Del Valle L, Wilk AM, Majumdar S, Wyczechowska D, Reiss K, Rodriguez PC. Anti-leukemic mechanisms of pegylated arginase I in acute lymphoblastic T-cell leukemia. Leukemia 2013;27:569-77. [PMID: 22926702 DOI: 10.1038/leu.2012.247] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 3.8] [Reference Citation Analysis]
670 Ranganathan P, Weaver KL, Capobianco AJ. Notch signalling in solid tumours: a little bit of everything but not all the time. Nat Rev Cancer 2011;11:338-51. [DOI: 10.1038/nrc3035] [Reference Citation Analysis]
671 Macy ME, Sawczyn KK, Garrington TP, Graham DK, Gore L. Pediatric developmental therapies: interesting new drugs now in early-stage clinical trials. Curr Oncol Rep 2008;10:477-90. [PMID: 18928662 DOI: 10.1007/s11912-008-0073-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
672 Gautam